health humanity report scientist jan show work johnson johnsons molecule library store million unique compound scientist access library order compound activity johnson johnson photo frederik beyen health humanity report approach diverse surgeon initiative participant ryan randle michelle salazar mhsc participate laparoscopic surgery handson labgri health year achievement evolution johnson johnson lead accountability innovation ground humanity report meet important global target include belief science technology advance healthcare decade century invest nearly billion championing global health equity please rank integrate digital capability work access medicine index evaluate world large pharmaceutical company effort use datum science drug distribute medicine low middleincome country message chairman ceo discovery advance treatment exceed health humanity goal support multiple myeloma second common million frontline health worker tool training initiative include johnson johnson center health worker blood cancer provide transformational care innovation commit million year cancer patient message africa frontline catalytic fund expand professional workforce community health worker african country datum science apply ecosystem medical chairman ceo devices software robotic solution help healthcare empower employee continue focus accelerate provider care patient great precision efficiency diversity equity inclusion outcome help meet follow acquisition abiome inc world leader change need community serve proud heart recovery solution integrate technology achieve health humanity goal reach percent expand leadership cardiovascular care racial ethnic diversity management role global community track achieve gender parity woman management position technology help supply chain leap forward world upskill employee launch learn productivity efficiency sustainability fact recognize world opportunity innovation johnson johnson dynamic development ecosystem ensure easy access learn world economic forum grant new committed improve health people growth opportunity enhance mental health resource lighthouse designation manufacture facility employee family guide credo set value reflect accomplishment eye inspire employee different exciting future track advance global company kenvuea new consumer health need wellbee people companyand johnson johnsondedicate pharmaceutical serve year motivated medtechthat uniquely position fastmove solve complex health challenge healthcare landscape spirit innovation report discover insight johnson johnson create longterm sustainable value improve health humanity purpose share responsibility honor chairman ceo continue year come committed lead seize legacy opportunity humanity follow credo value solid financial performance drive industry joaquin duato johnson johnson colleague attend american society thank interest hematology annual meeting new orleans louisiana leading portfolio scientific technological innovation advance environmental health secure deal reshape aspect healthcare environmental social source percent renewable electricity operation governance esg strategy underpin business performance brazil join collaboration pharmaceutical company health humanity goal key performance support ingredient supplier effort decarbonize addition indicator progress framework guide decision expand pharmaceutical safe return program joaquin duato direct positive contribution society economy switzerland plan add country year chairman board chief executive officer sustainable development remind europe expand singleuse device hospital recycle world program country health independent directorsprovide robust leadership oversight operation risk officer executive committee member humanity report board oversight time responsibility oversee board type oversight new stand committee evolve meet fiduciary responsibility board view compliance business obligation change need company example opportunity closely linkednot tensionwhen come board form special committee oversee strategy ethical compliant conduct basis separation consumer health business special successful business enabler opportunity committee remain active addressing esg matter strategic holistic way board johnson johnson realize connection long lead director johnson johnson embed esg ago significantly integrate esg matter business operation board agenda example join board committee johnson johnson longstanding commitment create chair oversee risk sustainability topic engage lead director longterm value stakeholder mitigate risk company recent esg priority topic assessment result explore develop new business opportunity inform company report disclosure responsibility outline company credo set play significant role johnson johnsons set business principle guide company year public goal board understand ofand perspective onenvironmental board decide realign committee responsibility anne mulcahy lead director social governance matter relevance value enhance expand scope regulatory creation evolve significantly past year johnson johnson board directors compliance sustainability committee action well take opportunity engage business position board oversee certain esg matter alongside play pivotal role ensure board help guide esg consideration decision make compliance matter aspect company activity example support deeply engaged esg strategy formalization johnson johnsons esg strategy progress anne share insight monitor progress esg strategyaligne health believe great opportunity johnson johnson create longterm value stakeholder response question reflect current humanity goal play integration global health equitya core esg key focus areain different business financial result important measure interest key stakeholder process example janssen companys pharmaceutical performance johnson johnson continue sustainable business actively address health inequity improve diverse longterm growth operating focus future change johnson johnsons business recruitment clinical trial support generation refuse compromise credo value core environment affect nature board underrepresente diverse physician advance environmental responsibility board capitalize company position oversight responsibilitie health esg priority medtech advance strength leader healthcare guiding johnson johnson circularity partner hospital europe recycle metal address press concern today prepare meet board helm dynamic organization plastic component singleuse surgical instrument challenge tomorrow investment data science constantly evaluate change world affect program currently active country excite digital innovation central advance company company business board respond project like underway esg strategy investment reflect strategy current emerge challenge opportunitie johnson johnsons business segment enterprise particularly true company navigate social take opportunity engage function emerge field drive value creation unrest conflict part world supply chain issue company increase inflation interest rate extreme weather event business help guide esg consideration prepare successful separation decision make aspect excited future johnson johnson especially consumer health business segment focus innovation enable company company activity pursue purpose performance equal commitment johnson johnson long thrive change environment transformational innovation science technology company year increase regulation expect esg matter fundamental company strong financial performance independent lead director johnson johnson board country world role board powerful financial performance enable johnson director work closely chairman board chief compliance opportunity johnson sustain exceed investment lifesave executive officer focus company trajectory highly regulate business johnson johnson rely lifeenhance innovation benefit million patient longterm growth current board structurean independent robust compliance organization lead chief technical consumer year lead director stand committee comprise entirely year brief health humanity report champion global health equity empower employee advance environmental health million year brief patient treat janssen medicine ethnicracial diversity management position renewable electricity achieve health humanity goal secure operation brazil start direct power purchase agreement cumulative dose sirturo bedaquiline treatment multidrugresistant tuberculosis ship employee respond credo survey cdp list favorability rate participantsa testament leadership climate action valuesdriven culture fifth year row rank access medicine index reflect strategy enable access medicine technology people low learn new multiyear middleincome country collaborative initiative launch dynamic learning development million dicedigital health circular economy ecosystem empower launch janssen cofunding nurse midwive community health worker employee continuous horizon europe program address digital support skill tool growth opportunity reskille health waste johnson johnson center health worker upskille development innovation exceed health humanity goal lead accountability billion responsibility innovation standard supplier invest research employee complete health care development compliance training highest update expand expectation supplier business completion number date diversity equity inclusion information security environmental responsibility fund johnson johnson foundation registered charity company limited guarantee corporation operate company johnson johnson family company foundation operate worldwide johnson johnson foundation united states found johnson johnson foundation scotland found health recognition esg rating humanity report improve maintain esg rater score note rank rank allstar pharmaceutical industry rank access medicine index fortune world list fortune world previous current feature index topthree performer score score admire company list admired company list sixth consecutive year consecutive year ninth year row year brief recognize cdp list rate previous current leadership climate action fifth score score consecutive year innovative rank climate company drucker institute medtech select bestmanaged company previous current achieve cdps rating water risk fast company score score innovative company water score percentile previous current pharmaceutical manufacturing sector score score fifth consecutive year year row ecovadis sustainability assessment trendsetter status include seramount name cpazicklin index inclusion index member include ftsegood index series corporate political disclosure diversity good practice previous current year score percentile score score accountability sector previous current receive iss esg good rating score score good employer consecutive year diversity member forbe billion dollar roundtable rank pharmaceutical supplier diversity moodys analytic previous current biotechnology sector north america score score moodys analytic esg scorecard rank sixth consecutive year eous bbb scu orr ent achieve msci esg rating gartner incs annual ranking name cdp company supply chain supply chain leaderboard previous current receive sustainalytic medium risk rating score score current iss esg score august update use johnson johnson msci esg research llc affiliates msci data use msci logos trademark service mark index name constitute sponsorship endorsement recommendation promotion johnson johnson msci msci services data property msci information provider provide asis warranty msci name logo trademark service mark msciabout johnson johnson gri health humanity report purpose business blend heart science johnson johnson family company company large ingenuity profoundly change diversified healthcare product company headquarter new jersey operate trajectory health humanity company employ approximately employee virtually country world engage research development manufacture sale broad range product johnson johnson healthcare field work supplier hundred external value manufacturer support development manufacturing product worldwide drive credo set company product portfolio include thousand pharmaceutical medtech consumer value principle health product address health wellness need people day challenge inspire need wellbee people serve financial result million sale business segment millions johnson johnson publicly own corporation stock trade pharmaceutical medtech consumer health new york stock exchange nysejnj market price consecutive cardiovascular interventional solution baby care tment share year dividend metabolism retina orthopaedic oral care yearend close increase immunology surgery general advanced overthecounter medicine infectious disease vision skin healthbeauty vaccine net womens health earning neuroscience wind care oncology pulmonary hypertension total sale november company announce intention separate company consumer health business new publicly trade company september kenvue announce plan new consumer health company kenvue million johnson johnson reporting period health humanity report kenvue complete initial public offering share common stock close initial public offering include dividend declare april company own approximately total outstanding share kenvue common stock company remain track complete separation subject market condition abiome headcount include total employee number yearend acquisition time human resource information system integration process esg governance gri health humanity report company dedication integrate esg business strategy start high level leadership board overall accountability esg risk management oversight effective esg governance require management engagement board priority topic matrix level oversight board esg risk management approach design effectively govern manage esg risk opportunity integral company core business strategy significant esg risk review evaluated board committee ongoing risk oversight esg governance company improve esg governance matter follow way announce evolve esg strategy focus championing global health equity empower employee advance environmental health lead accountability innovation foundational effort enterprise governance council company primary governance body esg matter update esg knowledge module available employee help understand esg management approach include esg strategy hold fifth investor relation esg webcast june update shareholder esg performance progress health humanity goal webcast include interview member johnson johnson board directors chief financial officer continue improve disclosure esg topic include enhance tax policy position disaster relief position employee development expand disclosure additional metric great transparency esg prioritie johnson johnson use materiality assessment priority topic assessment pta identify prioritize strategically address relevant esg topic significant impact society business conduct pta year pta conduct double materiality focus examine esg priority topic standpoint impact topic johnson johnsons business result impact johnson johnsons business people environment society general priority topic matrix present esg prioritie health esg strategy stakeholder engagement humanity report esg strategy ground credo value inform company purpose deep longstanding relationship cultivate stakeholder vital business change trajectory health humanity view external stakeholder set success esg strategy johnson johnson interact numerous stakeholder group esg strategy deliberate manner focus effort area position global national local level include membership participation broad range achieve great impact champion global health equity empower employee advocacy organization industry association advance environmental health lead accountability innovation foundational target engagement activity include effort esg approach design effectively govern manage risk include esg risk enable identify opportunity accurately reflect business strategy promote health legislation maternal mortality rate continue exceed rate sustain focused approach promote resiliency drive growth well position continue highincome country include increase medicaid vital invest future enhance longterm value business role play improve maternal health outcome nearly half birth finance medicaid esg governance strongly support state effort advance legislation extend medicaid postpartum coverage month new mother help address disproportionate maternal mortality outcome disadvantage communities johnson johnson join healthcare organization advocate lorna breen health care provider protection act federal legislation direct protect mental health countrys healthcare workforce facilitate reduction prevention suicide burnout mental behavioral health condition hcp act law march health worker burnout reach crisis point covid pandemic acute mental health need risk factor hcp bring sharp focus early day health worker experience severe work trauma burnout exhaustion tragic death suicide emergency room physician lorna breen april underscore urgent need provide well support service health worker july senator tim kaine dva introduce bill protect mental health healthcare workforce develop alongside lorna breen heroes foundation support johnson johnson bill eventually lorna breen healthcare provider protection act scroll esg focus area learn information help stakeholder understand manage risk relevant esg topic embed sustainability decision make critical component esg governance esg strategy esg resources hoyert maternal mortality rate united states cdc national health center statistic httpswwwcdcgovnchsdatahestatmaternalmortalitymaternalmortalityrateshtm health support healthcare policy make europe found strengthen healthcare industry asia johnson engage industry esg continue engage humanity report knowledge partner sponsor policy healthy europe johnson lead healthcare industry presence pharmaceutical industry ensure expertise coalition strengthen partnership development asia pacific economic cooperation apec leader week industry reflect esg metric relate disclosure numerous publication policy dialogue coalition bangkok thailand healthcare company speak relevant sector work area economy wellbee cover covid pandemic event apec critical highly influential forum drive biopharma sustainability roundtable bsrt network response health system resilience valuebase healthcare improvement healthcare policy innovation access support sustainability biotech pharmaceutical industry beat cancer policy digitalization health contribute large diverse region world leader week johnson johnson participate biopharma investor esg expertise emerge datum governance european health inperson apec gathering significant communication initiative support development datum space policy environmental health support opportunity global delegation engage head state decisionuseful communication sector important revision ambient air directive government leader apec country industry esg issue bsrt release biopharma investor esg academia shared johnson johnsons perspective key communication guidance result collaboration esg governance janssen lead industry voice shape healthcare challenge importance advance quality lead pharmaceutical company include johnson johnson pharmaceutical strategy championing patient access health datum health financing innovation supply chain investor group medicine strong right shone light resilience improve healthcare outcome change legislation diminish right critical element underpin medical innovation europe janssen participate global convening advance healthcare provide evidence datum help stakeholder appreciate system leader johnson johnson participate need strong protection develop new treatment key event meeting general leading pharmaceutical company address unmet medical need advocate agile assembly engagement emphasize importance seek respond positively investor information regulatory framework allow fast adoption innovative advance equitable access care invest health worker need stakeholder new medicine support use realworld evidence innovation eradicate pandemic epidemic disease value opportunity collaborate peer digital health technology datum sharing activity pandemic response company define disclosure guidance specific include direct dialogue european policymaker sector believe help elevate global health leader stakeholder gather stakeholder yearlong medium engagement add esg awareness set benchmark investor geneva switzerland annual world health assembly voice public debate expectation industry wha representation country delegation wha provide important opportunity partner sector engage build strengthen relationship accelerate action press health challenge face world global monica neufang healthcare leader johnson johnson active convenor vice president enterprise esg program office asset start work actually contributor event wha provide critical johnson johnson member biopharma investor make finish line allow generate esg communication initiative working group private sector lens bring great awareness unique return value bring patient labtolastmile approach advance equitable access care society therapy available engage stakeholder report internal stakeholder engagement cover key issue include vaccination return actually reinvest develop new johnson johnsons global team provide input eradicate disease ebola fight infectious disease like advanced lifesave breakthrough therapy report chairman board ceo disclosure support frontline health worker wha committee disclosure subcommittee review johnson johnson announce new global surgery initiative report outline metric disclosure committee reviewed join discussion importance invest sustainable report entire executive committee review dirk smaele surgical system advance equitable access care approve health humanity report share global head vice president regulatory compliance sustainability committee therapeutic development supply janssen board director board prior publication learn importance pharmaceutical innovation disclosure subcommittee comprise corporate secretary leader controller office treasury investor relation department disclosure committee comprise chief financial officer general counsel corporate secretary head litigation plus leader controller office investor relation global audit assurance departmentshealth humanity goal health humanity report ambitious set health humanity goal align esg focus area foundation goal key performance indicator target status accountability innovation hold publicly accountable create sustainable society measure track performance goal progress assure employee party health humanity goal support sdgs woman woman management position management scorecard ataglance ethnicracial ethnicracial diversity management position exceed exceed target progress progress slowly expect diversity achieve meet target plan place meet target management track expect meet target track progressing expectedcurrently risk meeting target blackafrican black african american employee american growth management position goal key performance indicator target status management health humanity goal global health equity healthiest johnson johnson leader manager leader identify assets johnson johnson global workforce score achieve annual healthy workforce score global access public health janssen infectious disease vaccine manager plan pipeline global access plan place girl participate virtual inperson woman access hiv activity lead employee partnership lai access program place rls country stemd treatment country nonprofit partner access cumulative patient receive access bedaquiline environmental health tuberculosis molecule brand generic globally treatment end renewable renewable electricity globally electricity stringent regulatory authority approval new drug new develop regimen reduce treatment length drug carbon absolute reduction greenhouse gas treatment effective safe current recommend treatment regimen neutrality ghg emission scope carbon operation credit baseline access complete clinical study demonstrate health complete schizophrenia economic social value paliperidone palmitate clinical scope emission absolute reduction greenhouse gas ghg treatment lai treat schizophrenia rwanda study reduction emission scope upstream baseline support frontline nurse midwive community health worker accountability innovation health worker reach globally supplier tec tun aof odst cla dre gerie base surgery report ros gta mability supplier include tier sull plier pav deere maa ine tsl rsa aak eec lel rad tin oac ceu edm ema eer eon nniz yht plr inil cvo leb ura dli enp isi eth ndie upplier social billion licensure submission covid vaccine partnership vaccination adoption endorse platform country good supplier partnership monitor country platform health humanity goal scorecard result healthcare bestpractice healthcare woman insight woman publish report gri health humanity report johnson johnsons health humanity report detail esg progress performance review conjunction disclosure esg policy position datum annual report cover period january norge bank investment management basel institute employee retention turnover december indicate governance measure effectiveness anticorruption employee engagement credo survey result select metric publish june reporting matter specific programme report framework add disclosure financial performance company subsidiary set indicator employee safety find annual report global compact ungc annual communication ethic compliance inquiry complaint record credo integrity line category progress report cover johnson johnsons worldwide operation business segment pharmaceutical medtech ethic compliance compliancerelate allegation materiality approach content report guide report investigate triage committee consumer health select metric report segment pta help identify prioritize esg topic level datum contract manufacturer exclude scope matter stakeholder company product quality indicator report note reference report priority topic assessment detail late update tax contribution johnson johnson company refer priority topic johnson johnson consolidated subsidiary global audit assurance organization review select state indicate context monetary reference independent review assurance erm certification datum accuracy completeness validity financial datum dollar refer dollar usd verification service erm cvs conduct independent review general information business report assurance follow information datum report previously audit disclosure annual report report cover activity johnson johnson foundation registered charity company limit progress health humanity goal acquisition ehs datum recently acquire company guarantee foundation separate legal entity associate datum present health humanity goal employee road safety datum site iso ohsa johnson johnson family company fund solely scorecard erm cvss health humanity goal certification datum include report year johnson johnson family company foundation assurance acquisition note approach allow operate worldwide johnson johnson foundation united select global ghg emission inventory percentage new acquisition adjust eh management reporting system johnson johnson standards states found johnson johnson foundation scotland electricity use generate renewable energy source nox found detail foundation activity find sox emission combustion source select water road safety datum integrate year acquisition johnson johnson foundation united states annual management datum ghg air emission electricity available year acquisition late report johnson johnson foundation scotland water datum assurance scope ghg emission iso ohsa certification datum integrate year director report report wbcsdwri ghg protocol corporate acquisition accounting reporting standard update report prepare accordance global january abiome acquire late december reflect report initiative gri standard esg disclosure index pricewaterhousecooper llp pwc perform limited assurance financial datum include health humanity report gri content index disclose performance certain datum follow category pwcs report time acquisition nature human additional esg standard framework esg disclosure resource information system abiome datum include independent accountant management assertion index include health humanity report johnson johnson sustainability accounting standard board sasb give annual report information abiome relevant standard hcbp hcms cghp diversity equity inclusion select metric date detail recent acquisition find task force climaterelate financial disclosure environmental health safety ehs compliance note acquisition divestiture tcfd building response cdp climate certification annual report change questionnaire johnson johnsons consumer health segment kenvue operate johnson johnson materiality report pta process different definition context filing securities exchange commission health divestiture injury statistic violation cautionary note forwardlooke statement separation new consumer health company humanity report fine ehs datum divest company exclude report contain forwardlooke statement define ability succeed standalone publicly trade company report year private security litigation reform act risk relate ongoing impact covid global thing future operate financial performance pandemic include continue supply chain disruption november company announce intention product development market position business strategy impact business list description separate company consumer health business new anticipate separation company consumer health risk uncertainty factor find johnson publicly trade company september kenvue business reader caution rely forward johnson annual report fiscal year end announce plan new consumer health look statement statement base current january include section caption cautionary company kenvue johnson johnson expectation future event underlying assumption prove note forwardlooke statement item reporting period health humanity report inaccurate know unknown risk uncertainty materialize risk factor johnson johnsons subsequent quarterly kenvue complete initial public offering share actual result vary materially expectation report form filing security common stock close initial projection johnson johnson risk uncertainty include exchange commission copy filing available online public offer company own approximately limit economic factor interest rate wwwsecgov wwwjnjcom request johnson total outstanding share kenvue common stock company currency exchange rate fluctuation competition include johnson forwardlooke statement report report remain track complete separation subject technological advance new product patent attain speak date report johnson johnson market condition competitor challenge inherent new product research undertake update forwardlooke statement result development include uncertainty clinical success new information future event development future report year start health obtain regulatory approval uncertainty commercial success humanity report kenvue datum include restate thirdparty trademark trademark new exist product challenge patent impact respective owner restatement use change threshold apply patent expiration ability company successfully significant change datum information restate execute strategic plan impact business combination note potential reason lead divestiture manufacture difficulty delay internally restatement prior period baseline data supply chain product efficacy safety concern significant change newly publish measure new acquisition result product recall regulatory action significant adverse divestiture datum error improvement datum collection litigation government action include related product liability methodology time depend circumstance claim change applicable law regulation include tax evaluate threshold appropriate disclosure law supply chain diligence regulation greenhouse gas include report datum disclose prior emission relate report global healthcare reform year note report relevant table trend healthcare cost containment change behavior report spend pattern purchaser healthcare product service financial instability international economy legal contact welcome query feedback system sovereign risk increase scrutiny healthcare report contact johnson johnson enterprise industry government agency company ability satisfy esg program office wwcorporategovernanceitsjnjcom necessary condition consummate separation company consumer health business timely basis visit report hub archive annual company ability successfully separate company health humanity report consumer health business realize anticipate benefit health humanity report global health equity healthcare worker bomu hospital kenya teach member maasai community obstetric fistula johnson johnson foundation continue support healthcare worker fistula foundation photo credit bomu hospitalaccess gri sasb hcbpa sasb hcbpa health humanity report johnson johnson continue build legacy year blend innovation scientific excellence care people tackle today tough health johnson johnsons current cumulative challenge help deliver improve health accomplishment recognize atmi include core mission commitment advance global seek enhance access innovative large course access health equity reality people need medicine vaccine medical technology priority pipeline medicine sirturo access affordable lifesaving lifeenhance treatment especially population resourcelimite setting share project address bedaquiline treat corner world need acute progress make medicine technology available disease hiv multidrugresistant covid pandemic severely disrupt essential health help combat specific disease hiv ebola certain dengue deliver large overall pipeline service shorten life expectancy exacerbate inequity ntds pandemic epidemic section report people scope atmi access basic health service project vaccinate ebola vaccine regiman billion people worldwide unable access essential taking lead access medicine access medicine healthcare service plan place digital public progress advance access innovate novel medicine good designation eligible latestage access medicine central global health equity strategy recognize access medicine foundation project project achieve vxnaid embed health humanity goal access medicine index atmi johnson total vaccination explicit commitment progress johnson rank second rise monitoring platform center global commitment describe report summarize initiative health discovery health humanity goal scorecard address health system support research strengthen address critical health million patient treat globally capacity building challenge include janssen medicine note meet good position company amr dengue practice standard worldwide atmi sixth consecutive year note patient treat represent estimate number people phase reflect decade commitment enhance initiative globally treat janssen medicine clinical study complete include patient reach vermox mebendazole access medicine strengthen healthcare evaluate dengue address supply chain donation program total exclude people vaccinate system testament colleague specific antiviral treatment manufacturing johnson johnson covid vaccine report partner world endeavor day prophylactic use capacity building enable million people low noted meeting good separately estimate number patient treat middleincome country benefit innovative billion dose practice standard convert quantity janssen medicines course therapy medicine technology medicine vermox total patient day therapy year convert mebendazole treat million number people base average utilization patient child infect invest help intestinal worm donate establish billion patient take multiple janssen product count jennifer taubert amr action fund multiple patient total methodology vary product executive vice president worldwide chairman type give nature product available datum pharmaceuticals johnson johnson estimate number patient treat revise time gain new information patient usage experience restatement underlie data source change product portfolio united nations department economic social affair sustainable development goal ensure healthy life promote wellbee age httpssdgsunorggoalsgoal access february big pharma access medicine foundation rdbased pharma company httpsaccesstomedicinefoundationorgsectorsandresearchbigpharma access february health make progress design apply janssen access relate pricing medicine investment healthevoice community reach vast digital humanity report pricing principle entire pharmaceutical portfolio patient support program notable detail include network advocate nearly health planning access early research phase work condition collective reach million patient billion pay rebate discount fee systematically asset development thoroughly caregiver healthcare professional understand disease characteristic patient burden disease average net price decline janssen medicines product characteristic access planning consider decline sixth year row health system characteristic access affordability apply advocate inclusive access variety approach include valuebased pricing equity signatory business social responsibility base tiere pricing access initiative tailor bsr guide principle access healthcare healthevoice diversity equity accessibility inclusion access disease product work stakeholder enable engage broadly industry improve access deai task force shape healthequityfocuse programming patient access medicine wide variety health system patient world collaborate patient advocate johnson johnson audiences characteristic country ability willingness pay member bsrs work group develop access support close follower social medium healthcare ladder healthevoice support deai task janssen global public health organization deploys force publish instagram live series transgender labtolastmile approach fight disease hiv access treatment mile johnson health advocacy allyship generate educational social ebola drive targeted innovation initiative overcome johnson commitment advance equitable access medium campaign awareness event barrier deliver access medicine strengthen health medicine fund innovative pilot study infectious year include juneteenth pride hispanic heritage month system support frontline health worker disease institute uganda assess impact medical issue public statement support aapi lgbtqia drone increase access improve community disease community follow violence management pilot study small unmanned aircraft participate discussion health equity johnson medicine prequalification world health deliver hiv treatment people kalangala islands johnson leader ongoing deai task force activity organization design ensure result pilot project researcher able quantify add vital momentum drive equitable change healthcare medicine supply procurement agency meet effectiveness medical drone hiv drug delivery help sustain trust patient community johnson acceptable standard quality safety efficacy inform future effort scale drone technology solve johnson team result strong patient voice broad mile delivery challenge uganda range healthcare intervention johnson johnson product receive prequalifie list status support patient advocacy community healthevoice leadership conference convene nearly lead online patient advocate day place life experience johnson johnson johnson johnson learning share debate topic impact diversity background find healthevoice product address product ebola culture health bridging change healthcare space great reminder chronic hiv intestinal vaccine regiman culturally inclusive marketing muchawaite event health issue come ethnic background worm inperson conference covid region country socioeconomic situation list prequalifie list prequalifie pandemic eighth annual healthevoice conference health condition come unique symptom medicinal product vaccine inception healthevoice design challenge treatment choose online patient advocate offer safe space deliver embrace diversity inevitably create authentic content press issue impact patient accept environment tackle difficult issue advance access equitable access strategy approximately johnson johnson leader attend important lmic higherincome country conference demonstrate keen commitment home vulnerable underresourced population understand patient need empower patient advocate focus access publish influence communicate patient howard chang seventh annual janssen transparency report sharing update improve patient experience psoriasis advocate healthevoice conference advisor medicinesfinishe pharmaceutical product httpsextranetwhointpqwebcontentprequalifiedlistsmedicines twodose ebola vaccine regimen comprise zabdeno adzebov bavarian nordics mvabea mvabnfilo figure accord janssen internal financial accountingadvance public health gri health humanity report decade johnson johnson remain steadfast commitment leadership public health health equity strategy reflect longheld belief create societal value go hand hand generate longterm business value champion health equity initiative maximize value reach business area advance public health great impact alongside increase access medicine ambition advance public health include believe strongly power strategic partnership excite collaborate collaboration address crosscut healthcare issue advance health equity enhance patient care advance global surgery capability provide great support nurse develop new solution enhance access quality mental healthcare deliver innovation well eye health sam hazen promote initiative eliminate health inequity chief executive officer hca healthcare people color support frontline health worker join private sector organization pledge funding support end critical disease help community need strengthen health system global fund seventh replenishment conference global fund international gph organization mission develop relevant innovation organization establish defeat hiv malaria ensure save life cure patient prevent disease healthy safe equitable future new global available affordable accessible world fund contribution form partnership skoll vulnerable underresourced population health foundation jointly provide million anchor investment humanity goal underpin mission empower fund accelerate professionalization community health target effort deliver improve health outcome worker section frontline healthcare communities johnson johnson convene collaboration multiple dimension advance public health address global disease disproportionate impact strengthen healthcare system example join hca healthcare lead healthcare provider address key industry issue improve health equity enhance nursing support improve patient outcome specifically collaboration encompass development program early stage lung cancer detection black community initiative improve cardiovascular health education training resource elevate family member patient caraes support nurse ndera neuropsychiatric hospital stand outside home kigali rwanda credit swanson devex global surgery health humanity report johnson johnson medtech business segment help transform example triale new surgical instrument freedom fistula hospital sierra leone collaboration future medical intervention tackle world press healthcare rachel pope associate professor urology institute university challenge surgical field hospital cleveland medical center progress trial instrument advance surgical technology transform medical care capability collaborator aim address kenya new case obstetric fistula highincome country quality surgical care remain healthcare inequity expand patient access improve outcome record year ongoing program seek feedback surgeon inform future innovation help scale largely reach people live lowincome country reduce health system cost commitment change global surgery billion people access quality surgical trajectory surgical care encompass health surgical capacity countrywide reach woman suffer careclose gap critically important advance global humanity goal strong progress far obstetric fistula health equity accelerate access surgery world health johnson johnson company partner million surgical procedure undertake worldwide assembly launch global surgery initiative catherine hamlin addis ababa fistula hospital year occur poor country goal advance entire continuum surgical ethiopia begin donation world population live carefrom prevention treatment rehabilitationacross suture fistula surgery significant area unmet need obstetric fistula long bone fracture announce beginning pilot program area kenya malawi working government academic ngo strengthen surgical system combine medtechs global core capability strength expertise johnson johnson global local collaborator aim accelerate access streamline ethicon depuy synthe supply chain reduce cost well equip surgeon surgical technology orthopaedic include health system meet need patient community include advanced joint reconstruction digital solution trauma spine sport serve robotic robotic obstetric fistula repair surgery support interventional johnson johnson johnson johnsons suture donation program year solution vision specialty surgery specialist eye healthcare neurovascular care heart include improve surgical instrument obstetric fistula repair rhythm disorder ear nose advance intraocular surgery obstetric fistula childbirth complication throat treatment contact lense preventable improved practice treatable access breast reconstruction surgical care johnson johnson help improve care develop provide access improve surgical instrument fistula scissor bladder sound suturecathet organizer improvement aim provide highquality instrumentation increase patient comfort maximize surgeon visibility johnson johnson commit elevate standard improve safety patient surgeon work care surgery bring insight scale new technology expert collaborator help train surgeon frontline health elizabeth yearold woman kenya receive fistula surgery gynocare meet need people community limited women fistula hospital flagship facility fistula foundation treatment worker effective use instrument surgical capacity world deploy global surgery network keyna johnson johnson supports donate surgical product photo credit roshni lodhia lancet global surgery evidence solution achieve health welfare economic development wwwthelancetcomjournalslancetarticlepiisxfulltext access february ibid unfpa kenya fistula camp tackle covid relate backlog case restore dignity woman httpskenyaunfpaorgennewsfistulacamptacklescovidrelatedbacklogcasesrestoredignitywoman access february health collaboration reduce burden obstetric fistula improve access care long bone fracture leave untreated humanity report johnson johnson foundation support long bone fracture crack break tibia long obstetric fistula procedure donate surgical product bone result longterm disability johnson johnson fistula foundation treatment network direct relief work malawi help train surgeon novel tool deliver suture new instrument hospital technique strengthen supply chain improve sustainable kenya fistula treatment network work access surgical trauma care people need improved instrument support training surgeon support johnson johnson foundation launch able perform safe obstetric fistula repair long bone fracture pilot program malawi introduce woman kenya novel device strengthen supply chain train districtlevel provider complete procedure elevate operating room woman year suffer process well patient care team experience aim global surgery obstetric fistula scale initiative lmic building experience malawi continue support ongoing obstetric fistula education surgeon nearly year collaboration mercy ship large nongovernmental fleet hospital delivery product implant instrument set queen elizabeth hospital malawi photo precious kamange ship world support help hundred surgeon operating room specialist receive advanced training collaborate design essential skill training provide hygiene kit surgical product health humanity goal progress reduce burden participant orthopaedic clinical officer train dowa obstetric fistula conduct practice exercise colleague photo katrin drner support delivery obstetric fistula repair surgery cumulative total begin new surgical instrument pilot sierra leone expand kenya increase patient comfort maximize surgeon visibility improve safety patient surgeon continue support healthcare worker fistula foundation obstetric fistula httpswwwwhointnewsroomfactsinpicturesdetailfactsonobstetricfistula access february mental healthcare health humanity report mental illness continue great unmet need healthcare intensify covid pandemic addition protract conflict grow social inequity world threaten exacerbate mental healthcare hardship challenge availability resource address truer vulnerable community improve access quality mental healthcare rwanda part world people mental fiveyear collaboration rwanda ministry health start disorder live lmic receive care achieve major progress create framework mental healthcare lack treatment option train mental health worker quality accessible mental healthcare country include associate stigma reason support training community health worker general practitioner nurse sign level public expenditure mental health low global symptom mental illness include unique median government health expenditure phonebase training program particularly meager lmic conduct national mental health survey rwanda half century develop innovative extensive nationwide survey complete treatment condition impact brain central nervous subsaharan africa date publish system building legacy expand access open access peerreviewe bmc public health journal mental healthcare innovation research program make available secondgeneration antipsychotic include empower frontline health worker well manage mental illness oral risperidone paliperidone palmitate longacte injectable pplai clinical study evaluate treatment realworld healthcare setting health humanity goal continue clinical study assess treatment caspar study team represent schizophrenia paliperidone palmitate rwandan healthcare johnson johnson tours laboratories university teaching setting caspar design assess impact pplai hospital butare patient schizophrenia realworld healthcare setting participate site caspar study photo carla decotellimende end patient screen nearly patient move treatment phase study include progress access clinical research training local principal investigator schizophrenia treatment study site rwanda site visit johnson caspar study assess treatment schizophrenia johnson research team caspar represent important step paliperidone palmitate lai rwandan healthcare forward generating evidence inform adoption setting achieve patient screen nearly pplai treatment option schizophrenia patient move treatment phase clinical research training site investigator rwanda ongoing world mental health report transform mental health httpswwwwhointpublicationsiitem access february mental health atlas httpswwwwhointpublicationsi item access february vision health humanity report accord world health organization sight dominant sense play advance eye health digital innovation asia pacific johnson johnson vision sign memorandum crucial role facet live unmet need eye health continue affect people understand agency science technology world especially vulnerable underresourced population research astar jointly establish eye health digital innovation consortium singapore host astars institute high performance computing consortium focus worldwide billion people visually impair improve vision digital world adult spend advance eye health research asia pacific region joint billion force live preventable time digital devices postpandemic world investment sgd million organization treatable condition care need hour day accord estimatesthe strain eye channel consortium course year johnson johnson vision medtech health noticeable eye lock screen long period kind region consortium initially bold ambition change trajectory eye health worldwide people blink destabilizing effect tear film focus following deliver innovation enable eye care professional cause dryness discomfort follow feedback eye care vision improve eye healthcare delivery eye care professional create well outcome patient live professional patient work help meet need patient singapore collaborate expand access quality eye care community digitally intensive lifestyle increase education great need launch new contact lens acuvue oasys max day help optimize collaboration private public sector enhance eye healthcare delivery reduce light scatter block uva uvb ray develop new technological process support enterprise cataract lead cause preventable blindness directly involve primary eye healthcare delivery worldwide impact million people globally prevalence distance vision impairment low thing important ability see well lowlight condition presbyopia simple middleincome region estimate time high world know healthy term agerelate condition reduce ability near highincome region sight lifelong journey johnson vision project affect billion people globally johnson vision work meet patient need provide relief people quality life life area reduce presbyopia johnson johnson vision introduce great impact deliver innovation nextgeneration presbyopiacorrecte intraocular lens pciol treat childhood myopia leverage cuttingedge tecnis symfony optiblue iol select country science bring forward good solution eye care high prevalence eye disorder emea highperformance technology eye surgery stage aim help singapore population cause concern care professional offer patient range highquality support eye care professional worldwide enable open innovation publicprivate partnership continuous vision lighting condition million patient well pave way leverage strength different half world population project myopic party develop solution address complex nearly billion people expect healthcare challenge peter menziuso high myopia company group chairman johnson johnson vision professor tan sze wee assistant chief executive enterprise astar world report vision httpswwwwhointpublicationsiitem access february covid screen time spike hour day accord eyesafe nielsen estimate publish https eyesafecomcovidscreentimespiketooverhoursperday access february blindness vision impairment httpswwwwhointennewsroomfactsheetsdetailblindnessandvisualimpairment access february grzybowski ruamviboonsuk pharmacological treatment presbyopia clin med httpsdoiorgjcm access february world report vision httpswwwwhointpublicationsi item access february blindness vision impairment httpswwwwhointennewsroomfactsheetsdetailblindnessandvisualimpairment access february health slow myopia progression child myopia prioritize eye south america johnson johnson vision humanity report call nearsightedness chronic progressive disease lead meaningful campaign advance access eye care lead sightthreatene complication time child people live remote area country include diagnose myopia great risk argentina brazil chile colombia mexico lead awareness develop high myopia late life industry campaign different medium channel raise awareness recognize importance myopia management follow work closely nonprofit region encourage decade research develop scientifically prove solution people eye test receive necessary treatment johnson johnson vision launch acuvue abiliti address prevalence progression myopia child abiliti design fit seamlessly lifestyle parent child launch abiliti day abiliti overnight people reach canada hong kong singapore receive fda vision approval lens parameter expansion abiliti overnight extend reach patient development patient part world enjoy well vision lifetime bring critical eye care child sight kid sfk eye examination found johnson johnson vision lions club student nairobi kenya path bright future thank vision screening sight kid photo lion club international foundation international foundation administer free volunteer direct vision screening million child country include india kenya philippines thailand today sfk celebrate year bring critical eye care child underresourced community largestknown eye surgery program kind world healthy sight critical child academic performance selfesteem overall wellbee sfk expand south florida region help vision sight kid second location team louisiana lion eye meaningful impact carry celebrate world sight day johnson johnson vision foundation provide free statewide eye care louisianas youth future study career select world sight day share vision good impact vision screen event tour mobile screening unit review additional example help change mark new activity trajectory eye health operate environmentally sustainable manner freddy simon ophthalmologist kerala india learn social responsibility johnson johnson vision race health equity gri health humanity report heart johnson johnsons commitment health equity desire create world johnson johnson award winner health equity innovation challenge design empower community color skin determine access care quality care health accelerate solution stimulate innovation entrepreneurship outcome launch race health equity orthe million enterprise social impact challenge call local entrepreneur wide initiative focus close racial health gap chicago detroit los angeles new orleans new york philadelphia deliver locally inspire innovative approach advance health equity engage credible community leader johnson johnson orthe initiative focus eradicate racial people color face high incidence understand local health challenge independent selection social injustice public health threat eliminate health death rate condition heart disease stroke committee choose winner applicant inequity people color commit closing cancer diabetes covid winner include community organization provide service racial health gap invest culturally competent community include free healthcare underresourced neighborhood care model create healthy outcome people color improve birth maternal health outcome black family race health equity community health capacity building provide youth educator community program end commit million design support mental wellness equity winner advance orthe program follow area program help expand access affordable community award seed funding pool million centric care mentorship renowned entrepreneur public health expert access jlab ecosystem follow community health worker alabama mississippi north carolina community inclusive challenge organization continue positively south carolina tennessee benefit health worker health capacity research impact community actively expand network collaborative grant contribute establish building representative alongside management skill train executive director clinical trial expand access leader communitybase healthcare organization work community engagement education affordable community increase access partnership organization aim help build trust centric care clinical trial underresource community health system back innovative program continue orthe umbrella investment diverse site selection community health patient recruitment commitment support hcp researcher help people inform option prioritize center community incorporate healthcare treatment health wait educational health worker equity endtoend effort resource hub create medtech inspire people care model therapy device end hcp researcher information need pursue care confidence innovation design provide development support help create especially experience covid pandemic equitable healthcare system cause americans delay healthcare treatment launch new initiative support climate resilience community culturally medtechs signature equity program community healthcare clinic serve people engagement competent care identify community help deliver limited access care community vulnerable impact education impact form partnership communitybase increase racial climate change collaboration americare organization offer johnson johnson resource empower patient ethnic diversity harvard chan school public health center climate expertise help meet community healthcare need end user healthcare talent pipeline health global environment harvard chan cchange tools resources workforce medtech janssen helped provide free health education aim bolster operational resilience clinic communitybase promote equitable access health screening thousand community member resilience healthcare worker help inimize disruption service point care experience event atlanta chicago columbia south carolina los health increase bipoc patient healthcare cause extreme weather event goal support angeles plan expand population health literacy medical clinic world department health human service office minority health profile blackafrican americans httpswwwminorityhealthhhsgovomhbrowseaspxlvllvlid access february health save leg change live multiyear initiative janssen humanity report address hide threat peripheral artery disease pad relate amputation black americans pad time high risk amputation white americans janssen collaborate lead professional association include american college cardiology healthcare system community organization raise awareness padrelate issue facilitate equitable access treatment janssen continue share pad information widely implement thousand free screening advanced research help overcome padrelate health inequity johnson johnson vision major eye health additionally expand pioneer climate company sign promise initiative create health equity fellowship create medical race health equity nonprofit black eyecare perspective increase equity society consortium climate health national representation optometry mirror black people medical association support physicians color population leader climate health equity education advocacy policy solution increase contribution second class culturally competent care fellow support physician represent diverse specialty advocacy experience cultural background line goal promote well care people color interest climate health enhance leadership address unconscious bias healthcare colaunche cross capability medical professional care patient sector partnership initiative unconscious bias disparitie planet healthcare action continue medical education program core program target hcp community color assist enact change daily practice inclusive research representative improve patient care outcome additionally maintain clinical trial sponsorship alliance inclusion medicine scholarship program scholarship mentorship commitment launch advance multiple initiative enhance diversity national medical fellowship nmf alliance healthcare dimension include johnson inclusion medicine aim welcome johnson outreach community representative cohort underrepresented medical student total advocate example research include initiative program commit million scholarship janssen communityfocused campaign design create funding cohort support johnson johnson awareness engagement black brown community nmf welcome inaugural cohort underrepresented elevate discussion clinical trial campaign help medical student select second cohort second build trustbase relationship community provide clinical thirdyear medical school scholar aim scholar pair trial information host educational website provide johnson johnson mentor provide guidance insight underrepresented patient great access information young scholar embark medical career journey resource clinical trial research learn race health equity national heart lung blood institute fact peripheral artery disease pad african americans httpswwwnhlbinihgovfilesdocspublicheartpad extfactsheetaapdf access february frontline healthcare community gri gri health humanity report line commitment advance public health invest extensively raise quality strengthen communitybased health system center help establish community health worker think tank lead health wellbeing community live work south africas national department health address critical gap face community health worker policy implementation communitylevel service delivery nigeria center johnson johnsons global community impact gci organization center advance initiative include collaborate widely internally externally help create funding johnson johnson foundation corporation roadmap partnership opportunity strengthen nursing support community health worker africa operate company johnson johnson family midwifery workforce nigeria emphasis mental professionalize workforce community health worker companiesdrive communitygive initiative health oncology maternal newborn health engage daily community key respond world align esg strategy health humanity center launch basecamp health system transformation disease outbreak make gain longstande global goal drive orthe initiative gci specifically school system change pilot program nurture system health priority include universal health coverage africa advance initiative line healthcare ambitious change practitioner build community health system capacity frontline catalytic fund affcf launch public goal europe subsaharan africa support community health worker african country frontline healthcare community million commitment johnson johnson foundation harness power datum support frontline health worker million commitment skoll foundation making trust datadriven decision center support health humanity goal investment match global fund fight aid thousand hour pro bono datum science service malaria affcf help accelerate progress improve subsaharan africa leverage datum set million health healthcare deliver community level ensure encounter generate community health woman large proportion community health worker improve datum quality inform good practice worker properly pay work fund aim triple center collaborating datakind communitybase number salary community health worker subsaharan organization champion datum collection practice enable progress support frontline africa expand coverage million people health system stakeholder healthcare delivery decision health worker back trust datum reach nurse midwive help health worker manage stress support health worker community health worker support manage stress exacerbate covid pandemic frontline health worker cumulative total resilience collaborative center global learning health worker cornerstone care training community launch grow member empower integrate community health opensource resource include spanish portuguese support frontline health worker worker exist health system possible hindi translation access extend care reduce burden disease organization country assist raise awareness believe solve challenge face frontline million people investment african way implement evaluate evidencebase program health worker improve healthcare frontline catalytic fund build improve health worker resilience wellbee johnson johnson center health worker innovation year support health worker especially center establish tasked guide resourcelimite setting million commitment support frontline health worker goal support million nurse midwive community health worker exceed million lauren moore goal advance plan continue work vice president global community impact center provide critically need support community johnson johnson health workers health support supply chain training health worker africa healthcare system work work support humanity report johnson johnson provide funding empower school health nurse advance well healthcare goal develop free online supply chain training curriculum aim work likeminde partner attract strengthen thrive help frontline health worker understand role supply innovative diverse nursing workforce empower advance work jjiv team allow improve chain delivery essential medicine treatment empower health equity transform healthcare support empower thoughtfulness create business school health deliver training east central nurse advocacy scholarship clinical leadership impact outcome inextricably link big southern african college nursing ecumenical education event teach hone healthcare innovation skill business impact achieve pharmaceutical network successful pilot botswana set mental health resource kenya curriculum currently roll work include advocate fundamental value additional country nigeria rwanda south africa nursing profession catalyze workplace culture farouk meralli enhance hcp education world medtech environment nurse thrive strengthen diversity founder ceo swiperx partner advance surgery industry association nursing bring great awareness extraordinary impact provide million hcp online webinar nurse healthcare key activity program range topic specialtie example dei series include social medium advertising storytelling progress new investment frontline healthcare community webinar dedicated discuss workplace challenge podcast note nursing work approximately half million fund good practice resilient resident series webinar spark interest profession diverse prospective committed company continent join targeted lead surgeon early career overall suite nursing student new series call future nursing portfolio company reach million patient directly webinar series attract hcp country support hcp event support event like nursehackhealth support support field fuel belief potential ethicon reignite partnership nursele innovation healthcare working collaboration marketbase solution address health equity issue jjiv society black academic sonsiel microsoft launch pitchathon provide funding early stage health impact entrepreneur surgeon expand diverse elevate foster nurseled idea redesign healthy work develop idea external partnership surgeon initiative dsi program environment workforce thrive nearly nursele program jjiv provide fund rock health focus equip promise interdisciplinary health system apply pitchathon equitable investment initiative research publish minority surgical resident select finalist represent transformative power calltoaction report great investment underrepresented fellowship attainment faculty nursele innovation team award entrepreneur additionally jjiv help fund appointment dsi support grant funding bring solution life development iris investment tool global impact clinical technical training investing network assist investor identify support mentorship surgical resident continue help wilson aloubia msc accelerate health equity entrepreneurship enterprise combat racial health disparity ladonna kearse realize potential future practice laparoscopic skill surgical training lab johnson johnson impact venture jjiv million impact milestone year jjiv return surgical fellow faculty leader diverse surgeon initiative investment patient know good personal health record fund johnson johnson foundation invest dsi participant prior cohort company help patient control healthcare company entrepreneur innovative business complete subspecialty fellowship obtain faculty medical information model improve health equity access affordable position follow year career quality care underresourced patient world financial return portfolio company reinveste enable championing nurse expansion fund impact jjiv leverage johnson johnsons network experience expertise healthcare johnson johnson proudly champion nursing provide resource support guidance portfolio company profession century innovative mindset invaluable insight handson experience nurse health give enterprise johnson johnson enterprise level ihps approve product donation partner offer increase humanity report operating company country visibility alignment streamline automate large diversified healthcare product company world donate fund product regional local cause approval system innovative technology improve johnson johnson essential fabric society align credo purpose specific need local speed product donation geography community globe care deeply community include disaster relief donation example support community strike disaster wellbee community use reach share discretion local johnson johnson leader globally humanitarian crisis include resource community world hundred million dollar year collaboration partnership forge healthy war ukraine contribute million overall equitable future patient assistance support independent initiative relief effort include cash product donation compliance donate medicine fund johnson johnson current international sanction donation include patient assistance foundation inc jjpaf independent give million humanitarian support refugee combine million nonprofit help eligible patient insurance coverage international rescue committee international federation scroll chart information receive prescription product donate johnson johnson red cross red crescent product value operating company million include medical device essential medicine consumer health product firstaid frontline healthcare community femininehygiene product disaster preparedness relief hurricane fiona continue work trust partner include americare ian partner heart heart international catholic medical mission board americare gulf coast map international medshare international health partner community foundation line care coordinate product donation address immediate support program help community recover rebuild need restore health resilient immediate aftermath major disaster service area affect provide essential pharmaceutical medtech consumer health hurricane ian central product monetary donation support florida hurricane fiona heart heart international disaster response puerto rico team provide free healthcare service product contribute cash contribute volcano tonga work unicef address chart include enterprise giving include disaster relief value million million need child caregiver follow eruption product donate janssen jjpaf significant increase underwater volcano hunga tonga hunga haapai give attribute product donation jjpaf value johnson funding provide johnson product readiness blanket majority tonga volcanic ash affect nearly community give categorize channel provide community immediate mid tongas population displace people impact natural longterm response include child foundation johnson johnson foundation register disaster natural disaster world flood kentucky join americare charitable organization fund solely johnson aftermath devastating flooding strike southeastern johnson family company foundation operate worldwide kentucky help restore health service clinic johnson johnson foundation united states found support people displace home johnson johnson foundation scotland found building year collaboration johnson johnson independent entity support regionspecific global international health partner ihp debut share global earthquake indonesia follow earthquake strike partnership initiative employee volunteer disaster donation platform harness good practice scale help west java indonesia displace people response activity specific initiative support foundation community crisis recover rebuild regain resilience provide project hope communitymanage mention report include center health worker disaster technology unified global system latrine water tank village offer access clean innovation johnson johnson impact venture product donation extend johnson johnsons water sanitation facility pandemic epidemic gri sasb hcbpa health humanity report united nations sustainable development goal urge work ensure healthy life promote wellbee age specific target end epidemic include hiv health humanity goal tuberculosis neglect tropical disease vaccine protection treatments pandemic epidemic disease critical achieving goal worldwide provide access progress development effective transformational impact public health expand use progress global access plan treatment vaccine combat world deadly vaccination monitoring platform vxnaid health disease long global public health priority johnson humanity goal crucial step advance largescale ontinue evaluation development access plan relevant pipeline asset include dengue johnson important global health equity strategy immunization protect people save life world amass century experience advance pecific internal milestone set progress novel treatment regimen vaccine facilitate access achieve address multiple disease include hiv covid ebola enable access vaccination dengue address grow threat amr monitoring platform pandemic epidemic progress preventive viral develop vxnaid vaccineagnostic digital platform vaccine capability support adherent vaccine administration framework emonstrate supply capability access pathways clinical study campaign vxnaid digital tool johnson johnson covid vaccine include integrate innovative technology improve patient trace shipping million covid vaccine johnson johnson credo inspire datum management communication implement impactful capture process internally future documentation responsible community live vaccination campaign resourcelimite setting playbook work world community internal external pandemic preparedness activity core tenet approach global health security platform deploy largescale continue potential threat aim stop spread lifethreatening disease ebola vaccination campaigncalle umurinziin collaboration potential wipe entire community government rwanda umurinzi large left unchecked determined use case platform fully vaccinate progress vaccination advance plan safeguard people rwandan ebola johnson johnson ebola monitoring platform threat pandemic epidemic vaccine regimen comprise zabdeno adzebov latform implement solidarity trial bavarian nordics mvabea mvabnfilo vaccine covid vaccine continue include expansion new country vxnaid optimize base umurinzi campaign vanessa broadhurst secondgeneration platform share opensource chieve external endorsement designation executive vice president global corporate affair digital public good dpg digital public goods johnson johnson code enable global open access platform alliance addition digital public good registry vaccination program ptimize platform share opensource code enable globalopen access platform vxnaid grant digital public good designation approach envision create robust health ecosystem advance vaccination program digital public good alliance add availability affordability need medicine vaccine digital public good registry omplete register trademark filing platform facilitate access include world vulnerable vxnaid population efficacious management vaccine administration especially combat urgent outbreak disease ebola health vxnaid adopt use solidarity follow inaugural satellite center global health develop effective response rapidly evolve global humanity report trial vaccine stv international multivaccine clinical trial discovery launch london school hygiene health environment blue knight offer physical residency evaluate efficacy safety covid vaccine use tropical medicine aim develop generation select jlab location virtual engagement option platform stv program acknowledge drug regimen need treat form open portfolio company eligible receive access jlab public statement vxnaid deploy satellite center resource program dedicated mentorship stv program expand country johnson johnson barda south africa satellite center global health discovery vxnaid share opensource code enable holistic drug discovery development centre blue knight expand portfolio company include global open access vaccination program university cape town focus outpace rise threat company end female lead amr minority lead firsttime entrepreneur singapore satellite center global health discovery learn vxnaid practice dukenus singapore focus catalyze investment bolstering discovery flavivirus invest research need collaboration healthcare sector large life science ecosystem critical forge safe pandemic epidemics johnson johnson commit address dual gap healthy future innovation today impact innovation health equity establishment approach potential solution future centers global health discovery join force academic institution leverage regional network grow scope center provide longterm opportunity support rachel rath talent discovery sciences hopefully speed director barda alliance johnson johnson discovery novel mechanism tackle expand emerge innovation jlab challenge global health year work expand connection strengthen potential global impact grow portfolio anil koul amarnath sharma launch satellite center advance innovation collaboration follow way global disease discovery dukenus campus singapore critical invest locally lead innovation hold second blue knight symposium bring people advance breakthrough science globally learn global health discovery center virtually person newly open jlab center global health discovery late washington blue knight hub symposium facilitate chapter effort advance solution grow global conversation health threat area research collaboration combat health security threat innovators investor need partner think leader blue knight collaboration progress discover accelerate portfolio company raise million secure nextgeneration solution contingent funding end year blue knight future pandemic emerge william hait phd joint initiative create jlab biomedical infectious disease executive vice president chief external innovation medical officer johnson johnson advanced research development authority barda know unknown health administration strategic preparedness response threat department health human service dedicated people country melinda richter global head jlabs gary disbrow barda director join anticipate potential health security threat aim register event blue knight symposium statement solidarity trial vaccine httpswwwwhointnewsitemwhostatementonsolidaritytrialvaccine health launch blue knight quickfire challenge covid vaccine humanity report invite innovator globe submit potentially groundbreake idea technology aim enhance act urgency onset covid johnson johnson preparedness future know unknown infectious galvanized resource help halt pandemic develop disease threat awardee select easytodeploy vaccine obtain regulatory authorization potential health security solution level building supply chain capability engage partner world support health system healthcare provider involve combat covid beginning identify enhanced reach influence blue knight new impactful way optimize clinical trial reach diverse community participation event community ensure appropriate representation congress include bipartisan commission biodefense population research meeting band partnership biodefense meeting examine way incentivize manage partnership johnson johnson covid vaccine federal government industry academia receive multiple regulatory authorization emergency use waiver ngo drive technology innovation improve biological import permit country worldwide include intelligence current future threat blue knight country africa company present nextgeneration preparedness pandemic epidemic solution meet time early stage company invite speak commission showcasing power publicprivate partnership accelerate scientific million technological advancement johnson johnson deliver million covid vaccine launchtodate ship lmic select blue knight company information relate covid vaccine generate immediate increase scientific annual report credibility exposure potential partner investor take long small company brian wiley strategic advisor ena respiratory bipartisan commission biodefense meet hiv health humanity report johnson johnson commit fight hiv decade help advance science enable access collaborate improve life world health humanity goal determine effort hiv history significant advance prevention fda approve label update product give hcp begin global epidemic million people acquire hiv people live hiv option start underscore high unmet need new option monthly everytwomonth injectable treatment need progress access hiv treatment continue drive inequality access hiv oral leadin phase additionally fda approve registration approval receive botswana treatment make hiv treatment easy effective cabenuva cabotegravir rilpivirine adolescent medicine regulatory authority mark rls available year age old lai hiv regiman approval codevelope hiv lai regimen janssen available eligible adolescent reduce daily pill burden rilpivirine viiv healthcare cabotegravir treatment offer day year adhere treatment linical study ongoing demonstrate safety regimen difficult adolescent skip hiv medicine efficacy hiv lai regimen adult adolescent dose hide hivpositive status multiple country subsaharan africa hiv remain focused help transform hiv regulatory approval study resourcelimite setting terminal illness manageable condition enable hiv lai regimen approve botswana affect virus enjoy productive life conduct andor support key additional medicine regulatory authority mark approval good science passion dedication scientist clinical study demonstrate safety efficacy randomize codevelope hiv lai regimen resourcelimite country extensive collaboration enable control trial feasibility acceptability continue seek regulatory approval additional rls significant progress implementation research hiv lai regimen adult include regulatory submission south africa adolescent subsaharan african country kenya thailand south africa uganda zimbabwe study different stage enrol total participant brian woodfall vice president global head development cabotegravir rilpivirine efficacy safety study care infectious disease vaccine janssen study hiv infect virologically suppress adult longeracte treatment regiman longacte treatment adolescent lata study hiv potentially gamechange young people hiv infect virologically suppress adolescent new expand regulatory approval hiv treatment particularly pill base fruitful collaboration viiv healthcare help deliver acceptability feasibility longacte injectable art new meaningful treatment option world complete adolescent afinaty study longacte injectable lai hiv treatment regimen lai regimen kati vandermeulen hiv infect virologically include arv drug develop janssen rilpivirine senior director compound development team suppress adolescent viiv healthcare cabotegravir regimen know leader infectious disease vaccine janssen cabenuva cabotegravir rilpivirine improve hiv control monthly everytwomonth version hiv lai treatment africa longacte regimen adult approve health authority europe antiretroviral impala study switzerland canada additionally oncemonthly version hiv infect adult approve health authority australia history suboptimal adherence participant unaid global hiv aids statistic fact sheet httpswwwunaidsorgenresourcesfactsheet access february hivinfo nihgov hiv child adolescent httpshivinfonihgovunderstandinghivfact sheetshivandchildrenandadolescent access february health combat pediatric hiv addition fda approval hiv prevention woman girl dapivirine vaginal ring learn hiv vaccine trial january humanity report hiv lai regimen adolescent work expand improve recommend additional prevention consortium global partner discontinue mosaico solution child live hiv ongoing combination choice woman combination prevention largescale efficacy study americas europe aim tablet contain product prezista darunavir fixeddose approach receive approval south african test safety efficacy specific composition combination ritonavir receive prequalification health product regulatory authority use woman age investigational hiv vaccine regiman man sex help meet treatment need secondline old help reduce risk contract hiv man transgend individual studys independent data treatment adult child johnson johnson approvals africa receive additional safety monitoring board determine regimen specific policy enforce patent own application currently pende effective prevent hiv infection compare placebo control prezista darunavir subsaharan africa study participant vaccinerelate safety issue identify develop country expand geographical scope policy pediatric product lmic effect gender inequality womens child account people live hiv risk especially hiv aidsrelate death disappoint study outcome pronounce subsaharan serve underscore unique challenge africa women johnson johnson cofounder new horizon face global scientific community account new collaborative aim improve treatment care year search hiv vaccine hopeful hiv infection hiv child young adult hiv country region learn mosaico provide important data drug donation capacity building johnson ongoing fight hiv remain committed johnson collaboration elizabeth glaser pediatric aids mother daughter wait test hiv clinic kihihi seek innovative solution hiv uganda photo new horizons collaborative foundation renew commitment initiative pledge extend darunavir donation program continue enrol dapivirine ring longacte hiv prevention method new pediatric young adult hiv patient design specifically woman develop penny heaton important step meeting commitment international partnership microbicide exclusive global therapeutic area head infectious help tackle challenge pediatric hiv rome license janssen use arv compound disease vaccine janssen paediatric hiv action plan own population council flexible silicone ring discreet child enrol treatment program subsaharan easy use minimal effect needs replace african country learn progress help hiv history monthly initial approval pilot implementation dapivirine ring south africa important step decade long fight hiv particularly adolescent girl young woman subsaharan africa time likely acquire hiv male counterparts johnson johnson founding member menstar coalition help million man live hiv subsaharan africa treatment virally suppress child wait test hiv clinic kihihi uganda photo new horizons collaborative unaid dangerous inequality world aids day report httpswwwunaidsorgsitesdefaultfilesmediaassetdangerousinequalitiesenpdf access february fund primarily johnson johnson foundation registered charity company limited guarantee foundation separate legal entity johnson johnson family company foundation operate worldwide johnson johnson foundation united states found johnson johnson foundation scotland found unaid dangerous inequality world aids day report httpswwwunaidsorgsitesdefaultfilesmediaassetdangerousinequalitiesenpdf access february ibidtuberculosis health humanity report challenge end tuberculosis remain priority healthcare especially resourcelimite setting johnson johnson continue meet challenge lab mile health drive year initiative decade experience fight global healthcare company johnson johnson commit utilize unique strength include decade experience research development year start covid pandemic deep understanding insight behavior world fight regain progress health humanity goal change help end pandemic combating time year increase people fall ill death continue increase year year howard reid global head global public health social impact globally estimate number death increased johnson johnson reverse year decline progress access million people die include tuberculosis treatment people hiv milestone fight patient receive access bedaquiline tuberculosis potentially avert million new mdrtb infection rise amr miss million undiagnosed people december mark year accelerate approval continue challenge great stride help rom patient receive access sirturo bedaquiline fda johnson johnson bedaquiline potentially avert million new reignite global fight collaboration receive approval sirturo bedaquiline mdrtb infection continue commitment patient reinvest medicine novel mechanism action development new treatment advocate behalf year bedaquiline recommend people affect core component alloral treatment regimen progress develop treatment mdrtb available country represent learn johnson johnsons work ontinue clinical development novel collaborative global burden asset include dose complete phase study help end rogress consortium group include unitetb pantb bedaquiline key treatment death rate high component study currently recommend treatment sixmonth course antitb drug people cure mother receive treatment child gqeberha south africa global tuberculosis report factsheet httpswwwwhointpublicationsmitemglobaltuberculosisreportfactsheet access february ibid ibid health reach milestone study help underscore importance humanity report course sirturo bedaquiline multidrugresistant bedaquiline helping solve today great global health tuberculosis mdrtb medicine deliver cumulatively challenge reinforce confidence effectiveness country include highburden country treatment adult adolescent child today medicine backbone whorecommende alloral treatment regimen milestone represent critical year initiative nearly drtb patient pantb collaboration help end work continue johnson johnson allow explore medicine potential continue collaborate sector enable access help transform treatment patient need medicine mdrtb patient world focus maintain longterm effectiveness face expand access pediatric formulation bedaquiline rise antimicrobial resistance rome action plan safeguard longterm effectiveness careful stewardship medicine continue support global effort help find ruxandra draghiaakli phd miss million people undiagnose advance global head global public health innovative develop generation treatment janssen bedaquiline register country medicine specifically develop large global gap estimate number treatment mdrtb advance availability country tuberculosis people fall ill number people newly great need diagnose million people diagnose scientist conducting research groote schuur research centre south africa disease officially report national authority mdrtb patient globally enrol oral million collaborate advance drug regimen bedaquilinecontaine regimen project accelerate new treatment tuberculosis addition pantb membership research new scientific datum generate support safety pantb collaboration announce execution joint collaboration consortium ongoing include efficacy bedaquiline stream stage clinical trial development agreement jda support progression follow initiative innovative world large clinical trial mdrtb conduct investigational combination treatment regimen phase medicine initiative imi medical research council clinical trial unit university clinical development collaboration evaluate unitetb global consortium collaborator college london sponsor vital strategy inc nearly novel regimen combine register product new country launch aim advance antitb science participant enrol country continent chemical entity effectively treat form active pulmonary enable progression new safe affordable treatment trial find bedaquilinecontaine regimen ninemonth substantially short treatment duration exist solution patient worldwide year oral regiman sixmonth regiman week second drug regimen goal identify regimen suitable project sponsor choose phase clinical line injectable superior efficacy compare ninemonth phase development trial innovative clinical trial design develop injectablecontaine regimen few case hear loss project shortlist trial site africa asia europe fill important gap evidence shorten regimen recognize single organization produce range south america mdrtb drug need respond pantb collaboration bring philanthropic nonprofit privatesector organization eratb eratb initiative integrate additionally study patient mdrtb accelerate development novel short drug regimen treat organization sixyear period site south africa show treatment bedaquiline form alongside johnson johnsons bedaquiline starting develop new contain regiman associate well survival additional antimicrobial agent evaluate new jda combination regimens treatmentshortene potential effectiveness compare nonbedaquilinecontaining regimen ready phase clinical evaluation patient mdrtb review data reconciliation process change need correct annual number course sirturo bedaquiline ship year result reduction total cumulative shipment goodall meredith nunn evaluation short standardised regimen treatment rifampicinresistant tuberculosis stream stage openlabel multicentre randomise noninferiority trial lancet httpswwwthelancetcomjournalslancetarticlepiisfulltext access february bmc bedaquiline safety efficacy utilization emergence resistance follow treatment multidrugresistant tuberculosis patient south africa retrospective cohort analysis httpsbmcinfectdisbiomedcentralcomarticlessx access february global tuberculosis report factsheet httpswwwwhointpublicationsmitem globaltuberculosisreportfactsheet access february health respiritb international research consortium highrisk population streamline case report southeast asia johnson johnson launch warrior humanity report european academic biotechnology organization imi tracking mechanism additionally collaborate launch initiative collaboration national program respiritb aim develop new efficient combination youth volunteer patientfinding initiative sichuan indonesia philippine thailand vietnam educate youth drug regiman cure mdrtb focus shorten zhejiang province support public awareness campaign fun entertaining way social medium mobile treatment duration minimizing likelihood resistance focus include great doctor special game philippine collaborate beijing philippine tuberculosis society inc launch youth community eupearl strategic consortium public private casefinding initiative awareness care sector shape future clinical trial develop specific investigational research platform framework trial south africa building pediatric drtb collaboration aquity innovation south africa johnson johnson ready operate disease area face high unmet need foundation scotland aquity collaborate epcon gph organization jointly lead working group launch initiative improve healthseeke behavior group present new approach design proud work key partner china youth conduct new insight study well understand adaptive platform trial drive impact base successful barrier care child youth outcome program extend key element integrate model achieve engage youth build tbfree future project place continue help enable tbfree china world day johnson johnson come global community progress series initiative individual organization potential tuberculosis highburden country aim help empower generation impact fight youth end initiative advance global effort help jenny zheng power multisector partnership come find miss million people live undiagnosed president xian janssen numbers unite common cause johnson johnsons year initiative help drive help turn tide devastating disease progress end disease align target sdg india collaboration national elimination wide collaboration initiative aim engage program india launch youthfocused digitalfirst young people drive healthseeke behavior build community campaign call change badlaav change hindi sarthak ranade awareness improve active case find reduce stigma social medium chatbot initiative aim area manage director south east asia enhance early diagnosis goal encourage create youth changemaker encourage health india janssen people seek care treatment need seek behavior increase awareness disease build youth engagement participation support example activation world day include indian government vision tbfree india additionally engagement end workplace initiative china celebrate conclusion threeyear sponsorship johnson johnson mtv stay multisectoral collaboration colaunche collaboration chinese government china alive foundation expand success mtv nishedh continued initiative grow highburden country role assist youthfocused edutainment campaign india launch multinational company pledge address chinese government address challenge new season november initiative workforce country build evidence support policy suggestion foundation develop episode drama series focus technical solution national health commission live young people india touch storyline learn progress help end china improve diagnosis rate project effort raise awareness disease reduce stigma carry population million promote early detection symptom prefecture ganzhou linfen yulin involve training healthcare provider improve access molecular test learn bethechangefortb india ebola health humanity report past decade ebola outbreak large frequent recognizing africanle pandemic preparedness decade deadly outbreak record west africa democratic republic johnson johnson support government rwanda congo underscore urgent need innovation protect community risk partner advance unprecedented movement drive unified rwandan initiative national ebola immunization umurinzi largescale vaccination effort ebola significant grow health threat recently additionally strategic advisory group expert prevent ebola rwandan border democratic rank africa centre disease control prevention recommend proactive use ebola vaccine regimen republic congo share insight umurinzi pathogen highestrisk trajectory epidemic nonoutbreak setting protect risk like healthcare symposium annual international conference public potential outbreaksone uganda worker frontline worker recommendation health africa rwanda umurinzi campaign vaccinate cause rarer sudan ebolavirus country additional tool deploy national pandemic people ebola vaccine regimen approve vaccine treatment outbreak cause prevention strategy protect critical health security provide valuable experience help prevent significant economic disruption illness loss life infrastructure country live threat disease respond quickly threat pandemic particularly dangerous healthcare worker work line december people worldwide ingabo study establish umurinzi receive dose ebola vaccine regimen evaluate vaccine healthy pregnant woman continue zaire ebola virus specie high mortality include fully vaccinate enrollment patient complete rate fully vaccinated end year johnson additional data safety immunogenicity ebola johnsons pregnancy vaccine trial positive result ebola vaccine regiman publish new england journal johnson johnson vision protect people risk offer ebola prevention option pregnant woman medicine datum generate phase clinical trial ebola prevent outbreak begin vision halt spread ebola partnership research ebola vaccination prevac accelerate development vaccine regimen response evaluate ebola vaccine regiman johnson johnson ebola vaccine regimen outbreak west africa help stop spread participant trial site guinea liberia mali grant temporary use authorization democratic republic outbreakadjacent area today johnson johnsons twodose sierra leone result add grow body scientific congo support plan prophylactic deployment ebola vaccine regimen comprise zabdeno adzebov literature demonstrate johnson johnson ebola vaccine vaccine regiman help prevent future outbreak johnson bavarian nordics mvabea mvabnfilo indicate regimen favorable safety profile tolerate induce johnson collaborating ministry health hygiene active immunization disease cause ebola virus zaire robust immune response zaire ebola virus species prevention democratic republic congo acting ebolavirus specie individual year age building adult child aged years national institute biomedical research launch early approval european commission new ebola prevention program mbandaka part prequalification quateur province program launch early aim regiman receive new strengthen local capacity expand capability prevent regulatory marketing ebola outbreak respond swiftly outbreak occur authorization cte believe proactive use ebola johnson johnson donate ebola vaccine regimen divoire ghana vaccine global health community help work closely support capacity development rwanda sierra protect vulnerable community live leone uganda early threat disease learn progress prevent spread ebola continue approval key enable access vaccine regimen people ruxandra draghiaakli phd community live global head global public health scientist work lab formulation ebola treatment leiden netherlands threat ebola janssen kadanali karagoz overview ebola virus disease north clin istanb apr httpswwwncbinlmnihgovpmcarticlespmc new england journal medicine randomize trial vaccine zaire ebola virus disease dec httpswwwnejmorgdoifullnejmoa access february neglect tropical disease health humanity report neglect tropical disease ntds cause significant illness disability death especially centre drug design discovery belgium develop denguespecific antiviral compound novel mechanism child world poor vulnerable community action potentially protect treat dengue serotype dengue eradication elimination feasible exist animal reservoir limitation current protective renew commitment fight ntds join vermox mebendazole program donate measure multiple strain serotype circulate global community include government foundation nonprofit billion dose treat million patient toolbox combat dengue need grow antiviral organization pharmaceutical company endorse annually countrie million dose vital new tool help slow outbreak limit kigali declaration neglect tropical disease vermox chewable donate epidemic level case recommit longestablished effort control eliminate ntds set debilitate disease risk health proofofconcept nonhuman primate model innovation combat flavivirus billion people world especially vulnerable follow result firstinhuman phase doubleblind underresourced commit follow invite scientist apac oceania study show compound safe tolerate onate million dose annually vermox region global health discovery quickfire progress phase clinical study evaluate mebendazole medicine treat intestinal worm challenge flavivirus infection challenge aim attract antiviral compound prevention treatment dengue potentially groundbreake idea treat control prevent study human challenge study conduct collaboration flavivirus disease innovators good potential solution johns hopkins university university vermont nih dvancing novel program discover new medicine receive grant fund total pool access conduct collaboration singapore dukenus need beat dengue leprosy jlabs apac community include dedicated workstation medical school home johnson johnsons neglect tropical disease year jlab shanghai mentorship satellite center global health discovery apac launch ntds prioritize roadmap johnson johnson experts june satellite center aim catalyze investment johnson johnson research medicine support bolster infrastructure flavivirus build johnson treatment prevention highprevalence ntds johnson decadelong legacy ongoing collaboration dengue soiltransmitte helminthiasis sth know treat leprosy dukenus public health research intestinal worm leprosy preliminary data janssen phase proofofconcept study promise result bedaquiline treatment donate billion dose vermox mebendazole leprosy share result international leprosy years johnson johnson congress note compound bedaquiline appear establishment satellite center duke forefront global effort generally tolerate dosed monotherapy nus build strong track record flavivirus beat ntds donating period week leprosy study population consist research benchtobedside innovation billion dose vermox mebendazole multibacillary leprosy patient advanced form leprosy facilitate antiviral drug discovery prevention treatment intestinal worm follow month whorecommende leprosy treatment treatment flavivirusassociate disease field partner regiman preliminary datum mark important milestone affect community southeast asia country bolster johnson johnsons pledge advance research development development new chewable formulation vermox program generate evidence need explore innovative mebendazole easily administer child treatment option tackle leprosy young year age support training community health professor patrick casey worker enable well datum management support senior vice dean research dukenus progress dengue treatment research medical school development new diagnostic tireless collaborative effort countless child need give opportunity janssen dengue compound discovery program start recover play learn thrive collaboration leuven rega institute learn progress address ntds httpsunitingtocombatntdsorgenthekigalideclarationthedeclaration access february end neglect attain sustainable development goal road map neglect tropical disease httpsappswhoint irisrestbitstreamsretrieve access february antimicrobial resistance health humanity report antimicrobial resistance amr crisis concern covid johnson johnson company lead way address complex health challenge pandemic microorganism develop resistance medicine million people rely amr assess independent access medicine year common disease difficult impossible cure spread infection foundation amr benchmark publish hard control large diversified healthcare product company invasive expec disease ie sepsis cause purpose profoundly change trajectory health humanity prevalent serotype expec adult aged year come advance investment care deeply reverse development amr rise amr old multicenter eventdriven vaccine efficacy study africanle innovation protect health rank significant health threat face feature groupsequential design include community world critical local world leave uncontrolle turn routine infection adult aged year old additional risk researcher opportunity investigate surgical procedure lifeordeath situation factor invasive disease challenge impact community help counter amr threat johnson johnson commit leave community collaboration invest advance critical science provide foster talent provide tool access antibiotic safeguard longterm effectiveness opportunity need create innovative solution meet public health need effort janssen public health antibiotic backbone modern medicine lead pursuit novel vaccine therapeutic tackle century increase resistance range drugresistant infection include drtb coli threatens render ineffective innovation specifically decade investment help end critical antimicrobial resistance new antibiotic drug discovery outpace rise kelly chibale phd contributor effort outpace amr threat multi extremedrug resistant pathogen founder director declare amr global public health threat face humanity annually million death attributable amr million death associate amr anil koul phd sharing datum accelerate amr research vice president discovery partnership please commit participate groundbreake datum global public health janssen sharing initiative increase understand amr launch johnson johnson found member amr action nonprofit vivli amr register make possible fund amr industry alliance focus create biopharmaceutical company share susceptibility datum sustainable ecosystem investment innovation tackle dedicate resource amr science expand infectioncause pathogen time online amr threat amr action fund centers global health discovery centers platform mark critical step combat grow global investment company adaptive phage therapeutic launch johnson johnson satellite center global health health threat amr active participation lead venatorx pharmaceutical promise deliver innovation discovery holistic drug discovery development pharmaceutical biotech enterprise include johnson change treatment landscape drugresistant infections centre university cape town south africa satellite johnson researcher able use amr register advance amr action fund goal bring center working drive new solution address present new antibiotic market decade million rise threat amr specific focus multidrugresistant translate mass amr surveillance datum meaningful action commitment fund help advance goal gramnegative bacteria mdrgnb team janssen save life preserve antibiotic future generation leverage combine global institutional regional advance expec vaccine expec lead strength bolster early stage science innovation learn progress outpace amr pathogen amr crisis year initiate phase talent development need tackle amr research new embrace study evaluate efficacy safety immunogenicity satellite center build johnson johnson decade work single injection investigational vaccine prevent accelerate innovationfrom labtolastmile healthcare outpace threat amr antimicrobial resistance httpswwwwhointnewsroomfactsheetsdetailantimicrobialresistance access february ihme lancet estimate million people die antibioticresistant bacterial infection death hivaids malaria httpswwwhealthdataorgnewsreleaselancetestimatedmillionpeoplediedantibioticresistantbacterialinfection access february healthcare innovation gri health humanity report innovation essential fabric johnson johnson year thank incredible effort tens thousand scientist researcher engineer designer clinician pioneer multiple breakthrough profoundly change trajectory health humanity advance innovation johnson johnson channel outline position innovation investment million new science facility bay area strengthen capability transform discover develop deliver innovative medicine fast efficiently integrate drug discovery data science digital health aim accelerate growth bestinclass portfolio deliver well health outcome people worldwide stacy feld site head san francisco bay campus regional head chairman ceo joaquin duato janssen employee open johnson johnson innovation west north america san francisco bay campus photo orange photography healthcare innovation open late stateoftheart janssen facility double presence san francisco bay world expand center area locate world establish global hubs global health discovery advance healthcare science target innovation campus bridge key scientific technological press challenge global health region great need capability colocate janssen johnson johnson launch satellite centersone south africa company thrive innovation innovation integrate company bay area address threat amr singapore focus johnson johnson state obvious innovation ecosystem strengthen increase collaboration dengue flavivirus investment billion past innovator accelerate growth year walk talk investment learn global health discovery center dual benefit patient globally gain access innovation johnson johnson innovation janssen advanced treatments johnson johnson continue billion lead impact healthcare marketscurrently brand platform generate invest past year deliver billion revenue annually investment innovation healthcare innovation advance purpose continue key element success improve live joseph wolk executive vice president chief financial officer johnson johnson pharmaceutical health humanity report pharmaceutical organization advance purpose change trajectory health advance treat leukemia achieve significant approval imbruvica ibrutinib humanity pursue breakthrough wide range therapeutic area biological pathway apply expertise small molecule monoclonal antibodie cell gene therapie marketing authorization grant expand use imbruvica ibrutinib fixedduration combination rna therapeutic regimen adult previously untreated chronic lymphocytic leukemia mark firstever approval imbruvica fixedduration regimen patient form cancer deliver numerous recent achievement agent anticd monoclonal antibody carvykti fda approval imbruvica ibrutinib grant therapeutic area chimeric antigen receptor tcell cart therapy work treatment child chronic graft harness patient immune system tcell attack versushost disease cgvhd lifethreatening complication cancer cell occur stem cell bone marrow transplant newly transplant donor cell attack transplant recipient learn story real patient treat body transplant treat child carvykti caregiver follow innovation lead johnson hemoglobin problem sickle cell anemia thalassemia johnson pharmaceutical team year child suffer leukemia deeply honor recently join talented fda approval tecvayli teclistamab novel firstinclass tcell redirect bispecific antibody activate pharmaceutical team pharmaceutical innovation additionally johnson johnson innovation enter new bodys immune system fight cancer grant critical component global progress healthcare collaboration advance research specialist oncology field treatment patient relapsedrefractory multiple myeloma johnson johnsons significant investment milestone mark significant development heavily seek new cancer treatment janssen oncology enable discover develop transformational hangzhou dac biotechnology discovery clinical stage pretreate patient limit treatment option today medicine improve human health patient biotechnology company form research collaboration serve world license agreement aim discover develop novel pharmaceutical antibody drug conjugate candidate target dac biotechnologys expertise innovative platform john reed phd combine janssen oncologys proprietary antibody give heterogeneity disease multiple executive vice president research collaboration focus prostate cancer hematologic myeloma incredibly challenging treat pharmaceutical malignancy solid tumor target therapy help maximize nonetheless dedication janssen impact early stage research meet significant unmet work cure disease enable need cancerrelate healthcare challenge conceptualization execution rich program oncology enable significant step forward entire optimizing car cell treatment janssen biotech form multiple myeloma community research collaboration serotiny gene cell therapy line strategy address unique cellular target development company leverage serotinys multiprotein immunotherapy treatment regimen deep expertise domain discovery platform janssen antibody development multiple myeloma realize breakthrough development cell therapy expertise create nextgeneration carbase multiple myeloma therapy address high unmet yusri elsayed mhsc phd cell therapies collaboration potential advance need profoundly impact live patient live vice president hematologic malignancies scientific innovation develop nextgeneration cellular therapy form cancer disease area leader janssen improve therapeutic function enhance clinical benefit fda approval carvykti ciltacabtagene autoleucel positively impact live patient family grant treatment adult relapse fda breakthrough therapy designation grant refractory multiple myeloma prior line talquetamab firstinclass bispecific antibody treatment therapy include proteasome inhibitor immunomodulatory heavily pretreate patient live multiple myeloma health immunology build legacy leadership immunology innovation myasthenia gravis highly debilitate rare humanity report janssen investigate target treatment nipocalimab autoantibody disease currently cure seek redefine standard care people living address underlie cause antibodydriven disease difficult diagnose investigate immunemediate disease focus unmet patient need nipocalimab investigate maternal fetal disease rare nipocalimab address range autoantibodymediate actionable science key product autoimmune disease prevalent rheumatologic disease unmet need disease include result phase study community stelara ustekinumab tremfya guselkumab high case therapy currently available nipocalimab patient generalize myasthenia gravis gmg progress show rapid robust sustain clinical response placebo phase trial adult phase study child stelara receive fda approval treatment pediatric neuroscience underway patient age year old active psoriatic arthritis psa janssen intend reconceptualize diagnosis treatment tremfya celebrate fiveyear milestone approval nervous system disorder aim reduce burden cardiovascular metabolism retina treatment moderate severe psoriasis disability experience patient worldwide researcher janssen publish comprehensive analysis demonstrate janssen pioneer multiple approach neuroscience cardiovascular metabolism retina therapeutic area cover tremfya rank highest approve therapy skin reduce disability cause neuropsychiatric common cause death cardiovascular clearance treatment psa neurodegenerative central nervous system autoantibody disease lifethreatening condition disease extend scientific advance precision medicine significantly impact overall health include chronic kidney disease advanced critical research immunemediate inflammatory retinal disease disease imid crohns disease ulcerative colitis alzheimer disease lead way revolutionize psa progress work study oral cytokine inhibitor differentiate tau portfolio employ latest announce result phase axiomatic new form treatment people live imid phase advancement precision medicine datum science digital secondary stroke prevention study milvexian novel oral trial treatment moderate severe plaque psoriasis health use unique biomarker speed early diagnosis drug anitcoagulant enrol patient investigational novel combination therapy development decision make primary ischemic stroke early stroke recurrence ischemic guselkumab golimumab tnf show promising stroke remain significant risk despite advance secondary pharmaceutical result treatment biomarker team develop evaluate blood test prevention data axiomaticsecondary stroke predict central amyloid positivity tau statusindicators prevention study show approximate relative risk adwith high accuracy develop novel digital reduction recurrent symptomatic ischemic stroke biomarker collaboration lead technology firm favorable safety profile arm study compare example kielements pilot speech placebo suggest milvexian potential improve biomarker technology machine learning identify pathway approach potentially outcome stroke patient clinical practice result abnormality speech pattern predictive treat multiple disease rare prevalent finding axiomatictkr study set stage early disease mechanism exciting bring comprehensive phase program therapy patient quicker efficiently depression neuroscience team lead charge excite potential nipocalimab receive encourage result phase form depression mental health condition bring relief patient suffer study evaluate investigational gene therapy botaretigene place heavy burden society affect million patient devastating disease sparoparvovec treatment xlinked retinitis pigmentosa worldwide launch new mechanism decade xlrp rare condition cause progressive vision loss start spravato esketamine ciii nasal spray use conjunction childhood night blindness lead legal blindness oral antidepressant march adult treatment middle age gene therapy approach advance katie abouzahr resistant depression august depressive symptom candidate therapeutic common ocular disease include vice president portfolio development leader adult major depressive disorder mdd acute suicidal geographic atrophy autoantibody janssen ideation behavior addition janssen advance drug candidate novel mechanism action depression include aticaprant seltorexant altogether effort aim provide patient potential option combat depression medtech innovation health humanity report century harness power technology breakthrough innovation elevate new standard care surgery orthopaedic heart rhythm disorder eye health neurovascular care field help save improve life create future healthcare solution smart invasive personalize period expansion innovation medtech deliver depuy synthe specialize orthopaedic solution help heal ethicon continue advance nextgeneration treatment option significant product launch past year restore movement million patient china work lung tumor minimize impact surgery patient bring advanced medical technology people johnson johnsons printing group depuy synthe allow speedy recovery ethicon solution world bring chinese market highly personalize dprinte transbronchial microwave ablation neuwave flex cranial implant thermoplastic polymer execution microwave ablation system guide monarch platform enable availability critical implant low ethicon clinical trial patient lung tumor power cost short lead time implant manufacture study aim demonstrate safety effectiveness traditionally help ensure surgery safe precise innovative approach december milestone medtech nurture connection time efficient production cranial implant achieve patient successfully treat healthcare professional late technology run depuy synthe suzhou manufacture plant power study improve save life forefront close december complete acquisition patient care uniquely position catalyst abiome inc world leader heart recovery solution drive scale progress creator world totally implantable artificial heart abiome bring rich history innovation cardiovascular care complement exist leadership diagnosis ahmet tezel treatment cardiac arrhythmias biosense webster medtech innovation company group chairman global head electrophysiology business medtech innovation johnson johnson advance treatment stroke collaborate physician academic invest scientific research advance treatment new patientcentere innovation wide range ischemic hemorrhagic stroke stroke leading cause innovative surgical technology solution patient death million people worldwide affect stroke annually hcps seek continuous improvement deliver well patient cerenovus medtech company launch outcomes safety efficiency reliability example emboguard balloon guide catheter cerenovus include dprinte cranial plate sample produce johnson johnsons stroke solution suite technology emboguard design printing group optimize removal blood clot control blood flow locally medtechs depuy synthe velys digital surgery thrombectomy procedure balloon guide catheter platform cuptimize hipspine analysis late surgical medtechs ethicon franchise receive fda clearance show increase ability restore blood flow planning feature vely hip navigation simple xray urology procedure monarch endoscopic robotic pass reduce procedure time reduce odd clot fragment base digital tool use patient specific datum help surgeon platform monarch multispecialty breaking cause new ischemic event assess dislocation risk identify patient abnormal pelvic flexible robotic solution use bronchoscopy urology tilt require unique cup placement dual mobility design stroke cerebrovascular accident httpswwwemrowhointhealthtopicsstrokecerebrovascularaccidentindexhtml access april medtech cerenovus launch emboguard balloon guide catheter use treatment acute ischemic stroke httpswwwjnjmedtechcomenusnewseventscerenovuslaunchesemboguardballoonguidecatheterusetreatmentacuteischemic health prevent treat atrial fibrillation afib advanced april biosense webster announce patient biosense webster build large online patient community humanity report solution address afib new product research enrol admire clinical trial evaluate global smart afib campaign awareness effort inform help patient include safety effectiveness company investigational participant effort dedicated europe biosense webster launch radiofrequency pulse field ablation pfa platform principal component educate patient caregiver healthcare provider afib balloon ablation catheter heliostar enable physician varipulse catheter trupulse generator sign symptom treatment option include catheter ablation treatment afib pfa represent new approach europe advance safe effective efficient treatment treat afib utilize control electric fieldinstead solution patient suffer afib europe catheter thermal energyto ablate treat cardiac tissue ablation recommend firstline treatment option exciting advance physician patient octaray mapping catheter launch mapping cardiac variety benefit biosense webster working bring arrhythmias include afib assist physician capture versatile portfolio pfa solutionscomplementary starlight action longterm education project precise information catheter ablation procedure catheter portfolioto address ablation strategy enhance clarity speed cardiovascular cerebrovascular health treatment afib aim pull strength party popularize medtech company biosense webster progress research afibrelate knowledge advocate healthy afib patient behavior north america help inform lifestyle entire population way support afib prevention treatment physician patient biosense webster afib pulsecheck survey spline electrode increase adult diagnose afib reveal despite fear surface area coverage improve signal quality anxiety afib patient delay seek treatment sun zhiwei octaray mapping catheter allow well end emergency room afib chairman beijing bethune charitable foundation understand anatomy conduction property insight provide clue well promote afib behavior chamber interest change especially highrisk patient china biosense webster support new starlight afib public awareness campaign help popularize knowledge amit thosani prevention treatment afib cause death medtech innovation director cardiac electrophysiology elderly cardiovascular disease major health allegheny health network threat chinese people afib frequent cardiac arrhythmia estimate million people worldwide suffer condition million people europe hindrick potpara dagre esc guideline diagnosis management atrial fibrillation develop collaboration european association cardiothoracic surgery eact euro heart feb https pubmedncbinlmnihgov access february lippi sanchisgomar cervallin global epidemiology atrial fibrillation increase epidemic public health challenge int stroke feb httpspubmedncbinlmnih gov access february data science digital health health humanity report johnson johnson view innovation data science digital health critical engine clinical trial subsequently deploy screen patient clinical site mark important advancement longterm business success foundation positive contribution sustainable development medicine datum science demonstrate potential equitable inclusive society rapid optimize care patient need early detection pulmonary hypertension fda grant breakthrough device designation aienhance sector combine innovative technology datum science project span development portfolio asset pulmonary hypertension early detection algorithm develop lead science deliver care groundbreake new way drive transformational innovation impact patient collaboration janssen anumana health technology vast diverse portfolio digitally power treatments company mayo clinic algorithm precise non solution aim people age stage life invasive screening tool help address unmet need early diagnosis patient unnoticed disease advanced point limit treatment efficacy downloadable physician digital johnson johnson continually evolve device access cloud algorithm accessible shape future healthcare unlock innovate stretch boundary broadscale use early detection approve power people technology insight possible combine late datum science doctor use scalpel stethoscope use digital health deep expertise science engage patient remotely study immunemediate skin condition launch remote immunodermatology connect datum automation robotic change develop gamechange solution tackle observational study capture image patient live digital build agile tough health challengesall goal patient live immunemediate skin disease support adaptive efficient sustainable process improve patient outcome change development algorithm need create objective business apply tech good trajectory healthcare measure disease severity diverse skin type study advance health wellbee people patient smartphone capture photo skin world time create unique datum set volume require najat khan phd detail analysis currently severity immunemediate skin datum science digital health chief datum science officer global head condition measure doctor naked eye strategy operation janssen jim swanson lead high variability severity assessment digitally executive vice president chief information officer enable remote study generate new way assess johnson johnson application data science digital health immunemediate skin condition enable improve treatment pharmaceutical program help transform solution future offer ability assess innovate example way skin condition remotely technology help reduce data science digital health datum science method leverage include burden patient require time pharmaceutical work family visit doctor office clinical center bladder cancer trial recruitment janssen establish example johnson johnson leverage collaboration paige global leader clinical application potential datum science digital health revolutionize digital tool help improve clinical trial diversity reduce pathology deploy firstofitskind aipowere biomarker healthcare immense large diversified healthcare burden participation clinical study test develop janssen screen presence certain product company johnson johnson data science alteration fibroblast growth factor receptor fgfr gene digital health reimagine discovery development patient advance urothelial cancer know medicine advance mission bring transformative bladder cancer goal provide physician insight treatment vaccine patient world help tailor patient treatment plan facilitate clinical trial method fundamentally shape way think work recruitment biomarker test validate janssen solve problem portfolio health enable healthcare selfmanagement develop empower team digital innovation humanity report diseaseagnostic digital health platform initiate clinical study utilize platform collaboration large diverse organization apply digital tool university nairobi uon local tech company savannah dimension work digital health process healthcare new place world map global health institute platform call mycarehub invest share work progress internally encourage time crisis industry demonstrate test young people live hiv kenya learn reapplication successful idea creating unify world common purpose integrate clinical site manage uon awareness late technology team bring good mind science kenyan health system develop educate empower johnson johnsons data science council publish internal engineering supply chain public health meet provide remote support patient manage datum science business impact report showcase evolving need patient health system health link medical record secure digital compelling example team commercial supply world stop vehicle facilitating engagement hcp connection chain enterprise function work promise medtech continue deliver innovation patient janssen mycarehub available potential datum science reality advance modern connected digitallyenable nonexclusive royaltyfree license uon experience representative health system patient hold annual janssen data science digital health gain help guide development platform center symposium bring colleague lie foundation potential future implementation day discussion presentation janssen region datum science digital health transformational force medicine patient datum science digital health project ashley mcevoy showcase symposium speaker deliver medical technology intelligence executive vice president worldwide chairman medtech johnson johnson include expert industry startup academia future medical technology smart invasive johnson johnson executives share insight personalize digital technology help enable future deliver datum intelligence personalize patient outcome improve efficiency accuracy knee surgery depuy synthe use rightsize total knee arthroplasty tka focus precision efficiency operating room total hip arthroplasty tha implant create deploy accelerated innovation industry advanced analytic mldriven prediction tka tha procedure direct datum science practice impact medtech industry want employee fluent language customer electronic medical record depuy synthe tailor datum science digital health connect device robotic software solution generate datum science achieve goal list require component meet need specific valuable connect datum medtech embrace personalize learn development opportunity surgery deliver possible standard size power datum science transform way help deliver support upskille critical capability make surgery coordination efficient accurate personalize healthcare well patient outcome need effective increasingly way run business automate imaging improve eye disease diagnosis digital world improve afib treatment complexity afib customdesigne aidriven device johnson myriad decentralize datum cardiac electrophysiologist johnson vision automate processing meibomian gland manufacturer struggle generate consistent result image lead well understand patient peter fasolo phd patient operator biosense webster introduce disease mgs produce meibum oily substance prevent executive vice president chief human cartonet cloudbase datum management system evaporation eye tear film necessary eye health resource officer johnson johnson potential improve procedure efficiency outcome connect new device johnson johnson vision deep learning algorithm cartonet evaluate pattern lipiscan imager enable consistent evaluation patient enable physician assess performance easily disease base realworld outcome enable well diagnosis cartonet compatible carto biosense websters medical intervention mapping system integrate electrophysiology mapping ablation catheter innovation collaboration health humanity report johnson johnson innovation accelerate early stage innovation strategic partnership seoul innovation quickfire challenge september seoul innovation quickfire challenge awardee sirnagen therapeutic connect good science technology entrepreneur global resources portrai recognize seoul international biomedical expertise world tough healthcare challenge aim improve health conference help advance science company receive krw grant funding year residency seoul bio hub access johnson johnson innovations apac ecosystem mentorship expert johnson johnson connect potential collaborator worldleade resource new quickfire challenge launch aim support advance transformation science challenge complete technology spectrum pharmaceutical medical device consumer healthcare similarly collaborate advance health equity quickfire challenge receive widely group partnership consortia research submission focus enable inclusive clinical trial design agreement accelerate progress way company equitable clinical decision make implement community achieve base early diagnostic education patient provider advance health equity awardee receive grant fund total pool access global jlab network mentorship expert johnson johnson quickfire challenge awardee include prepare future johnson johnson womenled team team lead people color promote diversity healthcare startup feel effort require new idea new generation quickfire challenge launch specifically johnson johnson innovation ecosystem empower entrepreneur deployment new tool health equity focus grant fund total pool healthcare startup embrace dei early stage scientific inquiry generate aggregate analyze million award team company lifewhen create identity research datum develop insight test hypothesis focus approach culture end introduce inform development new way prevent maternalfetal immune disorder quickfire challenge johnson johnson innovation health equity assessment intercept cure disease innovate health equity seek improve immunemediate tool heat johnson johnson innovation innovation collaboration pregnancy outcome mother child bipoc collaborate company voluntary survey design help early community challenge award total grant stage innovators benchmark health equity maturity william hait phd fund promising organization aim advance health consider health disparity company leadership executive vice president chief external innovation equity address unmet medical need pregnancy care potential healthcare solution delivery selfassessment medical officer johnson johnson pair johnson johnson innovation health equity vet quickfire challenge lung cancer physical elearning module raise awareness help establish baseline trauma reflect commitment keep veteran healthy understand completion elearning module activate health innovator entrepreneur jlab advance healthcare innovation benefit military available public quickfire challenge effective way advance research community challenge seek idea directly address practical innovation address range unmet medical need unique healthcare need military community include lung introduce johnson johnson innovation board fellow quickfire challenge crowdsource platform commit cancer physical trauma grant total program oneyear multifaceted education executive coaching identify cultivate potential health solution change awardee focus lung cancer offer mentorship program help strengthen diverse candidacy trajectory healthcare solution address physical trauma potential board leadership position june inaugural class johnson johnson innovation board fellow begin quickfire challenge champion health equity seek oneyear program board fellow pair jjdc mentor identify potential solution serve historically underresourced help understand developmental opportunity community reach wide range diverse scientist achieve potential potential board director researcher innovator world diversity equity inclusion clinical trial health humanity report johnson johnson diversity equity inclusion clinical trial priority help create janssen oncology provide million grant stand cancer nonprofit organization support cancer research transformational therapy work patient support development innovative approach remove barrier clinical trial participation patient racial ethnic background patient medically important step journey achieve health equity deict team complete clinical trial diversity plan resource community ensure opportunity participate clinical janssen therapeutic area include support local research right market metric report dashboard help guide progress approach aligns anticipate fda initiative underrepresented population face variety barrier expand action disclosure clinical trial diversity impact clinical trial enrollment include fear mistrust lack janssen different research team demonstrate commitment awareness logistical challenge structure process lead funder cancer research stand area example janssen immunology dei working examine advance dei clinical trial include multiple cancer believe critical ensure group formulate specific dei strategy progress partnership enhance awareness build trust lack diverse representation cancer clinical trial hire racially ethnically diverse leader janssen underresourced underrepresented community hope address national imperative enhance culturally relevant training host speaker event change trajectory health disparity clinical research turn away need fresh idea help innovate racial ethnic disparity healthcare engage redesign cancer clinical research enterprise innovation partnership promote inclusive research accord fda clinical trial participant include community long leave new molecular entity therapeutic biologic approve janssen organization proactively submit white black african american diversity plan fda oncology trial ahead asian hispanic regulatory bodys new guidance initiative expand action russell chew disclosure clinical trial diversity fda commitment janssen diversity equity inclusion clinical president ceo stand cancer prioritize diversity clinical research potential well trial deict team create template embed diversity connect regulatory approach industry broad health clinical trial process template relevant janssen janssen oncology provide grant million american equity goal help janssen deliver mission therapeutic area cover dimension diversity include race cancer society fund navigate patient care create future disease thing past ethnicity gender sexual orientation socioeconomic factor treatment continuum program janssen contribution support template insight janssen research include improve representation cancer clinical trial janssen collaboration health system year enhance dei clinical trial initiative equitable representation clinical trial oncology support enhance clinical research capability oncology patient experience addressing barrier strengthen africa collaboration african access initiative enrollment underrepresented marginalized community aai publicprivate partnership drive bio ventures research include meet community global health nonprofit accelerate povertyrelate accelerate diversity medtech research medtech educational material connect patient current trial disease africa address disparity representation take step improve meaningful representation clinical partner advocacy group understand community african cancer clinical trial janssen oncologys support study lead well product well outcome needs build trust safety clinical trial healthcare aai begin initial assessment access cancer develop policy position diversity research clinical system overall research include connect care hospital african country patient education trial outline policy reduce barrier million people message importance diverse community awareness program training program participation continue support diversify representation clinical research website cohoste hcp cancer diagnosis treatment investigation equitable research study multilingual event participation community event diverse trial act introduce house senate mobile health van provide expand legal authority company diversify clinical trial found sponsor medtech learn research include color medtech help advance representation person color medtech industry drug trial snapshot report httpswwwfdagovmediadownload access february consumer health gri health humanity report announce intention separate johnson johnson consumer health business support smoking cessation nicorette bring nicotine replacement therapy market year ago create new publicly trade company place leader andbacke year research innovation intersection healthcare consumer good remain committed eradicate smoking johnson johnson consumer health continue support smoking cessation join launch event tobacco cessation new company name kenvue commit help alongside preparation establish kenvue standalone consortium consortium publicprivate coalition support consumer realize extraordinary power everyday care company johnson johnson consumer health advance work tobacco cessation worldwide participation kenvue combine power science meaningful human mission improve total health allfor individual age consortium build nicorette previous support insight digitalfirst capability empower billion stage life community planet support access initiative quit tobacco deliver positive people live healthy life day kenvue portfolio iconic million investment healthy life mission aim result term smoker quit completely nicorette brand build moment uniquely matter consumer fight preventable disease impactful education donate million worth nicorette patch drive positive health outcome world partnership start smoking cessation skin cancer help people quit smoking prevention thibaut mongon worldwide chairman consumer world billion tobacco user access health johnson johnson serve chief executive officer enhance product transparency help consumer tool help quit successfully kenvue remain track complete separation inform choice personal health product subject market condition advocate menstrual dignity stayfree join improve sustainability product operation unicef year promote education menstrual recycled material make packaging easy recycle kenvue inspire powerful idea ken hygiene address menstrual poverty brazil reuse power operation renewable electricity mean knowledge vue reference sight rich knowledge human need deep consumer insight progress advance healthy life mission include million people directly affect menstrual kenvue deliver meaningful personal health solution poverty brazil lowincome woman know promote skin cancer awareness neutrogena sun menstrual poverty inschool program bring skin cancer prevention awareness student access menstrual hygiene public health issue follow release neutrogena studio awardwinne human right issue accord woman especially featurelength documentary film sun elevate lowincome region live menstrual poverty mean awareness understand sun safety skin cancer lack basic access buy hygiene product lack consumer health skin type color school participate access water sanitation stayfree join unicef inschool education program year feedback year address menstrual poverty brazil inschool program school student survey stayfree donate sanitation pad menstrual student say change sun safety habit result hygiene kit distribute unicef teenager brazil watch film support educational outreach widely country india stayfree continued period campaign globally million case skin cancer normalize topic menstruation india leverage daughter diagnose skin cancerassociate day second year occasion destigmatize period death report experience especially household menstruation consider taboo educating involve family kenvue plan new johnson johnson consumer health company member support announce purpose realize extraordinary power everyday care ultraviolet radiation httpswwwwhointnewsroomfactsheetsdetailultravioletradiation access february directorgeneral approve tobacco cessation consortium httpswwwwhointnewsitem tobaccocessationconsortium access february accord research commission stayfree partnership kyra institute mosaiclab women gender equality sanitation access httpswww unwomenorgendigitallibrarypublicationstowardsgenderequalitythroughsanitationaccess access february health expand product transparency consumer johnson alignment target eliminate polystyrene jar collaborate great impact johnson johnson consumer humanity report johnson consumer health expand product transparency black plastic bottle global portfolio cease health collaborate industry peer ngo supplier dashboard lead consumer health brand source packaging component resin material advance sustainability transparency objective help empower consumer informed choice addition improve sustainability product partnership collaboration include personal care product use rely transparency packaging include dashboard consumer launch include product animalfree safety assessment afsa collaboration listerine ogx introduce innovative product format forum bring collective voice nonprofit industry specific information ingredient science sustainability include mouthwash concentrate shampoo bar leader support education advocacy help meet consumer need expand product reduce need packaging eliminate need animal testing cosmetic transparency dashboard consumer health brand tailor information need consumer aveeno neutrogena johnsons baby petit ecobeautyscore consortium industryle collaboration marseillais launch reuse refill solution reduce brandbybrand basis johnson baby unveil company association help consumer plastic use compare exist packaging dashboard lead global market outside understand environmental impact cosmetic personal brazil canada introduce organic tampon certify care product launch environmental scoring organic cotton plastic free string system cosmetic product help inform consumer improve packaging sustainability advance healthy purchasing decision live mission take important step reduce environmental carefree launch organic cotton topsheet liner impact personal care product packaging virgin certify organic cotton topsheet company organization packaging value chain digital watermark initiative holygrail plastic increase use recycle material improve brand portfolio increase use pcr plan assess pioneer digital watermarking recyclability reusability packaging effort plastic packaging material forest stewardship council fsc technology enable well sort higherquality recycle align consumer health packaging target support certify paperboard rate package participation signatory ellen macarthur foundations new plastic economy global commitment additionally advance circular economy packaging sustainability continue collaboration organization include consumer good forum plastic waste coalition action close loop infrastructure fund consumer health sustainable packaging target astar institute materials research engineering circular material lab helping develop new global industry design rule eliminate reduce total sustainable packaging expand recycling infrastructure polystyrene jar black annual use plastic bottle global virgin plastic packaging north america research circular flexible film packaging solution consumer health portfolio weight respectively compare achieve use combination recyclable reusable recycle plastic plastic compostable plastic packaging reduction packaging reuse model learn consumer health advance use sustainable manufacturing environmental health certify postconsumer recycle pcr paper pulp base packaging learn progress signatory ellen macarthur foundations new plastic economy global commitment health humanity report employee employee tiffani renee collaborate tampa global services siteemployee attraction development gri sasb hcbpa sasb hcbpa health humanity report employees johnson johnson world continue energize purpose employee attraction blend heart science ingenuity profoundly change trajectory health humanity recruitment effort include outreach wide range single employee differenceand approximately channel partner encourage diverse representation individual corner globethat add huge impact qualified candidate employee referral generate significant proportion hire effort demonstrate employee confidence johnson johnson attractive workplace area progress related employee attraction attract develop retain inspire good people global workforce region development include globally crucial aspect johnson johnsons business employee attraction development promote culture respect inclusion excellence inspire people return work career break reignite inspire credo talent individual johnson johnsons global career reentry program offer johnson johnson leveraged ensure company experience professional take break community environment individual career year opportunity return thrive grow workforce specialize onboarding network development activity addition ambition support woman return stemd profession reignite genderinclusive program officially expand focus include return professional outside stemd role anticipate develop critical capability johnson johnson help accelerate asia pacific europe middle east africa inception reignite enable professional business outcome today futureproof latin america north america country region return johnson organization tomorrow effectively johnson workplace continue career create meaningful personalized learn meaningful role experience help shape highly capable leader empower employee chart individualized career new employee hire region path feed purpose like lot woman school gate highly peter fasolo phd skilled educate know break executive vice president chief human workplace self resource officer johnson johnson confidence sense hide workforce reignite provide support structure need help adjust return workplace direct global workforce include approximately participate program find slot individual include approximately new work environment like leave hire different region woman empower feel relevant asia pacific europe middle east africa lose skill latin america north america abiome headcount exclude global employee datum employee deirelate disclosure value round barbara mccarthy near tenth round number present add site pmo manager johnson johnson vision precisely total provide percentage precisely reflect absolute figure health hire military veteran alongside appreciation value advance leadership development develop leadership complete significant people leader assessment humanity report service appreciate unique skill experience military skill level career stage ondemand content time people leader receive report veteran military spouse bring business engage innovative personalize module suite provide valuable feedback people leadership skill government body veteran support organization expand leadership development program thousand support ongoing development empower hire pathway military veteran offer veteran employee level help organization deliver critical objective development program support transition civilian life work strong progress employer choice military community nhance expand hire development opportunity sale leadership program johnson johnsons learn development employee attraction development military veteran leadership development program launch number maintain retention cohort total veteran million ire veteran department defense skillbridge total spend employee employee program provide transition military service member learn development puerto rico participate civilian work experience final month service tuition reimbursement program johnson johnson offer internship program skillbridge participant complete learning hour program annual cycle hire skillbridge interns johnson johnson new leader participate johnson johnson fulltime employee learn host employee spend enterprise leader approximately average hour employee complete eaffirme commitment veteran military spouse hiring learn program train development program yearend performance veteran job mission coalition bring available employee review hundred lead company actively hire veteran manager move function voluntary turnover rate learn development country business segment line building continue invest heavily wide variety learning embrace learn mindsetboth diversity experience development program help employee realize career teamswe well able anticipate goal build capable resilient workforce develop critical capability need future example follow accelerate business outcome futureproof deliver new learn ecosystem launch learn organization provide rewarding career career progression movement opportunity allow employee realize include upward promotion global learning development platform integrate lateral transfer exclude curriculum multiple learn organization pursue unique purpose aspiration employee organization enterprise include leadership development program human performance institute program single source learn development needs leverage sandra humble late technology include learn deliver streamlined chief learn officer johnson johnson learning experience easy access navigate enable employee incorporate learn daily practice create career path right learn include learn program facilitate match mentor learn people development resource holistic career review development planning tool position employee development health building digital capability support everexpande use compensation benefit humanity report digital technology data science aspect work function business heavily invest compensation framework consistent worldwide build broad digital capability workforce focus include set core principle guide compensation effort provide common learning experience decision recognize important contribution johnson johnson launch digital upskille channel employee deliver mission way align support digital mission learn activation value commit pay equity include gender comprise learn format synchronous ethnicracial group pay equity asynchronous learning quiz article specific periodically analyze pay function assess digital capability provide team effective experiential market competitiveness eliminate unconscious bias learning opportunity support innovative approach employee attraction development barrier pay equity enterprise playbook local activation digital mission additionally invest significantly target salary increase johnson johnson employee continue access italk country enhance competitive pay position digital education series develop technology division influence inflationary pressure teach digital topic italk video available employee analysis year new framework monitor inflation highlight area alignment addition increase investment employee total health portfolio address rise rate mental health concern ongoing uncertainty consequence covid pandemic digital acuman continue critical capability believe investment employee spectrum johnson johnson enable team reimagine compensation benefit help johnson johnson transform business model accelerate outcome attractive employer resilient business futureproof organization additionally complete annual living wage assessment aim ensure employee globally receive pay competitive local market sufficient support michael ehret phd sustainable standard live family head global talent development johnson johnson section human right enhance hybrid working continue implement hybrid working model flex globally capture energy inperson interaction remote flexibility supply chain flexibility offering onsite employee establish combine locally relevant practice globally consistent hybrid work framework site new approach example remotely onboard thousand supply chain team member complete portion total require training assignment online diversity equity inclusion gri health humanity report diversity equity inclusion advance culture belong open heart mind combine unleash potential brilliant mix people work johnson johnson today join future strategic approach drive dei johnson johnson dei fundamentally embed human resource strategy section race health equity orthe way base mission vision dei strategy design health humanity goal helping eradicate racial social injustice public follow health threat eliminate health inequity people color build workforce reflect diversity diversity equity inclusion health humanity goal community accelerate global culture inclusion individual belong dei number transform talent business process achieve equitable access outcome progress woman management vice president director drive innovation growth business management position globally hold woman globally woman manager serve diverse market world identify ethnic racially diverse progress ethnicracial diversity dei mission dei vision management employee diversity equity management position hold ethnic latin america woman high rate woman workforce change world inclusion racially diverse employee region identify ethnic work day racially diverse progress blackafrican americans management workforce chieve growth black african management age employee engage position black african american employee employee resource overstate positive impact diverse represent management position group erg voice bring organizational culture community society large challenge remain continue create inclusive environment fourth annual dei impact review share insight employee embrace individual cultural evolution dei strategy wide range story difference drive innovation progress advance dei pillar strategy business segment wanda hope chief diversity equity inclusion officer johnson johnson health area progress advance equitable access outcome womens representation executive committee increase humanity report dei woman follow leadership restructure testify strong pipeline woman partner multiple initiative orthe senior level company commitment realize opportunity woman team business leader address mental diverse workforce key role appoint female general counsel company history health inequity diverse community strengthen development generation johnson johnson leader support effort advance inclusive rise ascend development program diversity clinical trial provide gender representation opportunity hcp include woman orthopaedic surgeon surgical resident fuc llc yle hve der miri ofi ser color skillbridge program skillbridge facilitate robust duallanguage campaign janssen research include initiative diversity equity inclusion intern johnson johnson hispanic heritage month well fulltime employee communicate importance participate remove barrier access expand clinical trial hispaniclatino community diverse slate broaden hire criterion remove bias job posting innovation growth culture inclusion advanced supplier diversity procurement team help achieve deliver conscious inclusion training significant increase diverse supplier spend vice president director woman fulltime woman woman women johnson johnson support brand team deliver brand employee management position executive position new hire innovation awareness campaign mpowere erg engage nearly address need diverse community colleague world skin care eye care oral health harnessing passion employee smoke cessation brand educate connect create space belong partner diverse community ethnicracial diversity multiple innovation quickfire challenge lead expand explore diversity jlab global immersive educational series build great cultural knowledge expand care pride initiative globally product brazil canada understanding employee white germany japan deliver interactive dei glossary asian evolving resource commonly dei recently file federal employer blackafrican american term ensure understand use information report eeo publicly available hispaniclatino language representative inclusive note federal reporting requirement require johnson johnson employees patient specific employee categorization differ consumer community way measure diversity progress decline answer reflect health humanity report directly comparable value round near tenth round number present add precisely total provide percentage precisely reflect absolute figure employee engagement gri health humanity report johnson johnson employee find inspiration purpose change trajectory woman stem health provide platform tool resource enterprise help aim encourage girl consider science technology contribute effectively engineering mathematic manufacturing design stemd study career opportunity knowledge advance gender equality technical profession strengthen encourage open inclusive communication society build strong pipeline diverse talent feel welcome offer idea suggestion underresource stemdrelate profession critical improve outcome patient consumer advance innovation healthcare credo survey demonstrate care community planet participation rate key result eligible employee connect employee platform use employee engagement track employee sentiment feel connected health humanity goal colleague value biennial credo survey administer country available language past year people globe agree favorability rate face overcome social economic challenge statement ensure reflect include relate covid pandemic face responsibility fulfil credo challenge employee maintain confidence commitment patient doctor progress woman stemd nurse mother credo value demonstrate strong support recognition employee father ngage girl way uphold value positively impact society use product event stemdorg activity total service girl engage follow analysis detail result communicate employee develop plan address main area opportunity identify employee feedback enterprise level individual team health humanity goal include specific target reach million girl stemd activity alternate year conduct global voice survey agreed agree lead johnson johnson employees partnership serve indicator employee satisfaction measure statement act statement provide nonprofit organization encourage employee play important aspect culture employee engagement responsibly inclusive work active role engage advance woman science inclusion development health wellness collaboration community environment execution innovation compliance risk live work employee consider johnson johnson employee world community individual recognize employee addition award honor volunteer directly engage stemd activity approximately girl program recognize contribution employee different function region maintain global woman science technology engineering mathematic peer recognition platform inspire reach global manufacturing design wistemd initiative support youth workforce country hundred thousand undergraduate scholar professional active recognition moment celebrate meaningful contribution wistemd youth pillar seek spark purposele behavior employee enchantment stemd young woman girl globe creative problemsolve play health wistemd undergraduate program collaborate engage employee healthy community bridge employment engage employee mentor help humanity report nearly university deliver event reach secondary school student improve academic performance university student variety activity johnson johnsons gci organization drive talent elevate career aspiration extension program pathway social medium campaign launch wistemd camp good strategy inspire employee help create healthy success help student succeed thrive high education weeklong pilot program europe student opportunity community globe talent good offer wide provide additional support fulltime pay summer internship explore postsecondary option stemd field initiative variety engagement opportunity employee invite johnson johnson internships plan extend expand wistemd preferred level participation focus area program apac latin america region interest talent good program include skillsbase young world engage employee support frontline health volunteering opportunity conduct partnership nonprofit leader project provide guidance mentorship wistemd scholars program select community partner program range shortterm build young leadership capacity globe change outstanding female researcher receive support drive volunteer local community mediumterm programs trajectory health important research program active connect employee nonprofit capacity select early midcareer woman faculty researcher build activity fully immersive engagement talent healthy community create great engagement employee engagement complete postdoctoral study make key month support nonprofit skill competencie awareness employee partner stemd discovery receive grant local community hybrid pro bono program address year mentorship receive quarterly giving initiative engage employee support critical capacitybuilding need community application highly qualified nominee local community encourage employee wistemd engage employee globally inspire young girl world applicant come outside volunteer community companywide day woman enter stemd field select wistemd scholar advance care pivotal global innovation diverse field aim global pro bono engage employee pair select significantly improve healthcare outcome partner organization work line health support build organizational capacity johnson johnsons wistemd scholar program provide outstanding female global secondment program enable empower select talent healthy community program researcher million grant funding advance johnson johnson employee support partner organization allow use professional skill set help pivotal healthcare innovation line health raise public health standard community project learn community globe share knowledge skill effectively manage project work passion sixmonth time frame multiple group people challenge rewarding ange therese akono pro bono health equity utilize skill talent awardee johnson johnson employee build capacity usbased work bone tissue community health center support community color regenerative engineering denivea williams program race health equity commitment focus discover senior manager acquisition divestiture value section race health equity excellence service lead johnson johnson nanostructure bone scaffold help restore quality life patient talent good program build longstanding require maxillofacial collaboration johnson johnson maintain bone repair year organization wide reach community help create meaningful volunteering opportunity johnson johnson employee maximize impact deliver tangible social benefit collaboration include health engage employee healthy planet humanity report johnson johnson employee passionate environmental talent good engagement employee engagement healthy planet sustainability seek impact engage inspire number number provide opportunity employee learn collaborate dedicated environmental sustainability programs bridge employment talent healthy learn ideashare platform wesustain community healthyplanet environmental sustainability train active wesustain team action complete country healthyplanet user employee volunteer protect environment employee water nourish well world simon year old china hour mentoring country volunteer win original piece employee engagement annual worldwide children energy color art contest employee training environmental sustainability student worldwide contest year open build online selfpace training module call sustainability community partner young relative johnson johnson job demonstrate johnson johnson employee employee opportunity contribute sustainability solution work follow engage future generation young world broad foundational sustainability training module launch play role reduce global secondment new training depict real employee example carbon emission program guide employee build action plan base employee role function interest optional sustainability training collaborate module strong employee world employee wesustain environmental sustainability employee volunteer engagement program wesustain mobilize passionate employee external scholar improve environmental health location live project address work sell product bring wesustain line healthcare ngo partner mentor student community global wesustain summit continuously provide opportunity employee globally join virtual live event hear internal employee learn build personal external speaker connect share idea professional sustainability capability decision pro bono sustainable future global pro bono today help protect environment health equity healthyplanet healthyplanet platform health future generation launch challenge employee calculate employee employee environmental sustainability impact offer personal carbon region volunteer volunteered calculator idea reduce footprint year deb gorhan employee complete action topic range director sustainability culture engagement ngo partner reduce energy lessen food waste eliminate johnson johnson ngo partners singleuse plastic incentive like charitable donation drive employee double action take previous year impact metric healthyplanet illustrate employeele saving include reduce paper use reduce trash low energy section woman stem detail wistemd activity consumption low water use employee health safety wellbee gri health humanity report johnson johnson uncompromise approach safety invest extensively health wellbee employee believe advance health humanity start protect enhance total healthphysical mental emotional financialof workforce aim ensure employee world temporary contractor visitor reinforce good safety practice commence yearlong global refresher program site work safely workplace health safety program include adherence robust safety habit framework employee space supply chain facilitiesand global safety standard risk assessment extensive training communication continuously work construction projectsto reacquaint workplace habit ensure safety expand health wellbeing benefit johnson johnson globally incorporate new continue essential culture thinking technology help employee achieve personal mind body health goal global employee safety employee health safety wellbee safety habit learn responsible learn success personally responsible failure safety safety care transparent demonstrate caring inspire feel safe suggestion andor strong value safety heart share complaint need know lose workday injury total recordable case rate illness case rate injury rate proactive inclusive anticipates actively seek diverse perspective share safety engage control safety hazard knowledge wall employee safety table esg performance datum section report footnote consideration relate global employee safety datum constantly reinforce uncompromise approach safety ensure people work safely foundational wellbee fact communication important continue remain vigilant employee facility operation world present potential safety risk world minute day rely approximately people contractor visitor site practice safe work single minute johan geerinck worldwide vice president environmental health safety johnson johnson health advance road safety road safety key element safe safety aspire healthy workforce inspire enhance employee assistance program care humanity report working program continuously seek improve continually examine expand total health benefit confidential accessible responsible engage service safety vehicle importantly awareness program offering support total wellbee select country intent introduce additional vigilance safe practice driver take employee embed culture health johnson country enhance service connect employee action improve driver fleet safety globally johnson healthiest workforce ambition track health professional assistance broad range topic mental humanity goal annual healthy workforce score health support professional life coach worklife service expand predictive analytic majority global elderadult care travel childcare education pet care fleet driver household service parenting employee easily digitize global road safety datum online ataglance health humanity goal navigate support need dashboard effective safety control management road safety assurance audit process introduce new virtual mental health resource support employee family include behavioral standardize global road safety training internal support child teen family lead online training platform accessible fleet driver company industry join thrive society distribute highly reflective inflatable airbag vest rider human resource management pledge continued employee health safety wellbee twowheele power vehicle india reduce risk potential injury commitment prioritize employee wellbee mental progress healthy workforce score health johnson johnson leader manager achieve healthiest expand travel benefit employee family workforce score provide reimbursement travel receive medical service inclusive limited reproductive healthcare available outofnetwork provider mile patient home comprehensive wellbeing portfolio available johnson global activity challenge hold seventh day johnson employee family reflect positive global activity challenge encourage employee join employee perception organizational support total health team boost health getting move employee global employee believe senior leader support able select walk run dancing cycling gardening health wellbee exemplified credo practice yoga prefer physical activity compete survey result global team challenge engage improve health benefit program participant country record support employee health wellbeing roll billion step challenge end challenge new initiative enhance robust portfolio wellbee johnson johnson donate operation smile johnson johnson donate offering include unicef lifesave helmet child vietnam potential injury mplemented expand pay parental leave benefit employee energy management enterprisewide energy world week pay leave cover maternal performance program help employee manage energy paternal adoptive surrogacyassiste foster parent capacity good work life consistently expand use program introduce virtual course continue deliver important training pandemic employee complete energy performance course health humanity report environmental health leed goldcertified janssen facility complete second phase photovoltaic panel installation climate action gri health humanity report johnson johnson understand human health environmental health health humanity goal fundamentally linkedhealthy people need healthy planet decade set achieve carbon reduction goal take sustained longterm action reduce greenhouse gas ghg emission encourage supplier large diversified healthcare product company johnson johnson set public goal reduce ghg progress renewable electricity recognize opportunity drive positive change issue emission value chain nearterm goal reduce affect health people serve continually scope scope ghg emission level electricity produce procure renewable energy source strive improve environmental footprint operation validate science base target initiative sbti climate action product value chain work consistent reduction require global warming johnson johnson sign additional renewable power purchase agreement ppa brazil india accelerate scale solution likeminde previously sign renewable electricity agreement partner work tackle today global challenge europe go effect intersection human environmental health include climate change health equity johnson johnson recognize cdp list rating progress carbon neutrality accord climate change single big health leadership climate action operation threat face humanity climatesensitive health risk fifth consecutive year disproportionately feel vulnerable disadvantaged company name int eio inp reis itio sns climate list johnson johnson sites newly certify carbonneutral external organization climate impact partner bring total number certify carbonneutral site absolute scope scope ghg emission reduce absolute reduction coe intentional approach climate action coe order benefit health planet health progress scope emission company health people include reduction disproportionately impact scope ghg emission coe increase greenhouse gas ghg emission scope effect rise temperature extreme weather upstream baseline tov rot ren oim cti ime glt wdi oti pru imr rio lyp rcis gin ore ero trr eiv partner strengthen climate resilience transportation distribution calculation emission category base spend datum category healthcare workforce healthcare systems specific economic inputoutput emission factor versus serve vulnerable health impact activitybase emission fuel price increase inflation change climate exacerbate cost calculation emission progress include found member pharmaceutical industry program activate support api supplier decarbonization effort pilot paulette frank joint climate action planning process high emit chief sustainability officer supplier identify area opportunity collaboration johnson johnson greenhouse gas ghg emission table esg performance datum reduce scope emission section report footnote consideration relate scope scope ghg emission datum climate change health httpswwwwhointnewsroomfactsheetsdetailclimatechangeandhealth access february health accelerate use renewable electricity minimize ghg emission humanity report operation product make meaningful progress deploy renewable renewable electricity electricity great portion operation operation end addition accelerate use renewable energy continue world global electricity use power renewable invest energyefficient process equipment green end construction lowercarbon renovation site north america europe global operation energy efficiency program energyintensive datum percentage electricity manufacturing site allocate million year johnson johnson johnson johnson generate renewable capital relief capital relief program energy maintain source include onsite offsite renewable project demonstrate potential saving financial return onsite renewable energy system like direct ppas virtual ppas utility green system country tariff europe virtual ppas finalize climate action execute bring equivalent renewable example janssen xian facility china complete second contract electricity europe renewable electricity phase photovoltaic panel installation capital offsite renewable certificate recs contract relief program integrate exist system electricity procurement global expansion use renewable electricity execution virtual ppas green tariff significant onsite cleanrenewable energy capacity type factor reduce scope scope emission line goal achieve carbon neutrality operation complete initiative procure renewable electricity globally propel johnson johnson solar renewable electricity goal global level cogeneration initiative include wind brazil direct ppa sign renewable electricity geothermal wind farm northern brazil johnson johnson operations country start large deal biomass south america date india direct ppa sign mulund india enable xian site team complete second phase photovoltaic mulund consumer health plant source electricity panel installation wind power greenhouse gas ghg emission table esg performance datum section report footnote consideration relate scope scope ghg australia china south america multiple utility green tariff emission datum complete renewable electricity site johnson johnson vision care achieve renewable mexico direct ppa wind farm mexico help deliver electricity global manufacturing operation utility ethicon juarez site renewable electricity september green tariff onsite solar onsite wind malaysia south africa spain expansion onsite solar power offsite wind power direct ppa ireland power generation complete consumer health site europe include belgium france germany greece ireland italy netherlands poland spain sweden switzerland north america include canada health total absolute energy consumption green building continue pursue leadership energy humanity report johnson johnson site reduce environmental design leed certification equivalent capital relief program overview represent energy reduction building research establishment environmental assessment intensity basis billion sale methodology breeam add leed certification facility bring total end million leedcertifie breeamcertified johnson total energy use annual energy project annual johnson site cost saving complete energy saving scroll chart information million total spend annual ghg approximately million square foot complete project emission avoid johnson johnson workspace leedcertified climate action green labs medtech depuy synthes johnson johnson sites france szanne germany lab leed janssen immunology lab california wuppertal italy pomezia switzerland neuchtel achieve green lab certification implement lititz pennsylvania newly certify carbonneutral sustainability good practice green lab certification external organization climate impact partner bring recognize race zero campaign key measure total number certify carbonneutral site include nonrenewable source renewable source progress zerocarbon future consider helsingborg sweden originally certify carbon emission gold standard laboratory sustainability good practice reduction achieve energy efficiency initiative world intend seek certification hvac optimization chiller system replacement wasteto energy intensity billion johnson johnson labs come year energy project renewable electricity use carbon credit carbon offset utilize remain emission reduce energy consumption overall base year health humanity environmental goal reduce total energy consumption business grow period word energy intensity express billion sale customer reduce strongly demonstrate cumulative effect continuous improvement deliberate energy efficiency initiative year year global operation greenhouse gas ghg emission table esg performance datum section report footnote consideration result complete project base fuel electricity reduction calculation avoidance energy consumption ghg emission calculate compare energy consumption project implementation expect consumption implementation engineering estimate time project approve internal process health drive carbon reduction value chain building capability helping educate supplier continue engage partnership coalition help humanity report emission measurement disclosure renewable energy positive impact health climate engage key supplier global supply base adoption train procurement team support value chain critical reduce absolute upstream scope ghg highquality datum submission supplier cdp early national academy medicine nam emission line health humanity goal drive reduction pilot joint climate action plan action collaborative decarbonize health sector reduction level process highemitte supplier industry publicprivate partnership leader health help understand climate goal effort need achieve system begin engagement form climate upstream scope ghg emission coe source joint climate action plan able identify collaborative forum align collective goal scroll chart information big opportunity collaborate supplier drive action decarbonization base evidence share solution reduction scope emission commitment improve health equity current work stream group focus develop sharing logistic continue work supplier reduce resource help healthcare supply chain company start climate action shippingrelate emission example europe johnson accelerate sustainability journey johnson introduce rolling highway project transport fully load truck rail italy belgium significantly reduce foundational funder megawatt initiative clean energy buyer institute emission road travel program expand include ceba charge create resilient equitable shipment environmentally sustainable energy system benefit leverage energy customer demand clean energy partner climate action work partner advance environmental health equity include support program empower healthcare engage initiative support collective worker strengthen resilience healthcare facility effort drive ghg emission pharmaceutical supply area need chain purchase good capital good energize program pharmaceutical industry collaboration service platform aim increase access renewable electricity upstream transportation fuel energyrelate pharmaceutical supply chain educate supplier distribution activity renewable energy adoption contract business travel upstream lease asset johnson johnson suppliers register platform energize program support renewable employee commuting waste generate operation electricity buyer cohorta group company come contract renewable electricity scale ppa greenhouse gas ghg emission table esg performance datum section report footnote consideration relate scope ghg emission datum activate program pharmaceutical industry collaboration progress area procurement logistic team launch bring pharmaceutical worked closely identify realize opportunity improve company include johnson johnson found member scope datum drive emission reduction introduce new support active api supplier decarbonization effort upstream scope strategy encompass measurement ghg emission provision practical decarbonization tool improve data quality pilot collection detailed source emission datum supply base datum science capability visualize cdp supply chain datum show maturity level largestemitting supplier include goal emission footprint reduction water waste management gri sasb cghpa cghpa health humanity report continue advance initiative facility supply chain minimize impact planet responsible use water avoidance waste reduction waste send landfill water stewardship effort continuously improve watersaving project helsingborg sweden consumer track achieve goal certify true zero waste management water resource water stewardship health site helsingborg sweden new watersaving project facility green business certification inc true zero waste pursue alliance water stewardship aws certification complete newly instal chiller closedloop certification program rate facility perform elect facility network johnson johnson water cool system reduce coolant water need minimize nonhazardous solid waste maximize consumer health thailand janssen xian china facility half require energy operate old model efficiency use resource new onsite waste achieve aws certification international aws certification production equipment cleaning process optimize management process include waste inventory management address sustainable water management confirmation shorten save purify water annually finally adjustment system internal packaging reuse system combine water waste management meet global benchmark responsible water stewardship reverse osmosis process equipment service methodology outreach supplier takeback packaging item reuse pursue additional site certification come year complete save additional water onsite recycling contribute reduction nonhazardous waste send landfill facility past year water withdrawal million waste management continually advance initiative billion sale johnson johnson globally reduce facility supply chain systematically total waste generate demonstrating efficiency water management alongside avoid waste reduce waste landfill increase sustainable scroll chart information business growth sale management waste waste stream generate directly operation include hazardous nonhazardous waste research laboratory manufacturing process warehouse total water withdraw million office waste management initiative progress include reduce hazardous waste aim reduce hazardous waste materialintensive api process implement green chemistry engineering principle improve chemical conversion yield increase reuse recycle raw material example janssen continue program reduce hazardous waste small molecule api production johnson johnson sites hazardous waste nonhazardous waste work zero waste brazil teams jos dos campos site house manufacture business segment johnson johnson working johnson johnson recognize cdp rating improve waste management program leadership water security initiative place advance recycling nonhazardous waste stream site achieve high recycling level start program product packaging sustainability gri sasb hcmsa sasb hcmsa sasb cghpa sasb cghpa health humanity report commit develop sustainable product support health people reduce medical ewaste medtechs biosense webster brazil implement initiative help hospital staff understand planet focus product category platform lifecycle area high potential change practice discard singleuse connector impact prioritize improvement implement multiple product cable surgical ablation procedure safely prepare reuse biosense webster cable design exclusive material perform sterile condition product endoflife circularity address digital health device waste janssen launch properly sterilize safely reuse time invest coordinate new multiyear collaborative initiative educate hospital staff sterilization procedure ton cable recognize product create continue fund horizon europe program address discard annually brazil avoid environmental impact use working offer issue increase digital health device waste initiative call reduce waste equipment expense hospital endoflife circular solution selection initiative include digital health circular economy dice bring organization field manufacture research refurbishing expand surgical device recycle expand hospital remanufacturing recycle social science policy surgical device recycling program pilot germany country europe aim examine lifecycle product packaging sustainability include country europe program allow digital health device design end life help extend hospital recycle specific metal plastic component lifetime andor responsibly manage end ethicon biosense webster singleuse instrument useful life use digital health device predict increase digitally capture communicate environmental impact rapidly collaborative solution timely salvage material steel titanium aluminum copper chrome steel specific plastic reprocess recycle medical device reduce endoflife impact medical device part environment component singleuse product medtech reprocess singleuse device manufacture recycle hospital johnson johnson company sterilme offer recycling program reprocess product original manufacturer line local law program expand recover ethicon absorbable suture aluminumbased packaging country germany medtech canada switzerland soundstar catheter show reusable ecocable connection expand pharmaceutical device takeback expand collect reprocess safe return program homeadministere janssen million million immunology product switzerland safe return allow patient return selfinjectable device paper medical device medical device envelope instead plastic container feature program removal hazardous material classification needlesafe authorization eliminate need additionally medtech biosense webster collaboration patient prepare special paperwork handle mainstream sterilme expand onsite support collect postal service program expect expand reprocessable ultrasound catheter diagnostic catheter additional european country electrophysiology cable maximize reprocess program canada help health system support environmental sustainability objective recycle vary country health sustainable packaging zero waste box distribute partner opticians store transformation engineering parameter scaleup humanity report provide nationwide access contact lens recycle consumer reduce manufacturing process mass intensity result diverse portfolio product work multiple provide simple accessible solution store shipping halve api manufacturing cycle time lower opportunity improve sustainability product packaging recycle contact lens waste include lense manufacturing cost significant process yield selection initiative include original foil cover blister packaging improvement patient access innovative medicine restrictive term affordability annual invest new circular technology johnson johnson johnson johnson visions acuvue manufacturing capacity aim work supplier attempt find solution help divert contact lens recycle scheme recycle million waste landfill develop technology turn divert pair contact lense blister pack foil pstream downstream process improvement manufacturing remicade infliximab enable significant increase batch waste new material ethicon enter yield improve product environmental profile new agreement eastman purchase eastman eastar renew collaboration sustainable product packaging remicade manufacturing process enable significant reduction copolyester medical device tray eastman global member organization promote sustainable require batch deliver final product lower specialty material company produce broad range advanced packaging circularity industry include healthcare quantity raw material deliver output material chemical fiber find item people use day plastic recycling council advance plastic recyclability healthcare sustainable healthcare coalition healthcare purchasing eastmans eastar renew copolyester ethicon sectorle group inspire sustainable practice healthcare pharmaceutical environment pie product packaging sustainability able attribute portion weight tray materials european federation pharmaceutical industry eastman collect recycle tray ethicon help divert association efpia advance transition circular play important role support initiative reduce waste landfill advance new technology solution economy pharma value chain key pillar activity potential impact pharmaceutical personal care product eastman molecular recycling technology know collective environment mature robust program manage pie approach essential tackle today great environmental learn sustainable packaging solution position find challenge important step advance consumer health circularity healthcare packaging progress include recycled packaging medical device medtech green chemistry technology continue active participation industryle eco company depuy synthe launch product item pharmacostewardship program release responsible synfix evolution brand postconsumer recycle pcr team continue integrate principle green chemistry manufacturing effluent technical guidance document paperboard material pcr packaging replace white engineering develop medicine progress include industry johnson johnson inform control box virgin paperboard new packaging go janssen obtain fda approval inline conditioning process concentration apis enter environment extensive testing confirm stand stringent instal janssen ireland facility process approve manufacturing plant supplier standard sterility structural integrity ireland health product regulatory authority develop member antimicrobial resistance industry alliance janssen team new manufacturing installation reduce recycle contact lens waste amria contribute publication amria antibiotic support plant expansion inline conditioning apply unique commitment reduce environmental footprint johnson manufacturing standard minimize risk develop antibiotic approach prepare supply releasing solution real time johnson vision remove plastic pouch outside resistance aquatic ecotoxicity environment result manufacturing process need largescale storage delivery box acuvue contact lense europe change manufacture human antibiotic capacity traditional manual batch approach make buffer involve place delivery note inside order external involve dissolve buffer component large tank fill water join innovative medicine initiative prioritization packaging save ton plastic europe year case transfer solution bag risk evaluation medicine environment premier transport point use inline conditioning save time project consortium bring public private sector johnson johnson visions acuvue contact lens reduce material waste energy use process organization proactively manage potential environmental recycle scheme launch collect million impact medicine initiative aim design novel information lense recently expand increase capacity lense blister janssen improve efficiency manufacturing process assessment system identify address environmental pack foil recycle year acuvue offer oligonucleotide api api manufacturing process highly risk medicine support new european standard contact lens recycling program expansion complex involve linear chemical step environmental protection achieve agreement terracycle johnson consume high quantity solvent reagent expand johnson vision funding zero waste boxes process development deep understanding chemical health humanity report accountability innovation manufacturing operator isabelle demonstrate manual intervention seidenader automatic inspection line syrinx inspect photo dry luytensupply chain innovation health humanity report innovation critical engine longterm business success driver positive contribution sustainable development johnson johnson deliver innovation multiple way janssen latina italy deploy streamline continuous pharmaceutical medtech consumer health business manufacturing line fully automate digitally segment combine innovative technology lead connect similar mirror line locate janssen johnson johnson lighthouse designations science generate transformational solution spectrum plant beerse belgium twin linesconnecte sensor march healthcare section healthcare innovation big datum digital analyticsenable quick seamless global operation supply chain deploy transfer product manufacturing greatly janssen vision advanced technology include digital support diverse accelerate time market improve product healthcare portfolio focus quality reliability efficiency cork ireland jacksonville process time efficiency bring product treatment patient enable well designation florida supply chain innovation consumer health bangkok thailand adopt quality health outcome equally advance sustainability latina italy london inspection listerine filling line replace manual technologydriven innovation support environmental inspection process new module fill line learn efficiency global supply chain example include depuy synthe consumer health visual difference bottle quality enable automatic identification defective bottle speed production embrace advanced technology early adopter cork ireland helsingborg sweden process reduce waste site ship listerine fourth industrial revolution organization suzhou china bangkok thailand directly pack line halve lead time mean deploy digital technology big fast leap forward productivity efficiency sustainability bridgewater mulund india customer enhance customer service approach recognize new jersey consumer health mulund india deploy solution world economic forum wef global lighthouse network demand sense smart logistic robotic printing identifie leadership technology deployment transform improve reliability accelerate new product introduction factory value chain business model global enhance costeffectiveness customer lighthouse designation grant wef johnson johnson improve customer service machine learn privileged lighthouse designationsmore janssen cork site ireland designate twice incorporate establish janssen track trace platform drive proactive company world technologies daily manufacture supply chain operation advance sustainability effort advance case risk management enhance customer experience management endtoend business model recognize johnson johnson partner internet thing sensor machine learn develop customer manage inventory point consumption effort ensure right orthopaedic implant right patient right time industryleade estimate arrival time capability provide customer minute delivery window unprecedented represent new era innovation technology recent johnson johnson site receive wef level accuracy predict inform customer build digital revolution precede lighthouse designation adopt technology follow shipment arrive new capability live mark shift innovation possible johnson johnson customer connect website game janssen cork ireland receive sustainability designation artificial intelligence robotic autonomous changer personalize medicine timesensitive product use adaptive process control automatically adjust vehicle print internet thing chiller system faultless operation build digital twin chiller cart technologybase cell therapy section breakthrough digital technology innovation pharmaceutical hospital trauma kit gene therapy loop connect plant energy provider allow base fusion technology share monitor single source datum dramatically reduce site carbon footprint gary hartnett vice president partnership external supply janssen supply chain health revolutionize transportation network realtime optimize surgical inventory realtime datum advance natural language processing deconstruct document humanity report tool implementation new johnson johnson global case management acm digitally enable system increase structured data set automatically populate new transportation control tower cover contract interregional perioperative efficiencya priority surgery center document submission require minor manual addition air ocean transport select road transportation hospitalswas scale year operation process increase efficiency result concise business segment revolutionize transport planning acm digitally integrate electronic medical record surgical documentsan additional advantage reduce turnaround time efficiency shipment visibility transit customer confidence schedule patient health information inform proprietary multiple language translation require document shipment status realtime communication aidriven algorithm accurately predict patientspecific control tower support logistic partner integrate implant surgical instrument need base patient joint size hundred shipping site thousands transportation lane biometric surgeon preference acm patient dozen erp system form single transport plan procedurespecific equipment supply surgery center hub offer benefit include endtoend visibility hospital enable reduce overall medtech inventory launch product supply chain movement standardize procedure shipment minimize operating room setup time achieve efficiency jurisdiction call book management nearreal time performance report lead high equipment availability alongside cost saving acm thing order require regulatory spend visibility freight audit capabilitie continuous double volume support surgeon documentation need create solution improvement freight optimization improve lead time health system improve overall patient care use gain knowledge determine supply chain innovation improve response times datum request create smart hot room china medtech ethicon suzhou plant china new smart hot room improve production efficiency optimize production environment joshua samuel reduce safety risk ethicon employee operate hot room director clinical evaluation intelligent automation complete hot degas global transportation control tower medtech important process suture production employee need important step journey agile enter room stage radio frequency digital unified transportation team identification rfid tagging track product end end globe accelerate reach key market real time enable touchless accurate supply chain meet reduce total spend help monitor china grow demand surgical suture delivery real time proactively resolve issue impact customer automate new product development launch medtech create tailor robotic documentdrafting solution accelerate new product launch timeline previously nico sacco medtech team submit thousand page document worldwide vice president plan customer regulator detail device datum clinical study result management deliver janssen supply chain apply new product authorization case different regulatory body require different datum mean medtech technical writer spend week review extensive documentation identify collate relevant content regulatory submission new tool machine learn responsible supply base gri sasb hcmsa health humanity report critically important link value chain johnson johnsons supplier network underpin business continuity enable manufacture deliver essential product service billion patient consumer customer supplier globally total supplier spend guide credo value aim maintain collaborative responsible supply base ambition reflect supplier relationship encourage broad diversity supplier health humanity goal supplier spend contract region work responsibility standard supplier supplier sustainability program ssp global supplier diversity inclusion program core framework underscore health humanity goal interaction supplier expect support partnership good encourage supplier join develop sustainable solution social environmental challenge responsible supply base progress supplier sustainability program supplier include tier vital role strong supply network evident represent johnson johnson supply base johnson johnson say take asia pacific europe middle east africa village write supply latin america north america chainalthough case ten thousand progress global supplier supplier johnson johnson employees diversity inclusion globe talk large village supplier spend contract business segment point clear achieve goal chieve exceed target consecutive year dedication collaboration responsiveness responsible conduct engage dayin dayout help meet commitment partnership good patient supply product good service technology organization establish total partnership include partnership focus women empowerment packaging sustainability fair chance employment odevelope womens empowerment program kathryn wengel focus ensure woman equal professional executive vice president chief technical access growth opportunity operation risk officer johnson johnson eploye recyclable ecommerceready pump johnson johnson packaging portfolio mplemente hire practice remove common barrier pharmaceutical medtech experience justiceimpacte community build equitable workforce consumer health corporate represent spend control overaddressable spend define product service procurement team negotiate supplier meet business goal supplier engagement gri health humanity report supply base extension business important link customer world large diverse organization johnson johnson set clear expectation supplier aspect interaction enable good outcome company supplier serve supplier diversity equity inclusion supplier expect foster culture dei organization johnson johnson name cdp supply basis supply chain leaderboard sixth consecutive supplier critical mission change year result strong participation information security supplier expect rigorously trajectory health humanity recognize supplier disclosure cdp program manage business activity employ appropriate information broadbase impact external partner security practice safeguard datum system maintain community commit business continuity work supplier provide highestquality product service environmental responsibility supplier expect align expand requirement cover ghg reduction share commitment diversity equity inclusion invite supplier participate supplier engagement willingness measure publicly disclose datum increase sustainability respect human right working cdp supply chain focus energy efficiency integration biodiversity climate program supplier embrace imperative consideration recyclability recycle material use drive great benefit society communicate new standard supplier support train ongoing engagement shashi mandapaty invite supplier participate chief procurement officer aim work respectfully collaboratively supplier cdp supply chain johnson johnson engage johnson johnson supplier sustainability water program program ssp key tool engage select supplier require conform responsibility standard supplier help deliver high standard embody credo regularly complete assessment ecovadi recognize assess engage supplier social risk continue seek relationship supplier uphold principle provider business sustainability rating global supply chain strengthen process tool assess verify address reflect responsibility standard supplier encourage transparency large supplier risk supply base compliance law standard outline expectation number important encouraging publicly disclose environmental regulation check conformance human labor topic integral supplierselection process help performance include ghg emission water use cdp right section responsibility standard supplier build supply base share commitment strong ethic human right supply base work include target quality global citizenship standard periodically diligence exist potential supplier include use update align current good practice internal advance update responsibility standard onsite smeta pillar audits full investigation potential supplier include new section cover highrisk commodity supply chain deploy techenable risk assessment tool gain upstream supply chain visibility potential highrisk commodity embed thirdparty modern slavery metric ssp assess potential supplier risk health hold dedicated human right training session partnership good execute new partnership particular maintain multiple multiyear forest partnership humanity report onward sustainability training programlaunche good advance progress health enable protection tropical rainforest critical sspfor supplier provide guidance develop humanity goal collaborate supplier create climate mitigation wildlife conservation longterm community human right policy commitment section human right solution drive environmental social economic wellbeing focus palm oil work earthworm improvement bring total partnership good foundation bsrs action sustainable derivative initiative build supplier capabilitie onward date new initiative woodfiber product work rainforest alliance johnson johnson procurement sustainability manager build transparency source supply engage collaboration british standards institute introduce fair chance employment partnership kelly service supplier responsible practice example forest initiative design remove barrier employment contingent new content supplier country continue support include initiative world wildlife worker job candidate previously overlook session design focus specific practical area fund restore forest protect hectare program kelly services work johnson johnson development measure report ghg emission rainforest sumatra indonesia initiative forest evaluate exist policy jobcategory basis craft start supplier diversity program establish health conservation fund loreto peru prevent deforestation introduce new policy eliminate unnecessary barrier safety policy employee intention support hectare pristine amazon rainforest develop new contingent assignment posting inclusive supplier help johnson johnson language achieve goal help supplier drive responsible conflict mineral member responsible mineral conduct supply chain result great recyclable pump partnership supplier aptar enable initiative line regulatory requirement remain efficiency resilience sustainable practice wide supply johnson johnson consumer health launch recyclable commit take step determine use country origin supplier engagement network launch onward session pump aveeno brand european market potential source tin tungsten tantalum gold global product attendee global supply base expansion internationally million pump portfolio annually aveeno innovation potential engage supplier innovation johnson johnsons supplier prevent huge volume plastic enter waste stream enable innovation program allow generate innovative solution engagement supply base womens empowerment initiative work supplier sodexo partnership focus womens empowerment innovation technology platform johnson johnsons emea apac aim promote equal access woman procurement organization hold second annual supplierenable growth opportunity workplace program innovation award event recognize innovation initiative deliver jointly sodexo johnson johnson programs award winner include mentor coach jobshadowe woman face manufacture design improvement work supplier barrier work skilled volunteering opportunity medtech able improve performance ethicon flagship stapler create new manufacturing process deliver enhance design responsible source enhance precision marketing capability otc team business source commodity raw china work supplier generate unique data insight material require heightened procurement focus consumer behavior datum help engage consumer critical environmental biodiversity concern elevated meet need effectively human right risk supply chain work understand improve product sustainability johnson johnson consumer potential risk impact procurement activity health brazil partner supplier develop area define appropriate standard control responsible sanitary napkin sempre livre brand use source commodity raw material concern plastic include pouch component recyclable paper supplier diversity health humanity report global supplier diversity inclusion program provide platform proactive outreach diverse small supplier collaboration partner advance supplier diversity guidance supplier engage johnson johnson decade program continue realize value inclusive supply base bring business people community expand global footprint drive social economic impact market include key measure progress advance supplier diversity consecutive year johnson johnson broaden diverse supplier capability compete global global impact spend represent addressable spend small maintain membership billion dollar roundtable market johnson johnson sponsor national minority diverse supplier globally small business global group company advance good practice supplier supplier development council nmsdc certificate excellence impact spend health humanity goal diversity spend billion annually program design broaden capability minorityowne exceed goal conclude confirm diverseowned supplier business compete global environment exceed ninemonth program launch select nmsdccertified woman minority business enterprise global impact spend number benefit coach relationship corporate leader supplier diversity mentor instructional seminar deliver rutger business school subject matter expert johnson johnson billion million proud partner johnson multiple industry partner johnson recognize total global impact small business high platinum level annual global spend increase compare champion supplier diversity inclusion awards johnson johnson well well globally regard inclusive spend partnership year continues grow johnson johnson substantial support diverse seek jointly drive action break supplier important indicator value million billion barrier prevent woman business owner sponsor cohort nmsdc center excellence tier diverse tier diverse spend access new market opportunity certificate program johnson johnson make supplier international million difference invest growth minority market tier diverse spend business enterprise woman business enterprise impact community economy elizabeth vazquez proud partner company long history ceo cofounder weconnect international community engagement corporate citizenship increase increase spend spend tier global supplier diversity inclusion team tier womenowne black hispanic additional focus partner external advocacy partner business compare own business expand capability capacity diverse business follow jeffrey robinson phd compare highlight academic director center urban entrepreneurship economic development rutger business school health expand mentoring manufacture logistic support development advocacy body world humanity report johnson johnson found sponsor support development advocacy body help diverse manufacturing supply chain alliance dmsca discover certify diverse supplier critical enabler foundation sponsorship enable organization program advance adoption supplier diversity expand training incorporate digitalization module inclusion practice company drive great impact assessment build capability supplier develop minorityowned supplier advocacy europe corporate partner dmsca development program johnson johnson found member european diverse manufacturer logistic supplier supplier diversity project esdp initiative lead minority building capacity woman colorowned business supplier development support ethnic minority migrant johnson johnson sponsor cohort total close own business esdp aim enable business certify woman women business enterprise council metro access opportunitie corporate supply chain initiative great dmv district columbia maryland virginia amplify support research sponsor johnson johnson program amplify program uniquely design engage document increasingly diverse europe need equality support woman color maximize opportunity scale procurement ethnic minority entrepreneur frequently business suffer discrimination basis race ethnicity sponsor buy social europe initiative support strategy procure social enterprise supplier diversity new relationship britain support procurement business own member lgbtq community enter program hope build foundational understanding run business solopreneur europe increasingly diverse minority business help local receive able expand economy thrive create job wealth innovate export network grow business revenue mention pay taxis minority entrepreneur economic social disadvantage engage customer supplier extend endtoend bianca ellis impact expand impact value chain ceo projacct workflow reporting engagement customer introduce customer engagement program partnership internal group connect major customer healthcare system share good practice support effort address social determinant health addition grow supplier tier spend reporting engagement johnson johnson prime supplier legrain fitzgerald equip europe increasingly diverse europe need equality procurement ethnic minority entrepreneur msduk httpswww msdukorgukstaticequipeuropereportpdf access february corporate governance gri health humanity report board director oversee company accordance credo value enable patient serve create value society maintain thrive business governance structure policy process design board director responsible oversee execution serve need business shareholder risk management duty assess johnson johnsons board stakeholder promote culture accountability approach risk management board review discuss director enterprise detail corporate governance principle strategic operational financial reporting risk april independent approach enterprise risk management erm framework nonfinancial esg risk include compliance environmental governance structure board charter organizational document social human capital management cybersecurity risk sec filing position corporate leverage erm framework information section governance corporate governance section esg governance johnson johnsons website woman ethnicallyracially diverse change governance structure include announce appointment joaquin duato chairman johnson johnson board director addition role chief executive officer effective january corporate governance decade johnson johnson announce alex gorsky step role executive chairman show robust corporate practice discipline leadership valuesdriven culture win annual review board evaluate mix underpin longterm value creation mitigate risk conclude regulatory compliance shareholder patient customer partner sustainability committee well position oversee employee world certain esg matter alongside complementary compliance era company history separation matter turn science technology committee consumer health business reliable legacy oversee medical safety devote great attention right thing right way position company product pipeline evaluation innovative continue deliver purpose profoundly technology restructuring help ensure governance change future health humanity structure reflect important issue opportunity face johnson johnson collaboration compensation benefit liz forminard committee audit committee board formalize executive vice president general counsel ensure incentive compensation appropriately johnson johnson align financial performance credo tax responsibility gri health humanity report publish credo stipulate pay taxis responsibility community live work johnson johnson commit pay fair share taxis tax footprint evolve time reflect healthcare total taxis collect additionally johnson johnson taxis tax tax contribution billion activity investment include research development borne collect collect billion relate commerce company manufacturing change waver generate collection form payroll social commitment good corporate citizenship demonstrate corporate income tax insurance taxis approximately employee sustainable value behavior relate tax world sale use taxis valueadde taxis taxis governance compliance planning risk management relationship payroll social insurance taxis collect behalf government employee customer governmental authority transparency business partner taxis collect important fully describe johnson johnson tax policy tax policy measure contribution johnson johnson salesuse taxis update provide great transparency job creation business activity country tax governance compliance tax planning incentive operate total johnson johnson contribute approximately billion taxis fee government economy total tax contribution world total tax contribution component total taxis bear company total taxis collect tax responsibility pwcs report independent accountant management assertion taxis bear direct cost company taxis collected collect customer employee behalf total taxis bear johnson johnson bore billion government ultimately remit taxis world taxis include corporate income taxis companys share payroll social insurance taxis intent provide comprehensive view total taxis pay company share sale taxis sale taxis include sale world corporate income tax represent payment use nonrecoverable valueadde tax taxis primarily market operate report comprise custom duty local taxis income taxis pay annual report tax special fee relate pharmaceutical industry show aggregate company datum major market represent vast majority revenue aspire include market future year tax information contain section intend provide reader overview taxis contribute johnson johnson income taxis read conjunction company tax information file securities exchange commission sec including recently file quarterly report form annual report tax information supplemental substitute information report company sec filing ethic compliance gri health humanity report value guide decisionmake spell credo guide act ethically law govern business time support corporate hero interactive game strengthen culture accountability compliance week comprehensive policy procedure train program johnson johnson know value right thing embe credo value company ensure statistically reliable year row indicate critical employee contingent worker know responsibility think require answer enterprise hcc annual training act accordance applicable law regulation industry assessment question correctly pass assessment code company internal standard expectation simply result guesswork ethical compliant conduct use biennial credo survey assess value come life enterprise supplement alternate year voice survey monitor employee sentiment relate topic include employee complete sale marketing ethical business conduct hcc training employee complete hcc training building credo value code business conduct cbc compliancerelate investigation responsible health care compliance hcc policy list comprehensive marketing indicator ethical standard decision action market operate mandatory cbc training conduct year ethic compliance number compliancerelate johnson johnson hcc training conduct year new employee allegation investigate enterprise hcc annual training assign require complete cbc hcc relevant measure effectiveness percentage compliancerelate allegation require training methodology award investigate category prestigious brandon hall gold aspect ethic compliance advance include award good advance healthcare compliance compliance training update compliance framework revise hcc silver award good advance framework provide update practical guidance compliance financial learning measurement hcc guideline base hallmark effective compliance program department justice highlight specific focus role business leader set strong message continue drive culture reinforce culture accountability number warning letter accountability organization communication training effort focus strengthen untitled letter issue opdp culture accountability initiative include aplb annual compliance training enterprise hcc annual training communication leadership ethical leadership workshop encompasse foundation compliance rolebase situational case train assist prevent detect pwcs report independent accountant management assertion pwcs report independent accountant previous health humanity report topic scenario drive training effectiveness design correct noncompliant behavior compliance week opdp office prescription drug promotion aplb advertising promotional training objective ensure learning achieve initiative contain interactive game contest appeal labeling branch fda center biologic evaluation research incorporate interactive challenge final assessment communication material support culturebuilde initiative evaluate learn transfer proprietary methodology tagline people follow people evaluation show learn transfer prove health johnson johnson name fifth consecutive data transparency conduct workshop bioethics humanity report inquiry complaint year cpazicklin index corporate political disclosure principle launch bioethicsrelate mentor program record accountability trendsetter status employee jjbc members undertake professional ethic training credo integrity line category fellowship auschwitz study professional ethic independent assessment external research proposal faspe addition ocmo sponsor harvard multiregional human resourcesrelate work yale university open clinical trial bioethic collaborative bioethic colloquium datum access yoda project enable consistent approach convene nyu new york academy sciences business integrityrelate independent assessment external research proposal cofounde cochair bioethic community dia request use clinical trial datum generate johnson global organization advance life science network privacy information johnson company research proposal security general security review article publish datum share promote animal welfare research involve animal lead ehs etc yoda project enable researcher create new insight major medical advance continue important general information advance science medicine lead improvement public discovery viable nonanimal alternative question health johnson johnson continue demonstrate support develop accept year year utilize nonanimal expand reach clinical trial datum join alternative possible work regulatory body financialrelate vivli antimicrobial resistance surveillance datum register gain acceptance appropriate nonanimal alternative johnson section antimicrobial resistance johnson commit principle ethical treatment human rightsrelate animal involve biomedical researchreplace reduce report refining use possible global animal product quality welfare officer responsible ensuring adherence collaborate nyu school medicine support patient safetyrelate monitor animal welfare standard support janssen decision make investigational medicine professional certify different aspect veterinary pwcs report independent accountant management assertion request know compassionate use pre ethic compliance pwcs report independent accountant previous health humanity report medicine animal welfare johnson johnson triage committee case investigator ability approval access compassionate use advisory change issue type case receipt credo integrity line committee compac comprise ethicist physician occur case commitment ethical humane treatment patient representative independently select laboratory animal care hold annual awards credo integrity line provide channel employee nyu provide recommendation janssen pre program recognize team outstanding achievement contractor customer thirdparty agency partner approval access plan individual request receive replace reduce refining use animal field report potential violation cbc company policy janssen compac affirm johnson johnsons biomedical research education training win applicable law regulation country operation commitment ensure transparent ethical innovation advanced use donate human cadaver avoid increase human resource inquiry complaint objective approach review compassionate use animal use hcp training medical device credo integrity line result period significant request janssen provide access organizational change patient globally preapproval transparent animal welfare practice engage access paa program advance widely inform share work improve public policy continuous improvement anticorruption control aim transparency provide time list animal testing example janssen beerse site achieve continuous improvement vigilance governance control potential treatment option available country belgium welcome animal welfare committee process prevent corruption business follow territory janssencom flemish parliament number stakeholder completion transparency international tiuk corporate life science ecosystem visitor tour animal facility anticorruption benchmark comprehensive selfassessment engage discussion janssen animal welfare policy tool measure compare performance anticorruption alternative reduce animal testing program company continue engage quarterly keep bioethic agenda office chief medical meeting tiuk company participate officer ocmo sponsors johnson johnson bioethics facility animal veterinary oversight benchmark share insight discuss good practice committee jjbc advise global team ethical issue site animal accredit aaalac international alignment ethical code conduct jjbc continue advise johnson johnson teams ethical earn anticorruption disclosure nbim question relate research access investigational medicine esg disclosure index human right gri health humanity report guide credo value respect promote human right operation business relationship community operate risk modern slavery supply chain critical company consider approach focus area line ungps focus effort area regulatory compliance sustainability committee rcsc respect human right work potential actual risk adverse human right impact board director provide oversight management approach collaboration johnson johnson link business significant establish respect human right rcsc receive update diligence approach identify respond fourpillar framework guide human right priority focus area outline continue evolution company approach potential modern slavery risk supply base relate action plan human right external regulatory stakeholder development improve human right diligence continually evolve rosey hurst strengthen broadbase human right diligence process founder commercial director impactt worked erm independent sustainability fair working condition consultancy develop risk identification tool well identify maintain living wage line commitment fair ensure fair working condition johnson johnson geographie site potentially high risk adverse human working condition continue implement annual employee engage supplier right impact johnson johnson operation living wage assessment collaboration business social supply base facility tool deploy prioritize targeted responsibility bsr ensure employee country diligence review supply base continue assess operate receive pay market competitive sufficient access healthcare human right risk supply chain use tool attain sustainable standard live previous year advance sustainable equitable access medicine ecovadis selfassessment supplier ssp supplier small number wage adjustment country ensure medical solution save improve life cure patient prevent disease need audits update responsibility standard supplier living wage standard meet rss strengthen guidance supplier human right safe effective product capability building johnson johnson employees certain establish policy management system identify address category contingent worker assign required provide patient consumer healthcare provider human right impact provide training supplier product effective safe possible complete code business conduct training available rss update section supplier engagement stage product development manufacturing language year training include guidance relate supply chain commercialization prohibit use force bond labor manufacture human right furthermore foundational human right sustainable environment product component product outline learn education course available employee globally antihuman traffic policy employment young person end employee contingent improve environmental footprint operation product value chain integrate policy establish antimodern slavery work stream worker key human right program complete module human right consideration environmental advance diligence effort area work johnson johnson procurement employee policy program impactta consulting firm specialize ethical trade human complete mandatory human right training rightsto support develop suite modern slavery diligence material training material supplier assessment collaborate advance human right continue questionnaire investigation guideline integrate verisk participate external platform share insight maplecroft risk indicator modern slavery supplier risk good practice industry include shift business governance johnson johnsons enterprise human right management system identify potentially higherrisk supplier learn program bsrs human right working group governance council ehrgc establish comprise work inform diligence pharmaceutical supply chain initiative human right labor crossfunctional group senior leader represent key function work group oversee company approach human right include set priority focus area implement action plan annual basis ehrgc support direction guidance learn approach framework respect human right position human right responsibility standard chief sustainability officer worldwide vice supplier relate esg policy position grievance mechanism section ethic compliance president legal strategy operation risk management product quality gri sasb hcbpa hcbpa hcmsa hcmsa health humanity report johnson johnson reach patient consumer world medicine medical technology consumer health product safety product critical priority johnson johnson insist quality safety stage product development manufacturing supply chain commercialization quality management product quality indicator commitment quality safety reliability basis bold ambition leading edge quality policy quality standard cover number fda warning industry quality compliance organization lifecycle product patient consumer letter issue enable fully connect digital ecosystem experience provide framework common foundation product recall rate business segment highly competent people skilled manage quality expectation help ensure reliable supply highquality addressing aspect quality spectrum product business segment market serve pharmaceutical future healthcare increasingly rely digital quality compliance organization lead solution continually evolve improvement quality compliance practice include system team embrace digital technology medtech support consistent quality compliance positive transforming quality process digital solution task experience product patient consumer quality compliance transactional date employee consumer health self customer care otc time spend manual process automate manual task apply intelligent analytical tool allow employee tackle pwcs report independent accountant management assertion highervalue task datadriven proactive decision make pwcs report independent accountant previous health humanity report product quality product recall rate define number lot remove market total carol montandon assess large datum set advance preventive quality globally manufacture base field action removal determine global vice president chief quality officer management create valuable product patient insight internally quality review board align johnson johnson enterprise compliance reasonable probability product cause johnson johnson continue progress digital transformation quality temporary medically reversible adverse health consequence certain case cause adverse health consequence pharmaceutical medtech process management system way include recall rate consider product business segment consumer health product quality recall rate inclusive consumer health product selfcare instal new datum portal increase access quality overthecounter otc business segment compliance datum source improve agility quality reinforce commitment quality employee insight analytical data tool dashboard business require interactive elearning quality segment management framework course course inform achieve considerable efficiency automation employee quality management system manual process enable application combination provide example role responsibility help data insight natural language processing solution maintain quality johnson johnson role play develop new digital tool assist simplify improve quality literature document report review capture product insight complaint improve product release cycle time transparency planning manage sample process flow health refresh quality compliance competency model introduce new quality model well customer experience employee johnson johnson engage quality humanity report model prioritize upskille people prepare customer experience engineering cxe new proactive month multiple inperson virtual event proactive capable quality management digitally enable quality model capability support involvement communication channel future encourage employee actively participate quality compliance organization technical improvement individual career journey promote culture continuous product service cxe focus entirely experience innovative learning customer lead internal quality expert practical contribution solve product challenge project pipeline cxe promise help transform experience patient physician surgeon enhance product delivery quality tangible customer outcomes johnson johnsons quality compliance example quality compliance cxe team engage competency model core category medtech depuy synthe team solve challenge core competency proficiency level relate purevue visualization system competency arthroscopic procedure system camera lens begin fog procedure temporarily cloud visualization operating area cxe team visit surgeon witness issue real time operate room contribute new design solution significantly improve temporary visualization issue employee janssen india engage quality month leave right mahadev desai shivani ganesh nalavade saurabh dole reimagine quality month theme quality month digitally enable endtoend quality support weekly topic encourage global site focus critical quality compliance initiative product quality digital transformation digital enable employee customer patient strategy lead way endtoend patient consumer customer experience enable fully integrate digital ecosystem innovation innovating use digital tool enhance customer success learn driving learning engagement quality month build digitally enabled workforce future quality compliance capability framework include competency model develop wide collaboration johnson johnson align enterprise approach judith boateng katherine buitrago participate learn development provide advanced platform quality month raritan new jersey site ensure employee develop critical capability need deliver quality compliance strategic goal include strengthen quality compliance talent pipeline medical safety gri health humanity report johnson johnson recognize fundamental responsibility provide patient consumer surgeon regulator study important provide information safety effectiveness device healthcare provider product effective safe possible evidence provide lifechange healthcare thousand patient sciencebase ethic valuesdriven approach medical safety put patient different part world consumer wellbee foremost decision making action janssen participate industry expert regulator international council harmonisation technical requirement pharmaceutical human use office chief medical officer ocmo global ich expert working group development ich functionally independent group medical scientific guideline aim support largescale efficacy safety professional work johnson johnson guide clinical trial excellence product safety development johnson johnson leading ocmo provide business segment apply expertise safety science entire team opportunity advance safety child safety child epidemiology bioethic inform evidence sciencebase farreache last contribution improve priority johnson johnson product decision people ocmo chair patient live deliver advanced otc medicine achievement include pharmaceutical development committee review product method assure product safety company development plan ensure product address unmet industry treatment child suffer active psoriatic arthritis needs benefit people ultimately use psa ocmos child health innovation leadership department child support janssen clinical development team healthcare woman goal reflect grow design execution pediatric safety study evaluate william hait phd importance rwd improve health outcome safety new treatment option pediatric patient active executive vice president chief external innovation medical officer johnson johnson psa generate datum label support need treatment option enable child suffer psa health humanity goal live full life ocmo collaboration internal external group medical safety advanced multiple initiative improve medical safety include spearhead medication safety education health education program help family protect small child innovative rwd method generate reliable realworld evidence accidental unsupervised ingestion medicine frequent patient health outcome numerous initiative occurrence require emergency treatment span pharmaceutical product vaccine medical device ocmo collaborate young mind inspire develop consumer health product highlight work include progress healthcare woman educational resource teach youth otc medicine safety achieve publication original publication insight improve access critical medical device rwd work nonprofit safe kid worldwide implement base realworld datum point represent conduct rwd study inform clinical regulatory safety medication safety program tool tip parent million woman research focus main area decision make key area evaluate safety safe storage dose medicine continue aternal health racial equity tfnadvance proximal femoral nail system compare advance safe pill storage innovation collaboration sex biologic variable woman traditionally nail implant treat hip fracture evaluate cdc protect initiative quickfire challenge awardee underrepresented medical research potential risk cancer reproductive issue associate gatekeeper innovation inc win quickfire challenge primary contributing publication include follow study cobaltcontaine device work area generate concept reinvent traditional pill minder improve new jersey maternal mortality dashboard interactive social extensive evidence comparative safety tfnadvance safety functionality patient adherence anticipate determinantsofhealth tool million datum point represent cobaltcontaining product confirm safe use commercialization female resident sex difference sequelae covid patient support publication paper infection long covid syndrome review peerreviewe journal drive transparency patient female participant health promote maternal health ocmo support advancement improve maternal health outcome black woman talc safety continue address allegation johnson humanity report maternal health maternal health equity activity include initiate effort design baby powder cause adverse health effect sympathize continued guidance clinical team conduct evidence care model reimagine role office staff deeply patient family appreciate generation activity include woman pregnant patient connector advocate critical member care seek answer science fact lactate woman collective action close black maternal team initiate effort elevate representation black people illness cause use talcumbase health equity gap work accelerate sex medical illustration continue advance multiple product information factsabouttalccom disaggregate datum uncover insight improve care pilot project investigate creation digital tool help talc transition johnson johnson consumer health outcome woman offer evidence pregnant advance maternal healthcare service black woman commercial decision transition cornstarch people provider informed decision birth people base baby powder portfolio large portfolio safe use johnson johnson products recent example include enhance patient voice clinical study coleade assessment result transition talcbase johnson accelerate womencentric science shift innovative medicine initiative prefer project fiveyear baby powder discontinue globally sexbiase sexinclusive science datum provide project establish recommendation industry regulatory treatment innovation specifically tailor woman authority health technology assessment body ocmo collaborate different group johnson use patient preference benefit risk medicinal johnson provide sexdifferentiate analysis immunologic product decision make johnson johnson serve neurologic condition understand experience prefer steer committee closely support man woman alter approach achievement treatment enhance health sex healthcare woman health humanity goal prefer release detailed framework recommendation industry regulator health technology assessment body deliver publication provide sexdifferentiated assessment use patient preference medical product analyse long covid psoriasis condition decision make advance pregnancy lactation science johnson johnson pregnancy lactation advisory group prefer framework receive formal qualification ema european network health technology jjpal compose expert function support assessment eunethta planning evidencegeneration activity pregnant medical safety lactate people jjpal progress area ema qualification prefer framework significant include internal consultation product team enable explicit pathway stakeholder help improve design interpreting evidence relate engage ema conduct patientfocuse structure safe use medication pregnancy lactation benefitrisk assessment help grow acceptability deliver searchable inventory global rwd source study clinical regulatory decision study medication use pregnancy lactation world chairing national academy science engineering medicine workshop facilitate inclusion pregnant coauthore new report council lactate people clinical research initiate survey international organization medical sciences ciom pregnant postpartum lactate person well recommendation involve patient lifecycle understand opportunity increase inclusion pregnant medicine lactate people clinical trial counterfeit illicit trade gri sasb hcbpa sasb hcmsa health humanity report johnson johnson trade counterfeit product enormously concern counterfeit healthcare product place peoplethe people aim helpat risk adverse event health problem potentially death fake medical product undermine confidence product quality safety reliability johnson johnson center constantly strive adopt new way monitor detect conduct training session lead ongoing continue deploy holistic brand protection illicit trade enhance product security analytic relate seizure illicit trade shipment region program enhance value chain integrity disrupt advanced technology critical addressing grow illicit supply chain partner internally function continue reinforce program engage sophistication illicit trade especially online marketplace engage widely array national international widely market include regulatory body online monitoring include global marketplace trade group industry alliance organization law enforcement protect patient combat fake product illicit trade dark web location social medium site agency educational coalition group share example half johnson johnson unique domain investigate bad actor seek determination eliminate counterfeit globally actively involved investigation counterfeit hiv stop flow illicit trade share relevant information law medication ring file suit number distributor enforcement assist tracking prosecute pharmacy involve scheme june endanger patient illicit trading activity department justice doj announce arrest fake medicine kill subsaharan african year indictment individual allegedly distribute million adulterate hiv drug unsuspecting patient continue engage doj law enforcement ongoing investigation guide credo aim safeguard patient medtechs ethicon create compelling educational brand reputation risk pose illicit campaign target healthcare facility raise awareness trade include product counterfeit tamper risk counterfeit medical device patient prevent counterfeit illicit trade illegal diversion protect patient consumer introduction supply chain informational material counterfeit version product essential distribute promote ethicon sale force promote worldwide access beneficial healthcare channel example ethicon present information genuine johnson johnson products illegal gray market conduit counterfeit product attendee american society healthcare risk management ashrm annual conference taira bell time topic present ashrm vice president global brand protection influential audience healthcare risk professional hope johnson johnson lead engagement collaboration combat illicit trade continue record trademark custom border protection agency help eliminate illicit version product cross border world conduct specialized training national international law enforcement agency globe united nations news fake medicine kill subsaharan african year unodc report httpsnewsunorgenstory access february information security datum privacy gri health humanity report believe maintain proactive information security strategy protect information asset law multiple privacy datum security legal regulation china support data science digital initiative deliberate inadvertent threat safeguard business include define standard anonymization pseudonymization deidentification increase ability compliantly leverage datum insight promote digital health solution sector improve robustness information security progress key privacy process design privacy program follow way consistently support right consumer patient management personal datum deliver privacy support enhance protection cyber risk critical ensure availability critical system prevent pharmaceutical research improve cyber posture ensure successful completion major deal unintende unauthorized access business multiple pharmaceutical site deploy additional cyber personal information foundational business reinforce cybersecurity privacy framework ensure capability protect system datum action continuity people rely johnson johnson continuous evaluation enhancement johnson johnson improve protection company resilience day cybersecurity program periodically undertake program environment meeting need healthcare maturity assessment pursue security certification way partner patient reduce potential example engage independent party negatively affect cyber event increase gary harbison conduct maturity assessment nist cybersecurity protection company new capability include technology chief information security officer ciso framework provide current view program maturity implementation research laboratory environment johnson johnson areas continue improvement obtain iso provide increase visibility security posture system certification environment support johnson detection potential cyber threat johnson cart immunotherapy offering emea extend similarly johnson johnson commit datum privacy expand cyber capability investment new number certification hold range company product ensure protect personal information integral core capability strategic partnership improve security parallel monitor introduction new standard way operate addition code business conduct company product datum system initiative include iso cover privacy design release early compliance law apply operate company strategic investment technology industryleade evaluate requirement technical control need handle personal information maintain robust data privacy security provider enhance security medical device certification process control protect personal information employee product suite deployment new capability support customer partner entrust information enhance cyber awareness offer continue adoption zero trust principle increase information security datum privacy employee globe opportunity improve cyber protection company customer cyber awareness learn smart cyber practice deployment advanced aisupporte tool well detect innovative way example cyberescape online escape block security threat room attract hundred employee work team complex patchwork compliance obligation protect personal information continue commitment solve series basic cyber challenge puzzle different active regulatory enforcement international protect personal information consumer clinical escape room scenario raise cybersecurity knowledge market impose great demand datum protection research participant employee expand effort additionally alongside ongoing information security privacy cyber professional design right type governance ensure compliance grow legal regulatory datum training employee expand johnson model solution ensure johnson johnson protection requirement broaden protection individual johnson phishsmarts phishing simulation program program compliantly pursue datarelate initiative datum subject right time continue participate provide quarterly simulated phishing email followup help globe industry association external forum help shape new employee well detect real phishing attempt defend regulation review crossborder datum flow datum phishe email threat pose potential risk organization localization healthcare initiative privacy winston khoo cybersecurity space focus area include establish chief privacy officer johnson johnson compliance program new expand state privacy health humanity report report hub report hub contain follow information follow download supplement health humanity report lobal report initiative gri ustainability accounting standard board sasb ask force climaterelate financial disclosure tcfd orge bank investment management nbim global compact ungc annual communication progress generation woman stem share knowledge experience inspire girl pursue career science technology reduce exist barrier increase number female role model industrie esg performance datum health humanity report financial result financial result million access medicine total sale number product list prequalifie medicinal product net earning prequalification medicine programme market price share yearend close number product list investment prequalifie vaccine sale business segment prequalification vaccine programme pharmaceutical medtech darunavir darunavir darunavir ethanolate tablet ethanolate tablet ethanolate tablet consumer health filmcoate filmcoated filmcoated darunavir darunavir darunavir number consecutive year dividend increase ethanolate tablet ethanolate tablet ethanolate tablet esg performance datum filmcoate filmcoated filmcoate approximately billion fiscal certain international otc product primarily china financial result reclassify pharmaceutical segment consumer health segment base operational change list product list darunavir darunavir darunavir global health equity include dividend declare april prequalifie medicinal product meet ilt mha ala mlet ilt mha ala mlet prequalification medicine programme etravirine tablet etravirine tablet etravirine tablet filmcoate filmcoated filmcoated etravirine tablet etravirine tablet etravirine tablet mebendazole mebendazole mebendazole tablet tablet chewable tablet chewable global health equity chewable vermox donation mvabea mvabea number vermox mebendazole dose donate mvabnfilo mvabnfilo list product list recombinant recombinant annual total million prequalifie vaccine zabdeno zabdeno cumulative dose donate start initiative prequalification vaccine programme adzebovgp adzebovgp private donation billion recombinant recombinant ebola vaccine ebola vaccine number country vermox mebendazole dose donate change average net price product portfolio prior year access tuberculosis treatment annual number patient receive access bedaquiline molecule brand generic health give million humanity report total product cash contribute product contribute cash contribute disaster relief million total allocate support immediate mid longterm response readiness natural disaster world worth johnson johnson product provide community impact natural disaster world global community impact number patient reach johnson johnson impact ventures jjiv portfolio company fund report date investment global health equity number hcp support jjiv portfolio company report report date investment metric assure erm cvs health humanity goal assurance pwcs report independent accountant management assertion pwc report independent accountant previous health humanity report average people infect nontreate drugresistant tuberculosis drtb patient base tuberculosis fact sheet cure rate patient treat bedaquiline contain regimen base lancet respiratory medicine volume september review data reconciliation process change need correct number course sirturo bedaquiline ship result reduction cumulative number reflect update represent yearoveryear change average net price list price rebate discount fee product donation include confirm johnson johnsons internal tracking system distribute calendar year number reflect donation regional johnson johnson operate company local partner patient reached define additional individual patient customer user healthcare product service provide company fund jjiv investment portfolio employee health global employee humanity report total number employee woman man decline answer region asia pacific europe middle east africa latin america north america gender representation decline decline decline woman man woman man woman man answer answer answer employement type employee fulltime employee parttime employee fixedterm employee region asia pacific europe middle east africa latin america north america job category vice president director manager professional management executive position woman management position woman executive position health diversity board composition ethnicracial diversity job category humanity report woman vice president ethnicracial diversity white asian blackafrican american global age diversity hispaniclatino decline answer director manager decline answer white asian age diversity job category blackafrican american vice president hispaniclatino decline answer professional employee director manager white asian blackafrican american hispaniclatino professional decline answer ethnicracial diversity white asian blackafrican american hispaniclatino decline answer health new employee hire yearend performance review complete humanity report job category total number new hire vice president region director manager asia pacific professionals europe middle east africa latin america overall employees north america gender representation woman global employee activity man number global activity challenge participant report decline answer number global activity challenge country age report number employee complete energy performance course report training development employee number leader train enterprise leader development employee retention turnover program cumulative ine ers mab sve function country thu tub tir mue roic mmployee participate overall voluntary turnover voluntary turnover high performer spend employee learn development million leadership training executive coach parental leave compliance professional skill gender composition employee take parental leave tuition external certification woman operation administration elearne man total gender composition employee return work parental leave end woman man health average employee training hour employee resource group erg humanity report overall average hour enterprise wide training employee number employee engage erg average training hour enterprise wide training employee gender number erg chapter woman number nonus erg chapter man number wesustain team report decline answer number country wesustain team report average hour enterprisewide training employee job category number action take healthyplanet platform report vice president number employee complete sustainability training report director manager professional credo survey result number language credo survey available number country credo survey administer response rate active employee employee increase participation compare eligible employee favorability rate increase favorability compare liketolike question percentage agree statement ensure responsibility patient doctor nurse mother father use product service provide inclusive work environment employee consider individual act responsibly community live work world community health pwcs report independent accountant management assertion pwc report independent accountant employee safety previous health humanity report humanity report employee define individual work time time exclude fixedterm employee intern coop employee employee safety global employee datum include population recently acquire company individual longterm disability exclude contingent worker contractor subcontractor exclude abiome headcount exclude global lose workday case rate employee datum employee deirelate disclosure fixedterm employee employee contract limited period end specific time period expire lose workday workrelate injury case rate report report specific task event attach time estimate complete exclude employee deirelate disclosure fixedterm contract total employee plus individual fixedterm contract lose workday workrelate illness case rate report report value round near tenth round number present add precisely total provide percentage precisely reflect absolute figure total recordable injury rate professional position define pay grade management position define pay grade executive define employee report directly ceo recordable injury rate report report figure april figure december figure december october new category add allow employee actively decline selfidentification remain unidentified recordable illness rate report report value decline answer round zero exclude report table gender ethnicracial diversity report accordance gender ethnicity race selfreporte employee injury illness case rate record human resource information system hris december define employee selfreporte american indian alaskan native native hawaiian pacific islander race serioussevere workrelate injury case rate report report career progression movement include upward promotion lateral transfer exclude employee organization category include employee merit plan compensation package serioussevere workrelate illness case rate report report number restate johnson johnson invest significantly internal learn platform identify area efficiency number fatality learn development vendor result decrease external spend overlap spend category johnson johnson return consolidated reporting approach learn development employee safety region average hour enterprisewide training datum represent available datum johnson johnsons primary learning management system work include train datum additional source available future training duration include apply estimate base training type lose workday case rate report injuryillness rate exclude covid case lwdc rate trir siic rate fatality calculate johnson johnson employees contingent worker contingent asia pacific worker worker supply thirdparty agency worker employer record intend supplement temporarily replace exist workforce directly supervise johnson johnson employee employees europe middle east africa lose day calendar day count begin day incident take place cpmm ipmm rate base safe fleet datum rate calculation methodology use actual estimate datum mile latin america drive collect safe fleet datum employee drive companyowne lease personally own vehicle company business employee category drive company business regular job duty north america receive car allowance purchase vehicle andor reimburse vehicle expense fuel maintenance insurance miscellaneous charge associate vehicle upkeep total recordable injury rate asia pacific europe middle east africa latin america north america injury illness case rate asia pacific europe middle east africa latin america north america road safety crash million mile cpmm rate injury million mile ipmm rate environmental health health energy use greenhouse gas ghg emission humanity report total energy use scope ghg emission total coe renewable source scope ghg emission source coe nonrenewable source facility energy intensity tjbillion sale fleet percentage change energy intensity compare baseline refrigerant tjbillion aviation percent renewable electricity region scope ghg emission facility coe north america locationbased europe marketbase global scope scope ghg emission total coe purchase energy use type ghg emission intensity scope scope revenue electricity coemillion natural gas percentage decrease ghg emission intensity scope scope diesel revenue compare baseline coe million direct heatingcooling total offset apply reporting year report report propane net scope scope marketbase emission coe reported report environmental health biogas scope ghg emission source coe fuel oil total purchase energy purchase good service upstream transportation distribution onsite generate energy use type business travel cogeneration employee commute wind capital good solar fuel energyrelate activity geothermal upstream lease asset fuel cell waste generate operation biomass available total onsite generate energy downstream transportation distribution onsite cleanrenewable energy capacity type use sell product solar direct cogeneration indirect wind endoflife treatment sell product geothermal biomass fuel cell onsite cleanrenewable energy technology capacity health capital relief fund water use million cont humanity report number project complete annual water withdraw source cont cumulative project complete spend project annual million gray water cumulative spend complete project million surface water total annual energy cost saving result complete project water withdraw category millions freshwater mgl total dissolve solid report report total annual energy saving result complete project water mgl total dissolve solid report report total annual ghg emission avoid result complete water withdraw area high extremely high baseline water stress source project coe municipal report groundwater report air emission source rainwater report report hazardous air pollutant hap gray water report mononitrogen oxides nox surface water report ozonedeplete substance water withdraw area high extremely high water stress category ozonedeplete substance cfc equivalents freshwater mgl total dissolve solid report report particulate matter environmental health water mgl total dissolve solid report report refrigerant total water withdraw area high extremely high sulfur oxide sox report water stress volatile organic compound voc water discharge area high extremely high water stress destination wastewater treatment plant report report water use million surface water report report total water withdraw irrigation report report total water consume report report total water recycle reuse ocean report report total water discharge total water discharge area high extremely high report report water stress percentage water withdraw region high extremely high baseline water stress water discharge destination percentage water consume region high extremely wastewater treatment plant high baseline water stress surface water water withdraw source irrigation municipal ocean groundwater rainwater health operational waste ehs compliance certification humanity report total waste generate number manufacture site certify iso hazardous waste percentage manufacture site certify iso nonhazardous waste number manufacture site certify iso percentage waste divert disposal percentage manufacture site certify iso percentage waste direct disposal number environmental noncompliance waste divert disposal fine pay environmental noncompliance thousand hazardous waste recycle leed building energy recovery number newly leedcertifie johnson johnson reuse building annual nonhazardous waste number johnson johnson building recycle leedcertifie total energy recovery percentage johnson johnson build space leedcertifie total reuse total area office building space total waste divert disposal leedcertifie million square foot waste direct disposal environmental health hazardous waste product end life million landfille number medical device collect incinerate number medical device reprocess biochemical treatment metric assure erm cvs ghg air emission electricity water datum pwcs report independent accountant management assertion pwc report independent accountant previous health humanity report nonhazardous waste include sitespecific data johnson johnson own lease site square feet johnson johnson operational control manufacture site square foot note landfille energy intensity ratio include electricity stationary fuel district heating cool percentage electricity johnson johnson generate renewable source europe include belgium france incinerate germany greece ireland italy netherlands poland spain sweden switzerland united kingdom north america include united states canada biochemical treatment value round near number round number present add precisely total provide percentage precisely reflect absolute figure accordance guidance world resources institute wri corporate accounting reporting standard restate value reflect newly release electricity grid emission factor addition removal acquisition total waste direct disposal divestiture threshold restatement deviate include report section currently use purchase sale transfer offset ghg accounting gas cover calculation include hfcs perfluorinate chemical sulfur hexafluoride nitrogen trifluoride result operation biogenic emission electricity emission factor obtain international energy agencys emission fuel combustion report environmental protection agency epa egrid publication locationbase scope reporting supply contract residual emission factor available marketbase scope reporting fuel emission factor obtain epa climate leadership publication global warming potential obtain intergovernmental panel climate change fifth assessment report choose consolidation approach emission operational control health emission calculate company spend reporting year pair appropriate economic inputoutput emission factor carnegie mellon data set specific primary datum able obtain place humanity report calculation methodology business travel emission personal vehicle travel reflect datum survey sample employee region extrapolate employee globally estimate average employee commute remote working emission intensity employee value calculate emission employee commute year year trend methodology adjustment emission fuel energyrelate activity calculate emission transmission distribution loss purchase electricity welltotank wtt emission purchase electricity wtt emission loss wtt emission purchase fuel emission calculate international energy agency iea loss factor electricity department environment food rural affair defra wtt emission factor fuel electricity emission upstream lease asset calculate apply energy intensity office location scope scope footprint building area lease asset square foot great square foot outside operational control exclude scope scope reporting emission waste generate operation calculate nonhazardous hazardous waste manufacturing operation department environment food rural affair emission factor waste emission downstream transportation distribution calculate epa smartway program provide shipper ghg cover calculation include calendar year upto date available datum available december report future report identify level uncertainty report boundary report value potentially overstate value restate correction calculation methodology emission use sell product endoflife treatment sell product calculate sale volume johnson johnson products combine lifecycle assessment lca model sale volume obtain obtain sale revenue average unit price estimate volume size product portfolio lcas perform johnson johnson product product place lca category representative product lca apply emission processing sell product downstream lease asset franchise investment applicable johnson johnson operations ghgs cover calculation include include sitespecific data johnson johnson manufacturing site result complete project base fuel electricity reduction calculation avoidance energy consumption ghg emission calculate compare energy consumption project implementation expect consumption implementation engineering estimate time project approve internal process municipal water groundwater rainwater surface water source consider freshwater category grey water water source consider water category environmental health certify iso iso mean site receive external certification valid december decrease site iso certification drive decrease overall johnson johnsonowned manufacture site denominator total manufacturing site exclude small manufacturing site define employee newly acquire site own year december environmental noncompliance represent instance noncompliance environmental regulatory requirement law selfreporte authority report year identify authority noncompliance occur report year authority include regional national statecountryprovince localcity regulatory agency environmental noncompliance fine pay exclude newly acquire site own year december fine pay environmental noncompliance include pay reporting year include fine assess andor negotiation pay december number regulatory noncompliance increase root cause analysis perform need corrective action identify total include breeam building research establishment environmental assessment methodology certify site accountability innovation health supply base overview diverse supplier spend million humanity report number johnson johnson suppliers tier supplier spend total johnson johnson supplier spend billion diverseowne supplier spend contract region disabledowne report asia pacific minorityowned report europe middle east africa lgbtowne report latin america veteran disable veteranowne report north america womenowne report supplier spend contract business total small business spend pharmaceutical percentage total supplier spend attributable small supplier medtech percentage total supplier spend attributable diverse supplier consumer health percentage increase tier diverse spend black report hispanicowne corporate diverse supplier spend global million supplier engagement total global impact spend billion report number supplier invite participate cdp supply chain climate program number country outside track diversity accountability innovation percentage participate inclusion indicator tier diverse supplier spend country outside number supplier invite participate cdp supply chain water program global tier supplier spend percentage participate womenowne ecovadis assessment complete minorityowned supplier risk rank base ecovadis assessment lgbtowne report low risk veteran disable veteranowne report medium risk total veteran disable veteranowne report high risk total tier diverse billion report tier diverse health supplier audits cybersecurity datum privacy humanity report supplier environment health safety ehs audits percentage employee complete information report report security training ehs audits technical visit complete ehs audits technical visit region board director composition asia pacific number directors europe middle east africa number independent director latin america percentage independent director north america number supplier identify high risk nonconformance independent lead director yes yes yes johnson johnson responsibility standard supplier independent audit committee yes yes yes number critical ehs finding identify result independent compensation benefit yes yes yes ehs audits independent nominate corporate governance committee yes yes yes safetyrelate finding independent regulatory compliance sustainability committee yes yes yes environmentalrelate finding independent science technology committee yes yes yes supplier social audits number regular special meeting hold supplier social audits complete total board director complete smeta pillar protocol social audits complete region tax contribution billion accountability innovation asia pacific payroll social insurance taxis bear europe middle east africa payroll social insurance taxis collect latin america salesuse taxis bear north america salesuse taxis collect number critical finding identify result supplier social audits corporate income tax total taxis bear animal welfare total taxis collect total tax contribution number facility animal veterinary oversight report report number site animal accredit aaalac international report report percentage site animal accredit code business conduct cbc compliance report report aaalac international percentage senior leader certify compliance percentage research perform rodent fish report report organization cbc nonanimal alternative available number warning letter untitled letter issue opdp aplb health health care compliance hcc training product quality indicator humanity report number relevant johnson johnson employee number regulatory inspection johnson johnson complete hcc training include anticorruption section site worldwide health authority percentage sale marketing employee complete percentage regulatory inspection result hcc training zero observation number fda inspection johnson johnson sites percentage fda inspection result zero inquiry complaint record credo integrity line category observation human resourcesrelate average number observation fda inspection number independent audits johnson johnson sites business integrityrelate ensure compliance johnson johnson quality policy privacy information security general security ehs etc standard general information question number independent audits external manufacturing site financialrelate ensure compliance johnson johnson quality policy standard human rightsrelate report number fda warning letter issue product quality patient safetyrelate product recall rate business segment pharmaceutical compliancerelate allegation investigate medtech triage committee accountability innovation number compliancerelate allegation investigate consumer health selfcare otc percentage compliancerelate allegation investigate category anticounterfeite healthcare compliance number anticounterfeite good practice training deliver financial law enforcement agent custom border protection etc number external trade group alliance organization agency johnson johnson engage leadership position industry work group collective bargaining agreement percentage employee cover collective bargaining agreement health metric assure erm cvs health humanity goal assurance pwcs report independent accountant management assertion pwc report independent accountant humanity report previous health humanity report represents spend control overaddressable spend define product service procurement team negotiate supplier meet business goal value round round number present add precisely total provide percentage precisely reflect absolute figure supplier ecovadis assessment report january capture supplier update assessment january tier diverse spend indicator represent spend johnson johnson control addressable spend define product service procurement team negotiate supplier meet business goal total global impact spend consist tier diverse supplier spend billion country outside plus small business spend overlap spend plus tier diverse supplier spend global million supplier classify tier diverse small business tier diverse small business overlap remove avoid double counting spend supplier designate multiple diverse category count category supplier qualify total tier diverse supplier spend billion count spend supplier technical visit followup visit initial audit define critical finding evidence high risk human life potential catastrophic impact facility community environment expect supplier potential supplier address critical finding immediately social audits conduct sedex member ethical trade audit smeta protocol figure march committee change name tax information contain section intend provide reader overview taxis contribute johnson johnson income taxis read conjunction company tax information file securities exchange commission sec including recently file quarterly report form annual report tax information supplemental substitute information report company sec filing certifier include senior leader level select manage director general manager base country business segment risk profile executive recently acquire company opdp office prescription drug promotion aplb advertising promotional labeling branch fda center biologics evaluation research johnson johnson triage committee case investigator ability change issue type case receipt credo integrity line occur product recall rate define number lot remove market total globally manufacture base field action removal determine internally quality review board align johnson johnson enterprise compliance reasonable probability product cause temporary medically reversible adverse health consequence certain case cause adverse health consequence pharmaceutical medtech recall rate consider product business segment consumer health product quality accountability innovation recall rate inclusive consumer health product selfcare overthecounter otc business segment result sporadic attendance log keep law enforcement training stem potential security concern number training session capture number attendee employee johnson johnson train code business conduct aware product complaint adverse event brand protection awareness include mandatory training raise understand awareness illicit trade issue employee supplemental brand protection training available stakeholder reflect number independent assurance statement health humanity report independent limited assurance statement johnson johnson health humanity goal erm certification verification services inc erm cvs engage johnson johnson inc provide limited assurance relation select information report johnson johnson health humanity report health humanity goal scorecard report healthforhumanityreportjnjcom conclusion engagement summary base activity describe come attention indicate select information detail fairly present report select information disclosure list scope fairly present material respect accordance report criterion report material respect accordance reporting criterion report progress health humanity goal cumulative scope vermox mebendazole dose donate million assurance activity assurance patient reach impact venture jjiv portfolio company fund date consider level assurance assessment risk material misstatement engagement investment number december select information multidisciplinary team sustainability assurance specialist perform issue healthcare professional hcp support jjiv portfolio company date range procedure included restrict follow investment number december assurance engagement extend information respect early period assess appropriateness reporting criterion select information include review information include report healthforhumanityreportjnjcom report principle boundary definition internal guideline health humanity goal report cumulative january december review external medium report relate identify issue report period period january december relevant assurance scope independent assurance statement interview management representative staff understand evaluate relevant reporting health humanity goal define report management system process include internal review control process criterion basis reporting describe applicable footnote report collect report select information perform limited assurance engagement accordance international review corporate level sample qualitative quantitative evidence support standard assurance engagement isae revise assurance engagement select information audits review historical financial information issue international assurance review ghg renewable energy datum confirm consistency finding auditing standard board standard separate ghg renewable energy verification engagement include completeness procedure perform limited assurance engagement vary nature timing level consistency assurance extent reasonable assurance engagement consequently level assurance obtain limited assurance engagement substantially lower review presentation information relevant scope work report assurance obtain reasonable assurance engagement healthforhumanityreportjnjcom ensure consistency finding perform limitation engagement responsible prepare report collection presentation reliability assure information subject inherent uncertainty give nature information design implement maintain internal health humanity goal dependence partner organisation provide performance control relevant preparation presentation select information respective information use estimate assumption extrapolation determine select erm cvs responsibility provide conclusion agree scope base responsibility information important understand assurance conclusion context engagement term assurance activity perform exercise professional judgement accept responsibility deny liability party conclusion reach health independence integrity quality control humanity report erm cvs independent certification verification body accredit ukas iso accordingly maintain comprehensive system quality control include document policy procedure compliance ethical requirement professional standard applicable legal regulatory requirement quality management system demand relevant section isqm isqm erm cvs apply code conduct relate policy ensure employee maintain integrity objectivity professional competence high ethical standard work process design implement ensure work undertake objective impartial free bias conflict interest certify management system cover independence ethical requirement demand relevant section part iesba code relate assurance engagement team undertake assurance engagement extensive experience conduct assurance environmental social ethical health safety information system process provide consultancy relate service johnson johnson inc respect independent assurance statement matter provide separate management report detail nonmaterial finding recommendation beth wyke partner corporate assurance malvern usa june erm certification verification services inc wwwermcvscom postermcvscom health independent limited assurance statement johnson johnson ghg air emission electricity water datum humanity report erm certification verification service incorporate erm cvs engage johnson johnson provide limited assurance relation select information set present jjs health humanity report report healthforhumanityreportjnjcom set engagement summary engagement summary report corporate datum follow select indicator fairly present year end december period report material respect accordance report criterion ghg emissions total absolute scope ghg emission metric tonne coe total absolute scope ghg emission locationbased marketbase wbcsdwri ghg protocol update january scope report calculation method metric tonne coe ghg emission criterion total offset apply report year metric tonne johnson johnsons internal reporting criterion definition net scope scope marketbase ghg emission metric tonne coe absolute scope ghg emission metric tonne coe follow category category purchase good service category capital good perform limited assurance engagement accordance international category fuel energyrelate activity standard assurance engagement isae revise assurance engagement assurance category upstream transportation distribution audits review historical financial information procedure perform standard scope category waste generate operation limited assurance engagement vary nature time extent level assurance category business travel reasonable assurance engagement consequently level assurance obtain assurance engagement category employee commute limited assurance engagement substantially low assurance independent assurance statement category upstream lease asset obtain reasonable assurance engagement perform energy electricity use generate renewable energy source electricity use generate renewable energy source north america electricity use generate renewable energy source global water responsible prepare report collection presentation total water withdraw million information design implement maintain internal total water consume million control relevant preparation presentation report total water recycle reuse million respective erm cvs responsibility provide conclusion agree scope base total water discharge million responsibility engagement term assurance activity perform exercise percentage water withdraw region high extremely high baseline professional judgement accept responsibility deny liability party water stress conclusion reach percentage water consume region high extremely high baseline water stress health conclusion percentage water withdraw region limitation engagement high extremely high baseline water stress humanity report base activity describe come reliability assure information subject inherent attention indicate data information percentage water consume region uncertainty give available method determine disclosure list scope fairly present high extremely high baseline water stress calculate estimate underlie information important report material respect accordance understand assurance conclusion context assurance activity report criterion independence integrity quality control consider level assurance assessment risk scope ghg emission coe material misstatement report multidisciplinary team erm cvs independent certification verification body scope ghg locationbase coe sustainability assurance specialist perform range accredit ukas iso accordingly maintain emission procedure included restrict follow comprehensive system quality control include document scope ghg marketbase coe policy procedure compliance ethical assess appropriateness reporting criterion emission requirement professional standard applicable legal select information regulatory requirement quality management system total offset apply coe virtual interview relevant corporate staff understand demand relevant section isqm report year internal reporting guidance process include use isqm net scope scope marketbase coe internal ghg protocol internal spreadsheet emission internal datum management reporting system erm cvs apply code conduct relate policy ensure metric scope employee maintain integrity objectivity professional scope ghg emission competence high ethical standard work follow category review report boundary compare jjs internal process design implement ensure work reporting criterion purchase good service undertake objective impartial free bias conflict capital good coe analytical review yearend datum submit interest certify management system cover independence location include consolidated group datum ethical requirement demand fuel energy relate activity select disclosure include test completeness relevant section part iesba code relate independent assurance statement upstream transportation mathematical accuracy conversion calculation assurance engagement distribution consolidation line state reporting boundary team undertake assurance engagement waste generate operation coe review estimate extrapolation assumption extensive experience conduct assurance environmental relation datum relevant ghg scope business travel coe social ethical health safety information system emission category employee commute coe process provide consultancy relate service inperson site visit site lititz pomezia italy respect upstream lease asset coe schaffhausen switzerland springhouse virtual visit site athens norderstedt germany ringaskiddy percentage renewable electricity ireland xian china review local reporting process region consistency report annual datum select underlie percentage renewable electricity source datum indicator interview relevant staff beth wyke region north america review site datum capture reporting method check partner corporate assurance calculation assess local internal quality assurance percentage renewable electricity malvern usa process region global june total water withdraw million confirm conversion emission factor assumption erm certification verification services inc total water consume million reviewing presentation information relevant scope wwwermcvscom postermcvscom work report ensure consistency finding total water recycle reuse million total water discharge million health humanity report report independent accountant board directors johnson johnson preparation sustainability metric require management establish criterion determination relevancy information include assumption affect review accompany management assertion johnson johnson sustainability report information selection management different acceptable measurement technique metric year end december management assertion present result materially different amount metric report accordance assessment criterion set forth management assertion johnson johnsons management responsible assertion selection criterion management base review aware material modification johnson believe provide objective basis measure report sustainability metric johnson management assertion order fairly state responsibility express conclusion management assertion base review review conduct accordance attestation standard establish american institute certify public accountant aicpa atc section concept common attestation engagement atc section review engagement standard require plan perform review obtain limited assurance material modification florham park new jersey managements assertion order fairly state procedure perform review vary june nature time substantially extent examination objective obtain reasonable assurance management assertion fairly state material respect order express opinion accordingly express opinion limited nature engagement level assurance obtain review substantially low independent assurance statement assurance obtain examination perform believe review evidence obtain sufficient appropriate provide reasonable basis conclusion require independent meet ethical responsibility accordance relevant ethical requirement relate engagement firm apply statement quality control standard establish aicpa accordingly maintain comprehensive system quality control procedure perform base professional judgment perform review perform inquiry perform test mathematical accuracy computation sample basis read relevant policy understand term relate relevant information sustainability metric review support documentation regard completeness accuracy datum sustainability metric sample basis perform analytical procedure health johnson johnson management assertion humanity report year end december johnson johnson management assertion year end december management johnson johnson responsible completeness accuracy validity sustainability diversity equity inclusion dei continue metric include table year end december reporting year global operation note metric round near number metric description metric value indicate gender representationabci management assert metric report table include health humanity report identify symbol present accordance assessment criterion set forth regiondj asia pacific management responsible selection criterion management believe provide objective woman basis measure report sustainability metric preparation sustainability metric require man management establish criterion determination relevancy information include decline answer assumption affect report information selection management different acceptable europe middle east africa measurement technique resulted materially different amount metric report woman givinga man decline answer metric description metric value millions latin america woman total productsb cash contribute man productsb contribute decline answer north america cash contribute woman man contribution include product cash donation qualified nonprofit entity organization ngo decline answer source equivalency determination organization outside johnson johnson reporting year administrative cost incur johnson johnson contribution process include cash contribution approximately cash employment type fulltime employee contribute woman product contribute measure fair market value price product determine internal price list usd december johnson johnson sell consumer market man independent assurance statement decline answer diversity equity inclusion dei parttime employee woman metric description metric value man global employeesac decline answer fixedterm employee total number employeesb woman woman man man decline answer decline answer job categorydgj vice president regiond asia pacific women europe middle east africa men latin america decline answer north america director manager woman man decline answer professional woman man decline answer management executive positionsg woman management position woman executive position diversity equity inclusion dei continue metric description metric value gender representationabci regiondj asia pacific woman man decline answer europe middle east africa woman man decline answer latin america woman man decline answer north america woman man decline answer employment type fulltime employee woman man decline answer parttime employee woman man decline answer fixedterm employee woman man decline answer job categorydgj vice president woman man decline answer director manager woman man decline answer professional health diversity equity inclusion dei continue woman diversity equity inclusion dei continue diversity equity inclusion dei continued humanity report man metric description dmeectrliince vda tolu aen swer mmeettrriicc ddeessccrriippttiioonn mmeettrriicc vvaalluuee mgeanndaegre rmeepnrte asnedn teaxtieocnuativbec pio sitionsg woman management position egtehnndicerr raceiparle dsievnetrastiitoynba inb tchei job categoryacdg diversity equity inclusion dei continue regiondj asia pacific regiondj asia pacific woman executive position professional white woman woman metric description metric value asian man man diversity board composition decline answer ina edfr hispaniclatino diversity board compositionf weuormopeen middle east africa europe middle east africa ewthonmicenr acial iversity woman decline answer man man global age diversity cle inr new employee hiresh decline answer latin america latin america total number new hire wom women dmeecnl ine answer regiondij amseian pacific age diversitye job categoryacdg decline answer eduercolipnee toid adnle weears frica north america lnaotrinth ammeerricicaa vice president uwnodmeer nwoormthe anm erica man man dec lined answer decline answer demirepclotoyrm eanntd ympaen ager ufunldletirm emplo yee eman loe mre ationbi fuo llm tie yee wome man nswer decline answer decline answer professional agee parttime employee parttime employee woman woman man man ethnicracial diversity decline answer decline answer independent assurance statement ethnicracial diversity usj wfixheitde term ployee global employee global employee headcount december johnson johf hte solo ury in mation system awsoiamne hris employee define individual work fulltime parttime exclude fixedterm ewmpolomyeeen interns coop employee fix bmleanck africa american term employee define employee contract limited period end spemcieficn ime peri expire specific task event attach time estimate complete fixedterm contract total employee plus individual hdiescplainneicd ltoa tainnos wer fixedterm contract employee datum include datum recently acquire company dwheoc alirnee ndot tyoe renfslewcteedr hris exceed year date acquisition individual longterm disability exclude contingent worker worker supply job categorydgj ovitchee resid ent jobby thaitredgpoarrtyy adgegnjc ies worker employer record contractor subcontractor arve iacleso erxeclsuiddeedn atsbio med headcount dweocmlineend ans wer exclude global employee datum employee deirelate disclosure woman gender ethnicracial diversity report accordance gender ethnicity race selfreporte employee record ethnicracial diversityb job categoryacdg men hris november define employee selfreporte american indmiane onr alaskan native native hawaiian decline answer pacific islander race decline answer vice president wdihreitcet or manager individual work fulltime define employee work hour week indidvidirueacl twoorrsk inagn pda rmttaimnea igs edersfin employee work hour week awsoiamne women bmleanck africa american region job category obtain hris december man hdiescplainneicd ltoa tainnos wer age diversity report accordance age selfreporte employee record inis das wat ire gender ethnicracial diversity board composition report accordance gender ethnicity confirm board oprtohfeers siona members april professional dweocmlineend an wer professional position define paygrade management position define paygwradoem executive define employee report directly chairman chief executive officer base organization chart include name position director managersj wmehnit december man adseicalnin nswer new employee hire external hire start date january december eclin eobdt atione nfrsowm ehrr management executive positionsg bwlaocmkeanf rinic amna anamgeermicaenn posit ion gre mthe clin tir nis nde zero zero prior year wxc olu mde inm mthe nre gor ete eta tle osition value round near tenth round number present add precisely hispan iclatino owtohmere xecutive position woman executive position decline answer health employee retention turnover employee safety continue humanity report siic rate calculate follow datum calculation obtain internal johnson johnson curve system number metric description metric value siic work hourstotal work hour manager move function country business segment ethic compliance inquiry complaint record credo integrity line category line abc overall voluntary turnover metric description metric value inquiry complaint record credo integrity line human resourcesrelate voluntary turnover high performer categoryab business integrityrelate privacy information security represent percentage employee manager job category define paygrade hris december general security ehs etc career progression move upward promotion lateral transfer reporting year employee count exclude fixedterm intern coop employee employee longterm disability employee recently acquire general information question company reflect hris exceed year date acquisition employee research development organization pharmaceutical medtech consumer health business segment employee movement track monthly hris consolidated year end employee move example function financialrelated country month count human rightsrelate employee count exclude fixedterm intern coop employee employee longterm disability employee recently acquire company reflect hris exceed year date acquisition voluntary turnover numerator product quality patient safety exclude employee leave company retirement death relate high performer define individual consecutive annual performance rating exceptionalexceptional exceptionalstrong strongexceptional note exceptional strong possible dimension rating employee performance management process exclude voluntary turnover high performer metric possible dimension rating johnson johnsons anonymous grievance mechanism include inquiry complaint category person report select employee performance management process exclude voluntary turnover high performer metric reporting inquiry complaint field report summarize seven report category johnson johnson consist follow category privacy information security global security environment health safety ehs legalregulatory report follow employee safetyab johnson johnsons triage committee case investigator ability change category inquiry complaint receipt set establish criterion credo integrity line occur total record inquiry complaint metric description metric value lose workday case ratecd global compliancerelate allegation investigate triage committeea asia pacific metric description metric value europe middle east africa number compliancerelate allegation investigate latin america independent assurance statement north america percentage compliancerelate allegation investigate category healthcare complianceb financialc total recordable injury ratee global otherd asia pacific europe middle east africa latin america compliancerelate allegation file internal external party allegation meet internal escalation criterion log categorize johnson johnson management johnson johnsons sensitive issue case management system north america present investigate johnson johnson triage committee internal escalation criterion include actual alleged non compliance internal johnson johnson policy result termination employee expense violation exceed injury illness case ratef global iii theft fraud misuse fund exceed noncompliance law regulation anticorruption law human asia pacific trafficking rule governmental noncompliance failure abide relevant term government invoice contract pricing program financial conflict interest false incomplete statement government data breach privacy incident europe middle east africa vii misconduct member senior leadership team latin america healthcare compliance allegation consist violation health care compliance guideline include foreign corrupt practice act fcpa violation north america financial allegation consist asset misappropriation conflict interest financial statementrelate allegation consist legal quality antitrust product registration privacy number fatality global include datum december hour work reporting year recently acquire site own year ehs compliance certification december exclude employee safety metric lose workday case lwdc rate total recordable injury rate trir injury illness case siic rate fatality calculate metric description metric value johnson johnson employees contingent worker contingent worker worker supply thirdparty agency worker employer record intend supplement temporarily replace exist workforce directly supervise johnson johnson number environmental noncompliancesab employee case contractorsubcontractor contingent worker exclude report illnessinjury rate exclude covid illness case fine pay environmental noncompliancesabc thousand lose day calendar day employee unable work illness injury begin day incident take place day leave exclude holiday vacation number manufacture site certify iso lwdc rate calculate follow datum calculation obtain internal johnson johnson curve system number lwdc work hourstotal work hour number manufacture site certify iso trir calculate follow datum calculation obtain internal johnson johnson curve system number recordable case work hourstotal work hour health ehs compliance certification continue credo survey result humanity report metric description metric value metric description metric value percentage manufacture site certify iso number language credo survey available percentage manufacture site certify iso number country credo survey administer response rate active employeesb environmental noncompliance represent instance noncompliance environmental regulatory requirement law selfreporte authority report year identify authority noncompliance occur report year favorability ratebc authority include regional national statecountryprovince localcity regulatory agency environmental noncompliance fine pay exclude newly acquire site own year december percentage agree statement ensure responsibility fine pay environmental noncompliance include pay reporting year include fine assess andor patient doctor nurse mother father negotiation pay december certify iso iso mean site receive external certification valid december use product servicesb denominator total manufacturing research development site exclude small manufacturing site define percentage agree statement provide inclusive work employee newly acquire site own year december environment employee consider individualbc product quality indicator percentage agree statement act responsibly community live work world community wellbc metric description metric value number regulatory inspectionsa johnson johnson sites johnson johnson conduct credo survey biannually track employee sentiment globally credo survey metric datum collect worldwide health authoritiesb tiv med eth lua drt ola nfo johnson employee december complete credo survey exclude percentage regulatory inspectionsa result zero nin hso employee employee longterm disability contractor employee johnson johnson observationsb favorability rate calculate determine percentage agree strongly agree response response credo survey question response type include strongly disagree disagree agree disagree agree strongly agree know question number fda inspection johnson johnson sitesc response remove numerator denominator percentage fda inspection result zero observationsc average number observation fda inspectionc tax contribution billion number independent audits johnson johnson site ensure metric description taxis bear metric value taxis collect metric value compliance johnson johnson quality policy standardsd independent assurance statement corporate income taxb number independent audits external manufacturing sitese ensure compliance johnson johnson quality policy payroll social insurance taxescd standardsd salesuse taxesce number fda warning letter issue product recall ratef business segmentg pharmaceutical total medtech consumer health selfcare otc total tax contributionf regulatory inspection define inspection conduct health authority determine compliance applicable law regulation taxis bear direct cost johnson johnson taxis collect direct cost johnson johnson represent taxis health authority organization authority development manufacture distribution place market post market collect customer employee behalf government ultimately remit government surveillance product example food drug administration fda korean food drug administration kfda british corporate income tax represent income withholding taxis pay market johnson johnson operate standard institution bsi health canada observation identify inspection list form provide thirdparty payroll social insurance taxis salesuse taxis base datum collect major market represent approximately health authority conduct inspection total party intercompany sale record market taxis report remaining market represent fda inspection define regulatory inspection perform fda observation define observed condition approximately total party intercompany sale record market practice indicate fdaregulated product violation fda requirement observation list fda form payroll social insurance taxis bear represent taxis pay directly johnson johnson payroll social insurance taxis collect represent inspection conduct fda provide manufacturer follow fda inspection amount withhold employee federal local country government state social contribution taxis contingent labor taxis independent audits conduct internal johnson johnson regulatory compliance auditor johnson johnson sites external collect manufacturing site salesuse taxis bear represent salesuse tax property tax nonrecoverable valueadde tax taxis comprise external manufacturing site define own operate johnson johnson customs duty pharmaceutical fee impose government legal entity pharmaceutical industry product recall rate define number lot remove market percentage total lot globally manufacture base field prescription drug salesuse taxis collect represent net valueadde tax vat vat output vat input sale tax action removal determine internally quality review board align johnson johnson enterprise compliance collect reasonable probability product cause temporary medically reversible adverse health consequence certain total tax contribution component total taxis bear johnson johnson total taxis collect case cause adverse health consequence lot define specific quantity material uniform character quality release market calendar year pharmaceutical medtech recall rate consider product business segment consumer health product quality recall rate inclusive consumer health product selfcare overthecounter otc business segment glossary health humanity report acronym definition acronym definition global nonprofit promote humane treatment animal science jjdc johnson johnson innovationjjdc inc aaalac association assessment accreditation laboratory animal care international medtech johnson johnson medtech aapi asian american pacific islander jlabs johnson johnson innovationjlabs afib atrial fibrillation lai longacte injectable artificial intelligence lgbtqia lesbian gay bisexual transgender queer question intersex asexual amr antimicrobial resistance lmic low middleincome country apac asia pacific mdrtb multidrugresistant tuberculosis api active pharmaceutical ingredient machine learn arv antiretroviral norge bank investment management nbim basel institute governance measure bipoc black indigenous people color nbim effectiveness anticorruption programme report framework add disclosure car cart chimeric antigen receptor chimeric antigen receptor tcell set indicator cdc center disease control prevention ngo nongovernmental organization cdp global nonprofit environmental impact disclosure carbon disclosure project nih national institutes health dei diversity equity inclusion nist national institute standard technology drtb drugresistant tuberculosis ntds neglect tropical disease ema european medicine agency otc overthecounter emea europe middle east africa orthe race health equity glossary erg employee resource group ppa power purchase agreement erp enterprise resource plan ppe personal protective equipment esg environmental social governance pta priority topic assessment expec extraintestinal pathogenic escherichia coli rls resourcelimite setting fda food drug administration rna ribonucleic acid gci global community impact rwd realworld data ghg greenhouse gas gas sdg sustainable development goal united nations gph global public health sec securities exchange commission hcp healthcare professional ssp supplier sustainability program hiv human immunodeficiency virus stemd science technology engineering mathematic manufacturing design hvac heating ventilation air conditioning tuberculosis intelligent automation ungps united nations guide principle business human right intellectual property world health organization health humanity report contact johnson johnson enterprise esg program office wwcorporategovernanceitsjnjcom johnson johnson plaza new brunswick new jersey healthforhumanityreportjnjcom